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Introduction: 
 
1. Historical background. 
As early as the 17th century it was recognized that one component in air is essential for life. 
This extremely simple molecule later known as dioxygen or commonly oxygen was 
discovered by Joseph Priestley and Carl Wilhelm in 1771-72 by thermal decomposition of 
mercury oxide and potassium nitrate respectively. During the next three years Lavoisier 
worked on the characterization of the new element composing dioxygen. In 1775 he named 
it oxygen due to its presence in numerous acids (oxy = acid, gen = generate). Lavoisier 
also established the role of dioxygen in the respiratory process. The fundamental equation 
dioxygen=life was formulated for aerobic systems. 
Nearly two centuries later, in 1929, the electronic structure of dioxygen was solved by 
Linus Pauling using the theory of molecular orbitals. Pauling could explain the 
paramagnetism of dioxygen (cM=0.994 T-1) as well as the interatomic distance (d=1.207) 
and the dissociation energy (Ediss=117.36 kcal mol
-1) which were until then poorly 
understood by chemists. This state is defined as the triplet state and depicted in term of 
molecular orbital in figure 1. 
O O O O
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Figure 1: Molecular orbital diagram of triplet dioxygen. 
The pioneering theory of Pauling could also predict the two metastable states of dioxygen 
where the molecule becomes diamagnetic. Both states are known as D and S singlet states 
(figure 2) and differ from the orbitals filling: the 1Sy+ state  has the two electrons paired in 
the p*2py orbital whereas the 1Dy has still on electron in each p* orbital but with reversed 
spin. The latter state has a life time of 45 Min. and an O-O bond distance of 1.223. 
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Figure 2: The singlet states D and S of dioxygen. 
These singlet states are important for the reactivity of dioxygen in particular in the 
generation of ozone and radical species. These radicals are responsible for the formation of 
hydrogen peroxide, a highly oxidizing substance discovered by Thenard in 1818. 
Accumulation of hydrogen peroxide in the cell is extremely dangerous as it destroys the 
protein structure. The relationship between oxygen, hydrogen peroxide and the respiratory 
processes has been more deeply understood during the 20th century. For example, 
myoglobin which binds oxygen was the first protein of which the structure was solved by 
X-Ray diffraction in 1960 [1]. This is showing the interests and efforts developed to 
establish how dioxygen is used by aerobic organisms. 
 
2. Biological relevance of dioxygen and derivatives. 
In the second part of the 20th century the progress of medicine and biology has provided a 
better understanding of the importance of dioxygen and led to the discovery of numerous 
enzymes which are related to dioxygen. 
Although dioxygen is the basic source of energy for aerobic systems, its consumption 
produces radicals such as superoxide ion (O2
-) in cells. This highly reactive radical is very 
toxic and implied in numerous pathologies. Fortunately a “dioxygen cycle” (figure 3) 
exists by which oxygen [3O2] can be activated or recycled such that toxicity problems are 
prevented. 
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Figure 3: Oxygen and hydrogen peroxide interdependency. 
The close dependency of hydrogen peroxide (H2O2) and dioxygen reflects the complexity 
of the nature despite the use of very simple molecule for ensuring life. Moreover, hydrogen 
peroxide which is known as a cell killer due to its high oxidizing power is required as a 
substrate for many enzymes. A real paradox exists: hydrogen peroxide and the superoxide 
ion have to be present in living organisms but their concentration has to be controlled 
accurately so that they are only short living in cells. 
 
3. The enzymes in the “dioxygen cycle”. 
It was recognized early that metal containing species, in particular iron complexes, were 
involved in these processes. Rapidly the idea was accepted that a relatively simple unit is 
responsible for the transport and activation of dioxygen. Küster postulated a tetrapyrrolic 
structure [2] termed porphyrin. Its synthesis by Hans Fischer [3] established that its iron 
complex known as heme was able to bind dioxygen. Such heme units were shown to be 
essential for activating oxygen for oxidation reactions. 
There are now seven hemes known which differ from each other by the nature of the 
substituents on the b-pyrrole positions. The most common heme is heme b or hematin 
(figure 4): 
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Figure 4: Heme b. 
Several hundreds of heme b proteins are nowadays known which have different functions 
such as electron transfer, oxygen or nitric oxide transport or oxidation as shown in table 1. 
As all these proteins share exactly the same metal complex, it has been pointed out that the 
protein environment around heme b plays a decisive role in determining the function of the 
protein: 
1) The amino acid residues maintain the heme unit bound to the protein 
2) One amino acid residue coordinates axially to the iron in all heme proteins. 
The nature of this axial coordination is thought to be the most important factor which 
determines the enzyme’s activity. Therefore heme proteins are often classified according to 
the nature of the axial ligand (table 1). Finally the hydrophobic or polar character of the 
amino acid residues on the side opposite to the axial ligand (= distal side) tunes the 
specificity for a particular substrates and aids the formation of catalytic intermediates. 
Axial Ligand Protein Class Function 
Cytochrome b e- transport 
Nitrophorin NO transport 
Hemoglobin, myoglobin O2 transport 
(His)N 
Peroxidases Oxidation by H2O2 
(Tyr)O- Catalases Dismutation of H2O2 
Chloroperoxidase (CPO) 
Oxidative Halogenation by 
H2O2 ,Cl
- and H+ 
P-450 Oxidation by O2 (Cys)S
- 
Nitric Oxide Synthases 
(NOS) 
NO synthesis by oxidation of 
Arg with O2 
Table 1: Heme b proteins classified by axial ligation. 
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The best known heme proteins are the globins, hemoglobin and myoglobin which are 
essential blood constituents. Peroxidases have also been the centre of intense studies as 
they were using hydrogen peroxide for oxidation in living organisms and have the same 
axial ligand, the nitrogen from histidine, as the globins. Less attention has been paid to 
Catalases which have a tyrosinate axial, similar to peroxidases. Finally heme-thiolate 
proteins are subject of special attention due to the unusual presence of a thiolate 
coordinating to the iron. 
  
  
 
PREVIOUS KNOWLEDGES 
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I. Heme-thiolate proteins. 
 
I.1. Classification and general features. 
Heme-thiolate proteins have raised the interest of chemists and biologists for more than 30 
years. The presence of an axial thiolate ligand for heme was unexpected with enzymes 
using molecular oxygen or even hydrogen peroxide as reagent. Namely thiolate 
functionality has always been claimed to be highly sensitive to oxidation in the presence of 
oxygen or peroxides. 
Heme-thiolate proteins are divided into three classes so far: the cytochromes P450 (P450s), 
chloroperoxidases (CPO) and nitric oxide synthases (NOSs). P450s display a very large 
repertoire of oxidation reactions of unactivated X-H bonds such as the stereospecific 
hydroxylation of camphor 1 or the N-hydroxylation of amines (figure 5). They also 
catalyse demethylation, dehydration, reduction, aromatisation or isomerisation reactions 
[4]. CPO catalyses the oxidative halogenation of (1,3) cyclopentadione 3 into 
caldariomycin 5, a dichlorinated natural product [5]. NOSs are responsible for the 
mammalian production of nitric oxide (•NO) which is a radical gas (figure 5). This radical, 
long disclaimed as a major air pollutant, is indeed a very important neuromediator at 
controlled concentrations. An overproduction of •NO results in pathologies such as toxic 
shock. A too low •NO concentration in turn is responsible for neurologic diseases such as 
Alzheimer for example [6]. 
P450s and NOSs in contrast to CPO use molecular oxygen and require an external source 
of electron to effect catalysis (figure 5). The electrons are delivered by either an external 
protein system or by two cofactors being tightly bound to the enzymes (figure 6). 
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Figure 5: Reactions catalysed by a) P450cam, b) CPO and c) NOSs. 
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Figure 6: Electron transport systems for heme-thiolate proteins. 
Abbreviations: BH4: tetrahydrobiopterin; e
- : electron; FAD: Flavine adenine dinucleotide; FMN: Flavine 
adenine mononucleotide; NAD(P)H: Nicotineamide adenine dinucleotide (phosphate). 
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Heme-thiolate proteins are not only different by their electron delivery system but also by 
their general structure (table 2). If P450s and CPO are monomeric proteins [7, 8] NOSs are 
dimeric proteins [9] where each subunit contains an oxygenase and reductase domain. 
The binding of heme differs from one enzyme subfamily to the other. P450s and NOSs 
heme are bound to the apoprotein via hydrogen bonds to arginine or histidine residues. For 
CPO the binding is ensured by hydrogen bonds to polar amino acid residues of the 
apoprotein and by an aqua manganese complex. The manganese atom is in turn bound to 
the apoprotein via the participation of amino acid residues [10]. 
Protein 
family 
NAD(P)H 
required 
Cofactors or redox proteins 
associated 
Overall structure 
P450s yes 
Flavoprotein + iron sulphur 
protein or FAD-FMN reductase 
monomer 
NOSs yes 
FAD, FMN, BH4,  
Calcium-calmodulin 
dimer 
CPO no none monomer 
Table 2: Main characteristics of heme-thiolate proteins. 
 
I.2. Crystal structures. 
The progress of X-ray crystallography and molecular biology have permitted to obtain total 
or partial crystal structures for P450s, CPO and NOSs providing milestones to the 
understanding of their respective catalytic activities. The first X-ray structure of P450cam, a 
heme-thiolate protein, has been solved by Poulos et al. in 1985 [11]. Since then the 
structure of five other P450s [12-15], of CPO [10] and of the oxygenase domain of one 
NOSs [16] have been elucidated. 
 
I.2.1. P450cam and P450s structures [17]. 
Although the identity of the amino acids sequence for P450s is less than 10% the overall 
folding of the proteins is quite similar. The proteins exhibit a two domain structure 
composed of a b-sheet-containing domain and an a-helix-rich domain. The dominant 
element is helix I that traverses the entire protein and participate with three other helices in 
defining the heme binding region and the substrate oxidation pocket. Two important amino 
acid sequences are highly conserved in P450s and are essential for heme and O2 binding. 
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First, the central part of helix I which forms an O2 binding pocket in P450cam (figure7) is 
highly conserved. It creates a localized distortion and widening of Helix I in P450cam which 
has the sequence: 
Gly/Ala-Gly-Xaa-Asp/Glu-Thr  
(Xaa = variable amino acid). 
The conserved threonine residue stabilizes the Fe(II)-O2 adduct [18] and has been proposed 
to facilitate the heterolytic cleavage of the O-O bond after its one electron reduction (see 
I.3.1). At the three positions preceding that sequence hydrophobic amino acid residues are 
always found. Otherwise helix I is rich in polar amino acid residues in the vinicity of the 
heme on the distal side. These polar amino acid residues have been proposed to create an 
electric field which could be important in tuning the electron repartition (spin state tuning) 
in the iron d orbitals. The determination of the spin state is an important factor controlling 
the redox potential and thereby the ability of the protein to accept electron from NAD(P)H. 
Further these polar residues could stabilize the catalytic intermediates via H-bonds 
formation. One of them, a tyrosine residue, permits the binding of the substrate camphor 1 
to the protein via a single hydrogen bond in P450cam. 1 is thereby positioned in the vinicity 
of the heme above the pyrrole rings bearing the propionate side chains. This places the 
position 5 of 1 which is hydroxylated within bonding distance to the oxygen of the iron-
oxo species formed during catalysis (figure 5). 
Second, the axial cysteinate which coordinates to the iron of the heme belongs to a heme 
binding decapeptide sequence which contains five highly conserved amino acid residues. 
This sequence is:  
Phe-Gly/Ser-Xaa-Gly-Xaa-His/Arg-Xaa-Cys-Xhy-Gly  
(Xaa represents a variable amino acid and Xhy an hydrophobic residue). 
This decapeptide sequence forms a loop where the cysteine proximal ligand is found at the 
N terminal end. The first amino acid of this loop is a phenylalanine whose phenyl group 
seems to protect the cysteinate ligand from oxidation. The second amino acid residue is 
either a glycine or a serine which probably also protects the cysteinate. The fourth amino 
acid is always a glycine which initiates the hairpin turn of the loop. The sixth amino acid 
which is a positively charged arginine or histidine is involved in an ionic or hydrogen bond 
with the heme carboxylates of the propionate side-chains. Finally the tenth amino acid 
residue is always a glycine which is in close contact to the heme. 
Moreover the amide NH bonds of the fifth and sixth amino acid residues have also been 
postulated – in analogy to CPO from Caldariomyces fumago (see I.2.2)- to form hydrogen 
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bonds to the cysteinate [19]. The hydrogen bonds could ensure the permanent 
deprotonation of the sulphur and are an important feature of heme-thiolate proteins. 
 
Figure 7: P450cam active site. 
 
I.2.2. CPO crystal structure. 
CPO share no markant amino acid sequence similarity with P450s. The crystal structure of 
CPO which has been solved recently [10] has provided a better comparison with P450s. 
CPO has been found to be 50% helical as P450s but the tertiary structure is completely 
different. Indeed CPO appears as a novel tertiary structure being a hybrid between P450s 
and peroxidases. 
CPO comprises eight a helices, three short 310 helices and a short antiparalell b sheet pair. 
Like P450s the heme environment comprises a proximal and a distal helix that provide the 
axial ligand and residues essential for the catalysis. 
On the distal side three polar amino acid residues have been found to be essential for 
catalysis [20]. These are His105, Asp106, and Glu183. The presence of polar amino acids 
residues is not found in P450s in the proximity of the heme. However the presence of a 
distal histidine in the vinicity of heme is a pattern found in both peroxidases and catalases 
[21, 22]. In these enzymes the role of the histidine is: 
1. to deprotonate the hydrogen peroxide which binds to the iron, 
2. to assist the heterolytic cleavage of the O-O bound of the iron peroxide 
complex to yield the so-called compound I and water. 
On the proximal side the thiolate ligand is found in a sequence of polar amino acid 
residues. The comparison with the decapeptide sequence of P450s reveals no amino acid 
identity. The sequence is the following: 
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Pro-Thr-Asp-Ser-Arg-Ala-Pro-Cys-Pro-Ala. 
Nevertheless the amino acid sequence provides a rigid scaffolding for the iron-sulphur 
interaction. The presence of two proline residues before and after the axial cysteine results 
in a very similar geometry pattern as found for the Xaa-Cys-Xhy sequence of P450s. Two 
clear hydrogen bonds are stabilizing the cysteine ligand. They originate from the amide 
NH from the Pro-Cys bound and from the Pro-Ala bound (figure 8). 
 
Figure 8: CPO active site. 
 
I.2.3. NOSs crystal structure. 
Contrary to CPO and P450s enzymes NOSs are the only heme-thiolate proteins which have 
a dimeric structure. Each monomeric unit is divided into an oxygenase and a reductase 
domain. NOSs are distinctive from any other heme-proteins as they require five cofactors 
to work. The dimers are hold together by the presence tetrahydrobiopterin (BH4) which 
role is probably further to serve as an electron reservoir during catalysis. The presence of 
calcium/calmodulin (CaM) units also maintain the dimeric structure as shown in figure 9. 
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Figure 9: Schematic representation of NOSs dimeric structure 
(Abbreviations according to figure 6). 
The oxygenase domain is located in the N-terminal part whereas the reductase domain is 
found in the C-terminal part of the amino acid sequence. BH4 binds in the oxygenase 
domain very close to the heme. The primary structure (oxygenase + reductase domain) is 
indeed very similar to the sequence of P450 BM3. Nevertheless the cloning of the 
oxygenase domain of NOSs has shown that no significant amino acid sequence homology 
to P450s exists. 
Recently the crystal structure of iNOS from murine macrophage has been solved by Tainer 
et al. [16]. The structure of the protein is unique. Contrary to P450s and CPO the heme 
binding domain is composed of b sheet and b wings. 
The sequence which contains the distal cysteinate residue in NOSs is a highly conserved 
nonapeptide sequence:  
Trp-Arg-Asn-Ala-Pro/Ser-Arg-Cys-Ile/Val-Gly. 
If one makes abstraction of the missing amino acid which would fit in the 7th position, a 
troubling sequence similarity to P450s does appear. 
A molecular modelling attempt of the nonapetide vs. the P450s decapeptide has indicated 
that despite the deletion of one amino acid the conformation of the nonapeptide is very 
similar to the decapeptide one [17]. Therefore by analogy to P450s decapeptide the 
tryptophane is proposed to protect the cysteinate as a tryptophane replaces also 
phenylalanine in two P450s [17]. Further the arginines of the sequence are placed so that 
they probably interact with the heme carboxylates as is the case for histidine (n-2) in 
P450s. The hairpin turn is initiated by an alanine (Ala 4 in the sequence) instead of a 
glycine in NOSs vs. P450s. As in CPO or P450s the cysteinate is stabilized by two 
hydrogen bonds from the peptide nitrogen at position (n+3) from cysteine and from the 
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indole of tryptophane. Finally the sequence is terminated by a glycine and the amino acid 
following cysteine is always an hydrophobic one. 
On the proximal side the amino acid residues are largely hydrophobic but the presence of a 
glutamic acid residue has been found to be essential for catalysis [23]. The role of this 
residue is to place the amino guanidino nitrogen of L-arginine 6 close to the heme iron. A 
tryptophane residue further stabilizes 6 by a second hydrogen bond to the carboxylate 
functionality of 6 and methionine and glycine residues further complete the hydrogen bond 
network which holds the substrate near the heme (figure 10). This high degree of 
stabilization is also an unique feature of NOSs compared to other heme-thiolate proteins. 
The high stabilization of substrate in NOSs may be related to the open distal pocket. In 
P450s the pocket is buried which provides a more rigid environment for the substrate. 
These unique characteristics may permit the better stabilization of the iron peroxo complex 
via hydrogen bonds. The absence of a structured water molecule network in NOSs, and of 
polar amino acid residues may also render the scission of O-O bond more difficult thereby 
favourising the iron peroxo complex as a catalytic intermediate as discussed in I.3.2. 
 
Figure 10: Active site of iNOS. 
 
I.2.4. Summary. 
The heme-thiolate proteins which are closely related to P450s oxygenase show very similar 
catalytic activities despite less than 10% overall sequence similarity. The only common 
point between all these proteins is the active site which contains an heme-thiolate complex. 
Nevertheless a very similar proximal environment for the heme is observed. A stabilization 
of the thiolate ligand is always achieved via a peptide loop and further by two hydrogen 
bonds. This pattern, unique to heme-thiolate proteins could be responsible for their close 
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reaction similarities (table 3). For example CPO is also able to catalyse P450 like reactions 
such as epoxidation and in turn P450s are able to use hydrogen peroxide to effect catalysis. 
P450s Phe- Gly/Ser- Xaa- Gly- Xaa- His/Arg- Xaa- Cys- Xhy- Gly- 
CPO Pro- Thr- Asp- Ser- Arg- Ala- Pro- Cys- Pro- Ala- 
NOSs Trp- Arg- Asn- Ala- Pro/Ser- Arg- … Cys- Ile- Gly- 
Table 3: Comparison of the peptide sequence containing the proximal cysteine ligand. 
 
I.3. Catalytic cycle of heme-thiolate proteins. 
 
I.3.1. P450s oxygenases. 
P450cam is the first non membrane bound P450 enzyme which has been purified and 
therefore the most studied heme-thiolate protein. The importance of P450s in the 
metabolism of xenobiotics has motivated an intense research on the mechanism of these 
enzymes. The catalytic cycle is still not fully characterized but the essential features have 
been agreed now for some time. The essential steps for catalysis involve (figure 11): 
(1) Binding of the substrate which in P450cam results in the displacement of a water 
molecule from the iron of the heme. This binding is also accompanied by a change 
of the spin state from low spin ferric six coordinated to high spin ferric five 
coordinated. This change in the spin state is also responsible for a anodic shift in 
the redox potential from –300 mV to –170 mV. 
(2) A reduction of the iron (III) to its ferrous form as the redox potential is now close 
to the potential of the redox protein. 
(3) Binding of oxygen to give the ferrous P450-dioxygen complex which has been 
recently characterized by X-Ray diffraction [18]. The remaining water molecules in 
the oxygen binding pocket enable together with the distal threonine a stabilization 
of this complex via hydrogen bonds. 
(4) A second electron transfer to give a peroxo iron (III) species 
(5) The protonation and cleavage of the O-O bond with the concomitant formation of a 
water molecule and of the reactive iron-oxo species or compound I. 
(6) The incorporation of the oxygen atom of the iron-oxo complex into the substrate 
molecule. 
(7) The release of the product and rebinding of water to give back the resting state. 
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Whereas the three first steps have been observed and characterized spectroscopically and 
by X-Ray diffraction the last steps of the process occur to rapidly to have been observed 
yet. Therefore the identity of the iron-oxo complex has been postulated based on the 
analogy with the so-called compound I of the peroxidases and model studies. Evidence for 
a compound I analogue has also been provided by the use of the so-called “peroxide-
shunt” pathway (figure 11). Upon addition of peroxide the same intermediate is obtained 
and is catalytically active. The mechanism of oxygen insertion has also been the subject of 
numerous studies which gave raise to several theories. A concerted mechanism was first 
proposed [24] but the stereochemistry of the product obtained was inconsistent with this 
pathway. A radical mechanism has then been proposed [25] but the use of radical clocks 
and the measurement of isotope kinetic effects gave no consistent results which would 
support this mechanism. The concept was refined with the theory of the “low spin high 
spin” surface developed by Shaik et al. [26, 27]. Therefore an ionic intermediate involving 
a carbocation is proposed by Newcomb et al. [28]. Despites all these efforts none of the 
theories fully accounts for the stereochemistry and kinetic data which have been measured. 
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Figure 11: Postulated catalytic cycle of P450s oxygenases. 
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I.3.2 The special case of NOSs. 
Contrary to P450s NOSs are catalysing the five electron reduction of L-arginine to produce 
L-citrulline and NO. The mechanism by which this unusual odd 5e- oxidation occurs is the 
object of intense investigations. Although NOSs are known only since 1985 the efforts 
developed by biochemists have permitted to establish the fundaments of the catalytic cycle. 
First it has been demonstrated that the catalytic cycle proceeds via two distinct phases [29]. 
The first phase is likely to be a classical P450 hydroxylation. A nitrogen of the guanidine 
functionality is hydroxylated to produce L-N-hydroxyarginine 7 (NHA) consuming one 
equivalent of NADPH and one molecule of oxygen. NHA 7 is an intermediate product in 
NOSs catalysis which is detected. The second phase involves the three electron reduction 
of NHA 7 to release L-citrulline 8 and NO. It consumes also one molecule of oxygen but 
only half an equivalent of NADPH. In both steps the oxygen incorporated to the guanidine 
resp. N-hydroxyguanidine functionality arises from molecular oxygen (figure 5). 
Much attention has been paid to the second reaction as it is unprecedeed in heme-thiolate 
protein catalysis. It is now agreed that an iron peroxo complex is the catalytic species for 
this step [17]. The discussion arises on how this peroxo complex can be formed without 
further reacting with a second electron to form compound I. Two hypotheses are being 
intensively investigated and are (figure 12): 
1. The iron peroxo complex is formed as in a classical P450 oxidation and NHA 
binds to this peroxo complex. In this scheme the radicals are so short living that 
they account for the absence of any detected radical during the second part of 
NOSs catalysis.  
2. NHA 7 which redox potential would permit to reduce iron (III) to iron (II) is the 
electron donor. BH4 acts as an electron donor to compound II which is formed 
upon deligation of NHA. 
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Figure 12: Proposed mechanisms for NOSs activity. 
This second hypothesis has gained some experimental evidence very recently as the radical 
of BH4 has been observed during NOSs catalysis [30]. Moreover the work of Groves et al. 
[31] with model and measurement of the redox potential of NHA 7 support this finding. 
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I.3.3. The CPO catalytic cycle. 
Contrary to P450s and NOSs CPO is the only heme-thiolate protein so far which uses 
directly hydrogen peroxide to effect catalysis. Moreover CPO works at the unusually low 
pH of 2.75. As formally CPO catalyses the Cl+ addition to the b-position of an a, g 
diketone much attention has been paid to its mechanism. The studies on CPO itself have 
only established that the first steps in the catalytic cycle are similar to the steps observed in 
peroxidases and catalases. These are (figure 13): 
1. The binding of hydrogen peroxide to form a peroxy-iron (III) complex 
2. The protonation of the terminal oxygen of the peroxy to furnish a water 
molecule and an iron-oxo species. 
After this step the way by which chloride binds to the active site was obscure. It has long 
been believed that free HOCl was the actual catalytic species in the reaction [30]. However 
the way HOCl could be produced from the established iron-oxo species was not 
rationalized. The crystal structure of CPO which has been published in 1995 by Poulos et 
al. [10] confirmed that a glutamine and a histidine residue are found near the heme on the 
proximal side. Modification of the enzyme on the histidine residues by Wagenknecht and 
Woggon [20] had demonstrated that one of these residues is essential for catalysis. This 
fact is already well established for peroxidase and catalase thereby apparently validating 
the first steps of the process. Namely in catalase and peroxidase an histidine residue assists 
the formation of compound I (see I.2.2). Contrary to catalase and peroxidase the essential 
histidine residue in CPO has been found not to be the final proton acceptor/deliver. But it 
is part of a sequence of three amino acid residues which forms a proton delivery system: 
the final residue in close proximity to the heme is a glutamic acid. With help of histidine it 
can be protonated and deprotonated. The protonation/deprotonation of histidine is favoured 
by an aspartic acid residue and assisted by a water molecule in the vinicity of heme. 
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Figure 13: The proton delivery system in CPO and its role in compound I formation. 
Based on model studies it could be established [20] that: 
1. The formation of the OCl complex is necessary for catalysis. 
2. The catalytic species is not the iron (III) OCl complex. 
3. The protonation of the OCl complex is essential for catalysis. 
4. Upon protonation an intermediate is formed that has the same UV-Vis properties 
than the native enzyme intermediate trapped under controlled pH=4.5 conditions. 
5. This intermediate is the catalytic species and is an iron (III) HOCl complex. 
Nevertheless despites these milestones a total physical characterization of the iron (III) 
HOCl complex for both the model and the native enzymes has not been done yet. 
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I.3.4. Which role for the thiolate axial ligand? 
Although the catalytic cycles of heme-thiolate proteins are distinctive the central 
intermediate is always found to be the high-valent iron-oxo species which structural 
characterization is attempted for more than twenty years. For example the compound is 
always described as an iron (IV) porphyrin radical cation but calculations have supported 
the existence of a radical centered not on the porphyrin ring but on the sulphur [33] (figure 
14). 
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Figure 14: Different structural formulations of the high valent iron-oxo species for 
heme-thiolate proteins. 
The “push-pull” effect proposed for peroxidase [34] would be replaced (figure 15) by the 
“push” effect of the thiolate ligand in heme thiolate proteins if the participation of sulphur 
as a radical could be confirmed. 
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Figure 15: Push-pull effect vs. pull effect. 
In peroxidase the distal histidine abstracts one proton. Departure of water is favoured by an 
arginine residue which protonates the terminal oxygen which is not binding to the iron 
atom. The distal histidine favours the process by enhancing the electron density of the iron 
as does the thiolate in heme-thiolate proteins which lack the distal arginine and histidine 
residues. The machinery which assists the heterolytic cleavage of compound 0 to 
compound I in peroxidase has no equivalency in P450s and NOSs. In P450s a water 
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molecule network is thought to assist weakly the push effect of the thiolate ligand whereas 
no feature is found in NOSs to facilitate the process. 
These differences may responsible for the specific reactivity of each protein class. 
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II. Catalases in comparison to heme-thiolate proteins. 
 
II.1. Reactivity and biological relevance. 
Contrary to heme-thiolate proteins catalases have been studied since the beginning of the 
century. The isolation of catalase is possible from almost all mammalian and non 
mammalian cells containing a cytochrome system. The source of catalase for biological 
studies is nevertheless exclusively the mammalian liver or erythrocytes as the 
concentration of the enzyme is the highest in these tissues [35]. Despites this efforts in 
understanding catalases the full catalytic cycle is still not clear. The amino acid sequence 
and crystal structure are known for Beef Liver Catalase [36]. Two other crystal structures 
of Penicillium vitale catalase [37] and lysodeikticus catalase [38] have been solved 
recently. 
Catalases are extraordinary efficent enzymes which have a turnover nearly at the rate of 
diffusion control. These are the only heme containing enzymes which catalyse exclusivly 
the disproportionation of H2O2 into molecular oxygen and water. This process is very 
important for the degradation of superoxide anion O2
.- which is released by the oxygen 
adduct of globins under oxidative stress for example. Superoxide anion is first reduced to 
hydrogen peroxide by SOD (see introduction). The only other known reaction of Catalases 
is the oxidation of low molecular weight alcohols such as ethanol at high hydrogen 
peroxide concentration [39]. This is referred to as peroxidatic activity of catalase. The 
degradation of ethanol by catalase is thought to be the main pathway of ethanol 
degradation in liver. It was suggested that this very high specificity is due to the presence 
of the phenolate axial ligand. Moreover catalases are not reduced by sodium dithionite [40] 
as is the case of all other heme proteins. This unique property of catalases may be 
explained by their low redox potential which has been estimated to be less than –500 mV. 
The difficult reducibility of catalase is of importance for the catalytic cycle which will be 
discussed in paragraph II.3. 
 
II.2. Crystal structure. 
Crystals of catalase were obtained as early as 1937 from Beef Liver Catalase [41] which is 
the most extensivly studied catalase. Nevertheless suitable crystals of catalases for a high 
resolution X-ray analysis were difficult to obtain. As a consequence the corresponding 
structure was only published in 1981 [36]. The preliminary crystal studies have established 
that the tetrameric protein is arranged with a high degree of symmetry [42]. This feature 
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resembles the structure of haemoglobin which has also four subunits [43] but has no 
markant similarities with heme-thiolate proteins. Each subunit of catalase is equivalent and 
contains one heme, working independently. One of them is even often inactive as the heme 
is degraded into bilverdin (= opened tetrapyrrole unit where two a pyrrole positions are 
oxidized and where the corresponding meso carbon is missing) [44]. 
The high resolution crystal structure obtained by Murthy et al. [36] reveals that the heme is 
bound in an hydrophobic part of the protein. Contrary to P450s or CPO the heme is found 
between a b sheet domain on its distal face and a “wrapping” domain on its proximal side. 
Catalase is bound to the protein via salt-bridges between the propionate side chains and 
two arginine residues. This pattern is reminding of the globins and is not encountered in 
any other heme proteins. The heme appears to deviate from the mean plane by 1 Å which 
is an unusual high value for heme protein and adopts a domed structure [45]. Contrary to 
heme-thiolate protein where the pyrroles are nearly coplanar and where the iron atom is 
displaced down to the thiolate ligand, catalases show no significant displacement of the 
iron to the tyrosinate. 
The proximal side of the heme is crowded thereby protecting the axial ligand from 
protonation. The proximal ligand, which has been identified as a tyrosine residue, 
interestingly has an adjacent proline residue in an a-helix chain. This pattern is reminding 
of the Pro-Cys-Pro sequence of CPO. The role of the proline is proposed to restrict the 
movement of the tyrosine [45]. The guanidinium group of the arginine residue found at 
position (n-4) respective to the tyrosine is proposed to be responsible for the ionisation of 
the hydroxy group of the tyrosine. The guanidinium group forms two hydrogen bonds to 
the tyrosinate oxygen. 
Hydrophobic amino acid residues are dominantly found on the distal side. The binding of 
the substrate hydrogen peroxide is ensured by the presence of an histidine residue and an 
aspargine residue. A water molecule possibly forms a bridge between the aspargine and 
histidine but its role is not rationalized. The histidine residue has been found to be essential 
for catalysis and its Nd is located 3.5 Å above the iron. This distance allows the hydrogen 
peroxide to bind to the iron and be deprotonated by the histidine. For the ethanol 
degradation pathway two hydrophobic amino acid residues, a phenylalanine and a valine 
enable the stereospecific abstraction of the pro-R hydrogen by compound I. These two 
residues also important in stabilizing the heme in the apoprotein via p stacking interactions 
between the phenylalanine residue and pyrrole ring II. The valine residue is also engaged 
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in a hydrophobic interaction with pyrrole IV (figure 16). This situation distinguishes also 
catalases from heme-thiolate proteins. 
 
Figure 16: Active site of Beef Liver Catalase. 
 
II.3. Catalytic cycle. 
The catalytic cycle of catalases share similarities with the corresponding reactions of 
peroxidases which have an histidine axial ligand [46] and with CPO which has a thiolate 
ligand. The cycle starts from a five coordinated iron (III) heme complex. The hydrogen 
peroxide binds to the iron atom after deprotonation by the proximal histidine residue. The 
so-called compound 0 is formed. On transfer of the hydrogen atom from the histidine to 
the terminal hydroxy group the heterolytic cleavage of the peroxy bond occurs to furnish a 
molecule of water and the high valent iron-oxo species. For the second step of the 
mechanism several hypotheses have been made (figure 17) [47] and will be discussed 
taking into account the following results: 
1) alkyl or acyl hydroperoxides are not reductants of compound I [48] 
2) only un-ionised donors interact with compound I but the substrate becomes ionised 
after binding to the reductant [49] 
3) compound II which is the one electron reduced product of compound I inhibits 
catalase activity [47] 
4) compound II can not be detected during the second step of catalase activity [47] 
5) the hydrogen abstraction to alcohols proceed stereospecifically but the kinetic 
isotpe effects are variable [47]. 
First the possibility of the oxygen transfer of compound I to the reductant followed by a 
rearrangement has been formulated [47]. Second, an hydride transfer to compound I has 
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been suggested [50]. Finally a mechanism involving outer sphere electron exchange or 
inner sphere electron transfer has been invoked [51, 52]. All these mechanism are not 
satisfactory for the reasons exposed in the next discussion. They have been proposed as 
isotope studies with enriched H2
18O2 seemed to indicate that the oxygen arises from the 
second molecule of hydrogen peroxide [53]. 
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Figure 17: Different mechanisms postulated for catalase activity. 
 
II.3.1. The “oxygen transfer” mechanism. 
This first mechanism assumes a nucleophilic character of the oxygen atom of compound I 
on the second molecule of hydrogen peroxide. The nucleophilicity of compound I is not 
known but it would imply that compound I must be reduced by poor electron donor. It has 
been found that the reverse happens that is only hard donors such as ethanol rather than 
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polarizable substrates can reduce compound I. Therefore this mechanism has been 
abandoned. 
 
II.3.2. The hydride transfer mechanism 
The transfer of an hydride from hydrogen peroxide can be ruled out by measurement of 
kinetic isotope effect using deuterated hydrogen peroxide or alkyl peroxides after 
formation of compound I. A better answer to this mechanism is the use of chiral deuterated 
ethanol as ethanol is also oxidized efficiently by catalases. The results obtained by using 
chiral deuterated ethanol revealed that the oxidation of ethanol occurs specifically by the 
loss of the pro-R hydrogen. The measured kinetic isotope effect of 1.9 is too small for such 
a mechanism. Namely the isotope effect should be around 7 for a primary hydrogen atom 
abstraction process if it is rate determing. 
If such a mechanism would be consistent this prerequisites that a compound I - reductant 
complex forms, an hypothesis which can be rationalized from the crystal structure [45]. 
The second molecule of hydrogen peroxide is proposed to bind to the histidine and 
aspargine distal residues. Thereby it places one hydrogen in the vinicity of the oxygen 
atom of compound I. The hydrogen is transferred to the iron-oxo complex generating the 
iron (III) hydroxy complex and oxygen, the remaining proton (figure 18) would be trapped 
by the histidine residue. This proton finally adds to the hydroxy complex to permit release 
of water and restore the resting state. 
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Figure 18: The hydride transfer mechanism. 
 
II.3.3. The electron sphere mechanism. 
The mechanisms which would involve an electron transfer process is favoured by 
Schonbaum et al. [47]. The hydrogen peroxide adds to the iron thereby reduces it formally 
to iron (III). The hydroxylated peroxide complex then rearranges to yield water and 
oxygen. Such a mechanism is rather unusual with iron complexes as it implies a seven 
coordinated iron atom or the loss of the phenolate coordination. Therefore this mechanism 
was not retained. 
 
II.3.4. Proposed mechanism. 
Based on the results obtained for CPO where the chloride acts as a nucleophile adding to 
compound I [54] one can propose that the mechanism of catalase could be the following. 
The second molecule of hydrogen peroxide is probably deprotonated by the distal histidine 
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residue. The peroxide then attacks the iron-oxo species to give an ozone-like intermediate 
(figure 19). Upon protonation of the oxygen bound to the iron oxygen evolves. As in the 
case of hydride transfer mechanism the iron hydroxy complex formed is protonated to its 
corresponding water complex and deligates from the heme to restore the resting state. 
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Figure 19: Proposed catalytic cycle of catalase. 
 
The distinction between mechanisms II.3.2) and II.3.4) relies on:  
1. the redox potential value of compound I which is unknown 
2. the possibility of the formation of an ozone like iron porphyrin complex. 
Since no conclusive experiments have been reported so far, the validity of both 
mechanisms is not established. Nevertheless if compound I of catalase would be reduced 
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by hydride from hydrogen peroxide it should also be the case for compound I of heme-
thiolate proteins. Namely the redox potential value of compound I is, based on the value 
for the resting state, excepted to be more positive for heme-thiolate proteins than for 
catalase. Therefore the mechanism proposed in figure 19 could be more consistent with the 
data collected as it implies a role of the distal amino acid residues also in the second step. 
Finally the main difference between catalases and heme-thiolate protein is the ability of the 
former to react with a second molecule of hydrogen peroxide in a two electron process. 
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III. Synthetic active site analogues. 
 
To obtain high resolution X-Ray structures or satisfactory physical characterization of 
catalytic intermediates is not always possible with enzymes. Therefore the development of 
active site mimics is still a powerful tool in the elucidation of catalytic cycles. The 
advantage is even more evident for organic chemist who can use an efficient active site 
analogue as catalyst for chemical reactions which are only feasible under drastic 
conditions. The mimic is namely often soluble in organic solvents contrary to proteins. 
Among other the analytical physical methods which are now routinely used for proteins 
could not have been developed if models had not been synthesized to validate and optimise 
the parameters. Also the identification of short living intermediates is due to the existence 
of models e.g. CPO models. 
The design of models has primarily been devoted to models for haemoglobin and 
myoglobin with the hope to create in hand “artificial blood”. Therefore more attention has 
been paid on the stabilization of the diogygen adduct of heme models rather than to the 
specificity of the axial ligand. With the discovery of heme-thiolate proteins models have 
been developed to rationalize the effect of axial ligation during catalysis. 
Porphyrins which are active site analogues of heme proteins can be divided into several 
classes (figure 20): 
· The simple meso tetraaryl porphyrins which have the main advantage to be 
generally robust for catalysis [55]. 
· Also widely used are the octaalkylporphyrins being only substituted on the b-
pyrrole positions [55]. 
For both models, the synthesis is short and high yielding. These models have been widely 
used to characterize postulated intermediates such as the iron oxo complex or compound I; 
they suffer, however, from disregarding the axial ligation. 
· The more elaborated “tailed-porphyrins” [56]. They are usually diaryl or tetraaryl 
porphyrin where on one aryl an “arm” is anchored to introduce a fifth axial ligand. 
If they have the advantage to take into account the axial ligand, the binding of the 
latter often suffers from “on-off”. Dimeric or polymeric species can be obtained if 
the tail binds to another porphyrin molecule which is a severe limitation. These 
models for heme-thiolate proteins suffer moreover from the insufficient protection 
of the sulphur towards oxidation [57]. 
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· The “strapped porphyrins” are similar to the tailed one. The axial ligand is 
introduced via a bridge between two meso or b-pyrrole positions. The advantage is 
to hold the axial ligand in the vinicity of the central metal. Usually the meso 
positions bear substituted phenyl rings which are properly functionalised [55]. The 
synthesis is dependant on the yield obtained for the bridging step which is usually 
not very high. 
· The elaborated “capped porphyrins” protect one of the porphyrin face and 
thereby form a binding cavity for reagents and substrates [55]. Their synthesis is 
often tedious and yields are poor. 
· The combination of the “capped” and “tailed” concepts has given raise to “pocket 
porphyrins” which allow to study the influence of the axial ligand on the binding 
of reagents or substrate [55]. 
· The “picket fence porphyrins” developed by Collman are very popular as they 
have revealed good binding ability vs. dioxygen [55]. They are characterized by 
meso aryl moieties which carry in the ortho position a bulky e.g. amide group, 
usually a pivaloyl moiety (= picket). 
The concepts mentioned above can be varied to give raise to “picket pocket” [55], 
“gyroscope” [58] or “basket handle” [58] porphyrins among others. 
As the enantiomeric excess in catalytic reactions still gains more interest chiral porphyrins 
have also been developed such as “chiral basket” or “twin-coronets” [59] porphyrins. 
Increasing the complexity and size of the substituents of the porphyrin macrocycle suffer 
from the drawback of poor overall yields of the synthesis. 
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Figure 20: Some of the most used porphyrin classes as active site analogues. 
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IV. Problem to be addressed. 
 
The progress of enzymology and biochemistry permits to work directly with the proteins 
themselves to obtain a certain degree of information on possible intermediates of the 
catalytic cycle. Nevertheless this approach still suffers from approximations and requires 
much more time in data collection and analysis than with a simplified model. 
In particular the recent cryogenic X-ray studies on P450cam have not permitted to solve the 
structure of the iron-oxo species [18]. Neither is the mechanism of oxygen insertion 
solved. And finally none of the studies P450 enzymes accounts for the specificity of the 
axial ligand in the formation of intermediates. 
 
Therefore the aim of this work was to develop iron porphyrin complexes as model 
compounds which would permit to rationalize the specificity of the axial ligand. In a first 
part the synthesis and characterization of a CPO model designed by Wagenknecht and 
Woggon. had to be verified carefully to improve the purity of the iron complex. As catalase 
is very close to CPO it was decided to prepare two models suitable for the investigation of 
the thiolate vs. phenolate axial ligation to iron porphyrins. The models for the resting state 
should be investigated by UV-Vis, NMR, EPR and ENDOR techniques to have a complete 
characterization. 
 
A study on the generation of the postulated intermediates of CPO should then be 
undertaken to fully characterize the HOCl complex as a key intermediate and to confirm 
the conclusion by Wagenknecht and Woggon.[20]. Finally it was anticipated that models of 
compound I could be prepared to gain information on their electronic nature for heme-
thiolate proteins and catalase. 
  
  
 
RESULTS AND 
DISCUSSION 
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V. Design and Synthesis of Models. 
 
V.1. Design. 
 
V.1.1. Criteria for a suitable model. 
Although numerous heme models have been published, the necessity of improving them is a 
challenging task for the organic chemist. Most of the models do not respond to the elegant 
definition of Bruice et al. [60] for the ideal active site mimic. The structural characteristics of 
the ideal analogue implies to have: 
1. a domain that holds the catalytic functional groups at the active site in a geometry that 
mimics the active site structure of the enzyme, 
2. a binding domain for the substrate and 
3. a structure that protects the catalytic functional groups from side reactions with 
species other than the substrate. 
According to this definition the model should respond to the following criteria: 
4. the original ligands from the active site have to be conserved. In our case an iron 
porphyrin with a thiolate or an oxygen coordinating axially to the iron atom is 
required. 
5. easily observable spectroscopic properties close to the one of the enzymes. 
6. at least a stochiometric reaction (single turnover) between the catalytic intermediate 
and the substrate. Ideally the turnover should be near the value obtained for the 
enzymes. 
Most of the compounds synthesized as heme-thiolate models or as catalase analogues until 
now do not respond to point 1. above as they do not retain the proper axial ligand. 
The models where a free thiolate or phenolate ligand mimics the sulphur respectively oxygen 
ligation and the tailed-models suffer from an “on-off” equilibrium ( see chapter III). Moreover 
in protic solvents the protonation of the oxygen or sulphur has been reported [61]. 
Models with a tight coordination of the axial ligand are in general not good catalysts as the 
thiolate and/or the porphyrin is rapidly oxidized in the presence of oxidants [62]. 
Good catalysts for P450 like activity are known but the central metal is not iron [63] and all of 
them do not retain the sulphur ligation. The work of Wagenknecht et al. [64] describes for the 
first time an efficient iron porphyrin catalyst with an axial thiolate ligation but the model did 
not permit the complete characterization of the P450 like catalytic species. 
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For catalases only two iron porphyrin models 9 and 10 (figure 21 and table 4) are known 
having phenolate ligation [65, 66] but their pendant thiolate analogues have not been studied 
until now. 
 
9: Bruice et al. 
 
10: Meunier et al. 
Figure 21: Models 9 and 10 for Catalase with phenolate ligation. 
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 9 (Bruice et al) 10 (Meunier et al.) 
UV-Vis (l in nm) 325, 420 (Soret), 490, 552, 
608, 653 in chloroform 
420 (Soret), 509, 580, 657 in 
toluene 
NMR (d in ppm) 122.4 (meta-phenol H), 83 (b-
pyrrole), 13.1, 13.4, 11.9, 
11.6 (H meta from meso 
phenyl) 
n/a 
EPR n/a n/a 
Redox potential n/a n/a 
Catalase activity n/a TO: 71, or 21% yield of 
dioxygen 
Table 4: Available analytical data for catalase models 9 and 10 taken from ref. [65] and 
[66]. 
Clearly if the axial ligation is recognized as a determining factor in the catalytic activity no 
study has been undertaken to correlate the phenolate (O-) versus the thiolate (S-) ligation to 
the difference between catalases and heme-thiolate proteins. 
 
V.1.2. Choice of the models. 
Since several analogues which meet most of the criteria mentioned in V.1.1. have been 
characterized [57, 67, 68], we decided to pursue the development of a promising mimic of 
CPO [69]. Figure 22 summarizes the features of our targets which respond almost completely 
to the definition of Bruice et al.: 
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Figure 22: Target molecules 11 and 12. 
 
V.2. Synthetic approach. 
 
V.2.1. Retrosynthesis. 
The retrosynthesis (scheme 1) relies on three building blocks which are provided by the 
disconnection of the ether bond of the axial “bridge” moiety 16 or 15 and by the Mac 
Donald’s porphyrin synthesis. This step requires an aldehyde 14 and a dipyrrylmethane unit 
13 which are condensed under acid catalysis. 
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Scheme 1: Retrosynthesis. 
The dipyrrylmethane unit 13 has been synthesized according to the procedure described by 
Aissaoui and Woggon. [68] and the aldehyde 14 via an ortho-directed lithiation of the N-
pivaloyl activated m-anisidine [20]. The bridge 15 is synthesized by a modified literature 
procedure [70] and bridge 16 by an adaptation of it (see V.4.1.). 
 
V.2.2. Porphyrin synthesis. 
Although the CPO model 11 has been already described, several open questions required a 
more careful characterization. Particularly the facts that: 
a) Atropisomers were never separated and could not be distinguished by any 
spectroscopic or chromatographic method. This case was unpreceded in the 
literature. 
b) The introduction of the bridge moiety was not accompanied by a red shift of the 
Soret band in UV-Vis spectroscopy as is the case for similar molecules [68]. 
c) The NMR data of the metal free precursors of 11, compounds 21 and 22 (see 
scheme 5), were badly resolved suggesting a mixture of conformers or possibly a 
mixture of several compounds. 
d) The mass spectra (MS) has not be obtained despites the use of several MS 
techniques. 
e) The ESR data of the resting state were indicative of several species. 
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Moreover as NMR spectroscopy is nowadays a tool of choice for the structural determination 
in solution we wanted to determine the conformation of our compounds by this method as it 
would help refining the structure for improving our model if necessary. The understanding of 
the factors influencing binding constants could also be gained from this structural elucidation 
combined to other spectroscopic methods. 
The first step of the synthesis (scheme 2) is the Mac Donald’s condensation of 13 and 14. This 
step was examined in details as the separation and characterization of atropisomers had not 
been solved previously. 
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Scheme 2: Synthesis of the porphyrin macrocycle. 
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V.2.3. Separation and structure of atropisomers. 
 
V.2.3.1. Definition. 
The existence of isomers in meso substituted porphyrins having functionalised aromatic 
substituents has been pointed out in 1969 [71]. The existence of atropisomers is due to an 
hindered rotation of the aryl-porphyrin bond. The energy barrier required for rotation is 
known to increase with a more rigid porphyrin nucleus. The transition state goes namely 
through a highly distored porphyrin ring [72]. If sterically hindering groups are close enough 
this process could be impossible even at 200°C. 
In our case we can only have, assuming a symmetry in the spatial arrangement of the butyl 
side-chains, two isomers. The first isomer is the one where the same substituents of the aryl 
are facing on the same side of the porphyrin plane. As it is reminding of a cis conformation in 
alkenes the isomer is defined as the a,a isomer. The second isomer is the a,b isomer. It 
corresponds to a trans geometry where the same substituents of the aryl are on opposite sides 
of the porphyrin plane (figure 23). 
N
N
N
N
OMe
OMe
NH
HN
O
O
N
N
N
N
OMe
HN
NH
O
MeO
O
18a: a,a isomer
18b: a,b isomer
Zn2+
Zn2+
 
Figure 23: Atropisomers. 
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V.2.3.2. Separation of atropisomers. 
Since the first report on isolated atropisomers [73] it has been only few cases where the latter 
have not been separated directly by chromatography and where a proper derivatization was 
necessary. Until the design of our target the absence of distinction between geometrical 
isomers of porphyrins has not been reported. Moreover tetraarylporphyrins having ortho 
pivaloyl groups on the aryl moiety are cases where the separation is most documented and 
where the spectroscopic properties also allowed the attribution of the proper structure [74-76]. 
(5, 15) diaryloctaalkylporphyrins were even used as model compounds for atropisomer’s 
characterization as the latter are thermally stable [20]. 
From these various reported data and given the intriguing behaviour of the “bridged” species 
we have postulated that atropisomers 18a and 18b are not interconvertible. Probably the 
desired isomer 18a has been previously discarded during purification. 
To verify this working hypothesis we turned to a more careful TLC control of the reaction. 
From the crude mixture after zinc insertion we were finally able to well distinguish two spots 
on TLC for 18a and 18b having the proper mass (figure 24). 
M=870 
M=1055.5 (product: 18a and 18b) 
TLC on silica gel. Eluent: Hexane: 
Ethylacetate (5:1) + 1%vol triethylamine. 
18a 
18b 
 
Figure 24: TLC of the crude reaction mixture after zinc insertion. 
These spots corresponding to 18a and 18b gave also two distinct peaks on the HPLC by using 
a reverse phase C-18 column at 50°C and a gradient of a MeCN: H2O mixture as eluent (see 
experimental part). The HPLC ratio has been calculated to be 8:2. Most likely 18b which is 
the most apolar and the most abundant compound was the compound that has been isolated 
previously by Wagenknecht and Woggon. and that was used to finally obtain the CPO model. 
As it is known that usually the most polar compound is the a,a isomer it was necessary to 
first characterize completely and unambiguously both products 18a and 18b and then find out 
why such a selectivity appeared. 
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V.2.3.3. Characterization by NMR spectroscopy and derivatization. 
After separation by column chromatography and removal of zinc both compounds 17a and 
17b were analysed by proton and carbon NMR spectroscopy. The chemical shifts which were 
assigned by using 1D- and 2D- NMR spectra (see experimental part) differ principally for the 
Butyl, NHPiv and OMe substituents as summarized in the table 5. 
Protona) da,a isomer (18a)/ppm da,b isomer (18b)/ppm D (d)(18a/18b): 
10,20 (meso H’s) 10.20 10.20 0.00 
5’ 8.45 8.45 0.00 
4’  7.78 7.79 0.01 
3’ 7.08 7.11 0.03 
NHPiv 7.06 6.90 0.16 
CH2a 4.02-3.91 4.05-3.91 0.00 
OMe  3.54 3.62 -0.08 
Me Pyrrole 2.59 2.57 0.02 
CH2b 2.16 2.15 0.01 
CH2g 1.75 1.70 0.05 
CH3d 1.1 1.06 0.04 
NHPiv (tert-Bu) -0.05 -0.13 0.08 
NHporphyrin -2.21 -2.24 0.03 
Table 5: 1H-NMR chemical shifts for both isomers. 
a): Numbering according to figure 22, Conditions: 2 mM porphyrin in CDCl3, 295 K. 
The largest difference in chemical shift is observed for the proton of the OMe group and for 
the N-pivaloyl functionality. This reflects that the placement of the aryl regarding the 
porphyrin plane is not the same. From studies on di- and tetra- aryl porphyrins it is known that 
the aryl substituents can adopt the two following conformations: 
1. be perpendicular to the porphyrin plane 
2. be tilted from the above mentioned plane 
The tilting is more important when sterically hindering substituents are found on the aryl 
moieties [78]. Nevertheless the shifts difference is not a decisive argument to assign the 
configuration. Namely the difference could also be rationalized by a different geometry of the 
porphyrin macrocycle. Porphyrin ring systems are not always planar [79] and can deform to 
adopt: 
1. a domed conformation 
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2. a ruffled conformation 
3. a saddle conformation 
4. a waved conformation 
5. a propelled conformation 
Since there is little knowledge on NMR data of one or the other conformation the chemical 
shifts are not a decisive argument in the assignment of the structure of atropisomers. However 
the analysis of the carbon chemical shifts in iron porphyrin complexes gives an indication on 
the degree of ruffling [80]. Finally the question addressed is a geometrical problem in relation 
with spatial distances and symmetry. Therefore the measurement of Nuclear Overhauser 
Enhancement (NOE) in proton NMR spectroscopy is the most reliable technique for 
determining spatial configuration in solution. 
Prerequisite for observation of NOE effects is that the protons of interest are close enough in 
space and resonate at different frequencies. In the case of the a,b isomer 17b such a NOE 
effect may likely to be observed between the proton of the CH3 from the pivaloyl and the CH3 
from the OMe substituents. Unfortunately the actual distance which has been ruled out from 
molecular modelling was too large (> 5 Å) to give a positive result. As a consequence no 
corresponding NOE was observed in the NMR spectra. The methyl ether functionality was 
therefore subsequently replaced by a larger protecting group of the hydroxy function. A p-
nitrophenylester was synthesized as the presence of a phenyl ring could induce a p stacking 
stabilization of the phenyl moiety above the porphyrin plane. Thereby the proton of the 
phenyl ester should lie very close to the pivaloyl moiety (figure 25). 
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Figure 25: Derivatization and expected NOE effects. 
As expected a strong NOE effect was observed between the pivaloyl protons and the protons 
of the nitrophenylester. Thereby the most apolar compound 17b was unambiguously 
attributed to the a,b isomer whereas the other isomer 17a was determined as the a,a one. 
The question of the ratio (85:15) obtained has to be answered because such a selectivity is 
unprecedeed in porphyrin synthesis. For example Aissaoui and Woggon have reported with 
similar structures a ratio of 60:40 in favour of their corresponding a,b isomer [67]. 
 
V.2.3.4. Why such a ratio and no interconversion? 
Compared to porphyrins which have been published in the literature our models indeed 
combine the steric hindrance of the “picket fence porphyrins” of Collmann and of the 
“octaalkyl” porphyrins. 
Atropisomerization has long been recognized to be slowed down by the presence of bulky 
substituents on the meso aryl groups. The increase of the steric hindrance results in a higher 
energy barrier for atropisomerization [81]. This is related to the necessity for the porphyrin 
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macrocycle to distore during the transition state. This distorsion allows the substituted phenyl 
ring to pass above the b-pyrrole positions. If the latter are also substituted the distortion 
required is again increased [73]. 
In our case we have not only one but two ortho substituents which can come in contact with 
the pyrrole rings during atropisomerization. Such a situation generates a conflict for the 
direction in which the pyrrole ring has to be deformed to enable a rotation of the Caryl-Cmeso 
bond (figure 26). 
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Figure 26: Schematic representation of the required distortions for isomerization. 
Several attempts to interconvert the isomers failed (table 6). A prolonged heating only results 
in the destruction of the porphyrin. 
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Method: Result: 
Heating, 60°C, DMF No interconvertion 
Heating, (120°C), DMF No interconvertion 
Heating, (160°C), DMSO degradation 
Heating, 200°C, decaline degradation 
Table 6: Attempts for atropisomerization. 
This result was first surprising because porphyrins having (ortho, meta, para) substituted aryl 
groups were isomerisable at 90°C [82]. Nevertheless it appears that the presence of two ortho 
substituents on the aryl groups is the reason of the thermal stability of these isomers as 
confirmed by the synthesis of analogues [83]. 
 
V.2.3.5. NMR solution structure of 17a and 17b. 
Taking advantage of the thermal stability of the compounds we have pursued the three 
dimensional characterization of our intermediates 17a and 17b by NMR spectroscopy. The 
first question to be addressed is the geometry of the aryl substituents. For the ortho 
substituents (position 3’ and 6’ on the aryl moieties) the Caryl-X-Csubstituent bond can adopt a cis 
or trans configuration. Moreover the amide substituent can also adopt a cis or trans 
configuration for the Namide-Camide
 bond. Therefore eight (23= 8) structures are possible (figure 
27). These structures can be distinguished from each other by the NOE effects measured. 
 49
 
O
H3C
N H
O
N H
O
O
H3C
N H
O
O CH3
N H
O
O CH3
N
H
O
O
H3C
N
H
O
O CH3
O
H3C
N
N
H
O CH3
ttc tcc ctc ccc
ttt tct ctt cct
H
cis
trans
trans
O
O
H5'
H4'
H3'
 
Figure 27: Conformation of the aryl moiety and expected NOE effects. 
(The coloured arrows represent the NOE effects). 
The NOE which are observed are summarized in table 7: 
NOE 
between: 
H3’ H5’ OMe NHPiv NHPiv 
Me 
pyrrole 
H3’  - s - - - 
H5’ -   w - - 
OMe s -  - - m 
NHPiv - w -  s m 
NHPiv - - - s - m 
Me pyrrole - - m m m - 
Table 7: NOE effects observed in the ROESY and NOESY spectra of 17a or 17b. 
Abbreviations: w: weak, m: medium, s: strong. 
As the NOE between the OMe group and H3’ is strong the Caryl-Cether bond geometry is cis and 
the structures ttt to cct can be excluded. For the amide substituent the absence of NOE 
between the NHPiv proton and H5’ implies a trans conformation of the Caryl-Namide bond. 
Thereby only structures ttc or tcc are dominant. Last the NOE effect between the NH and the 
tert-butyl group of the NHPiv moiety indicates that the Namide-Camide bond is also in a trans 
configuration. 
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ttc in figure 27 is thereby the preferred conformation at the aryl moieties. Moreover the 
relatively high field shifted chemical shift of the amide proton NH which is found at 6.9 ppm 
and the shift of the tert-butyl substituent around 0 ppm also supports this conformation. The 
shielding effect can namely not originate from the phenyl ring as the entity is planar. 
Therefore it can arise only from the porphyrin ring current [58]. 
The planarity of the amide moiety and its coplanarity with the phenyl ring can be determined 
from the 15N-H coupling constant. It is namely established with peptide models that the value 
of this coupling constant reflects the sp2 hybridisation degree of the nitrogen atom in the 
amide bond [84]. In our compounds the value measured from the 15N satellites peaks of the 
NH signal in the proton NMR spectra was of 90 Hz. This implies that the sp2 character of the 
nitrogen is about 100%. The sp2 character of the nitrogen atom results in a partial double bond 
character of the O=C-N bond. Hence is the amide bond planar. Due to this double bond 
character a conjugation of the N-Phenyl bond with the O=C-N bond occurs. It results in a 
planar structure for the whole system Phenyl-N-C=O (figure 28). 
 
O
H3C
N H
O
= porphyrin ring system
 
Figure 28: Conformation of the aryl substituents. 
The structure of the aryl moiety obtained from the NOE observed is in good agreement with 
the crystal structure data of Collmann [85] for its (5,10,15,20) [tetra-(o-N-aminopivaloyl)-
phenyl] porphyrinato iron (II) model (TPivPP) which binds dioxygen. 
Finally the degree of tilting from the vertical plane passing through the 5, 15 positions can 
also be appreciated from NOE effect. If the phenyl rings would be perfectly perpendicular to 
the porphyrin ring the NOE effects observed for the tert-butyl groups of the pivaloyl 
substituents to the butyl side chains should be quasi inexistent. As a medium to strong effect 
is observed even to the butyl protons, the titling of the phenyl substituents is probably 
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relatively important. Moreover the detection of a NOE effect to the butyl side chains raises 
the question of the spatial arrangement of the butyl side-chains. 
Until now it was assumed that the b-butyl groups are more or less lying in the plane of the 
porphyrin. The NOE observed are inconsistent with this assumption. For example the NOE 
effect from the CH2a to the neighbouring meso proton is not strong as well as the one to the b-
methyl groups. Further the CH2a protons are splitted in a complex multiplet which at higher 
field proved to be a set of two multiplets. In other words either the protons are diastereotopic 
and the Cpyrrole-Ca  rotation is blocked or the butyl side-chains are distributed on each side of 
the porphyrin plane in a symmetric manner. With help of molecular modelling and based on 
the published crystal structure of octaethylporphyrin we propose that the butyl chains are 
arranged in an “up-down” conformation [86]. This minimizes the steric interactions between 
two chains and an overall C2 symmetry is conserved. 
Last point to be discussed is the planarity of the porphyrin core. The splitting of the CH2a 
signal in a complex multiplet is an indication that probably the porphyrin core is not 
completely planar. Moreover the UV-Vis spectra of 17a or 17b show a maximum of 
absorption at 408 nm. This value is less than the value obtained for tetraphenylporphyrins 
which are known to be ruffled. However this does not exclude the possibility of a saddle 
conformation. The saddle conformation would limit the interaction between the adjacent butyl 
chains. Nevertheless as no crystal structure has been done the degree of deviation from 
planarity can not be judged. 
The NOE effects observed and a force field calculation using the MM2 method [87] led to the 
model structures depicted in figure 29. 
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17b 
 
17a 
Figure 29: Proposed structure of both isomers. 
 
V.2.4. Synthesis of the bridged porphyrins 21 and 22. 
The methoxy ether, the protecting group for the phenol, was subsequently deprotected 
(scheme 3). Two methods were considered: the use of concentrated HBr at reflux [88] and 
Lewis acids such as BBr3 at low temperature [89]. Both methods, however cleave also the 
pivaloyl group, even faster than the methyl ether. Accordingly a milder Lewis acid with a 
nucleophilic co-solvent [90] seemed suitable. Indeed the Lewis acid aluminium chloride in 
the presence of an excess of ethanethiol selectively cleaved the methyl ether bond in 75% 
yield for 17a and 97% yield for 17b (scheme 3). 
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17a
AlCl3, EtSH
CH2Cl2, RT, 14hr
NH
N
NH
N
OH
OH
NH
HN
O
O
20a: 75% from 17a
20b: 98% from 17b by the same reaction  
Scheme 3: Deprotection of the methyl ether. 
The isomers 20a and 20b were found to be not interconvertible. As for 17a and 17b their 
NMR and TLC behaviours of 20a and 20b are distinct. For example under the purification 
conditions initially used for 20b by column chromatography, 20a remains on the column. As 
20b can not be interconverted into 20a the target 11 can not be obtained from the isolation of 
18b. 
 
V.2.4.1. Bridging. 
The further confirmation of the non conversion of atropisomers into each other was next 
established by the introduction of the bridge 15. If the a,b isomer 20b is used one can obtain: 
1. a tailed monomer having one or two bridges hanging 
2. an oligomeric porphyrin array or oligomeric cyclic structure (figure 30) 
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Figure 30: Formation of polymeric species upon bridging with the a,b isomer 20b. 
The a,a isomer 20a is the only isomer which can yield the desired bridged structure. 
Nevertheless oligomers can also be obtained from 20a as the step involves the reaction of 
bifunctional compounds. The reaction conditions have therefore to be carefully optimised to 
minimize the formation of polymeric species. 
The experience in “supramolecular” chemistry with polyfunctionalized compounds has shown 
that bridging is favoured under high dilution conditions. The presence of one of the reagents 
in a controlled low concentration during the reaction also favours the ring closure process 
over the reaction with a second molecule of reagent [57]. 
Therefore we have achieved the bridging step (scheme 4) by typically working with porphyrin 
solution having a concentration of 1 mg ml-1 (approximately 1 mM). The bridge was added 
over 3 hours at a concentration around 6 mM. 
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Scheme 4: Bridging step. 
Note: the real conformation of the amide moiety is shown in figures 31 and 32  
With 20a we obtained from the crude reaction mixture a mass spectra composed of two peaks 
by MALDI-TOF: the M+ peak and a peak with [M+133]+ corresponding to the cesium 
complex of the desired porphyrin. The cesium was removed by an acidic work-up to furnish 
the S-protected bridged porphyrin 21 in 60% yield. 
When 20b was used the product mixture could not be directly analysed by MS. Upon repeated 
column chromatography purification using a mixture of toluene: methylene chloride and 
methanol (1:1+10% V/V) and addition of a matrix for MALDI-TOF we were able to obtain 
peaks with masses corresponding to: two porphyrins + two bridges, three porphyrins + three 
bridges. This result demonstrates that the mimic obtained with the a,b isomer 20b is a 
mixture of porphyrin oligomers. 
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V.2.4.2. Characterization of the bridged porphyrin 21. 
 
V.2.4.2.1. Differences upon bridging attempts. 
The bridged compound was compared to the compounds obtained by working with the a,b 
isomer 20b. The first markant difference is the TLC behaviour: whereas the desired 
compound runs with a retention factor of 0.3 in a system hexane: ethyl acetate: triethylamine 
(5:1+1% V/V) the products obtained in the second case stay on the baseline. 
Second the UV-Vis spectra are different: the maximum of absorption (Soret band) is found at 
414 nm for 21 and at 408 nm for the oligomers’ mixture. This represents a 6 nm red-shifted 
for the bridged compound compared to the oligomers’ mixture obtained from 20b. The red 
shift which is observed after bridging could relate the increase of electron density on the 
porphyrin macrocycle. This could be the consequence of an interaction of the phenyl ring 
from the bridge via p interactions. If this hypothesis is correct the phenyl ring should be 
almost parallel to the porphyrin plane and relatively close to it. The second explanation for 
this shift could be a change in the geometry of the porphyrin macrocycle. It is known that the 
introduction of nitro groups or of further phenyl groups at the meso positions also induces a 
red shift which has been rationalized by a more distored structure of the porphyrin core [91]. 
Therefore the shift could indicate that from the proposed saddled conformation of 20a the 
core becomes either domed or ruffled. A second proposal, based on a study with 
tetraphenylporphyrins where the degree of phenyl substitution was increased, relates the red 
shift to a more important tilting of the phenyl substituents and not to an increased distorsion 
of the macrocycle [92]. In the case of 21 probably both factors, a more ruffled porphyrin core 
and a more important tilting of the phenyl groups accounts for this results as further indicated 
by NMR studies and force field calculation (see V.2.4.2.2.). 
Next the NMR spectra are not superimposable: the bridged compound 21 gives a well 
resolved set of signals (table 8) whereas the oligomers’ mixture gives raise to broad 
overlapping signals. The presence of the desired compound in the mixture can be excluded as 
signals found in the bridged compound 21 are absent in the spectra of oligomers. 
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Protona) 
d/ ppm for 21 (obtained with 
pure 20a) 
d/ppm for the oligomers 
(obtained with pure 20b) 
20 10.11 
10 9.72 
10.15-10.11 
5’ 8.61 8.45 and 8.40 
4’ 7.77 7.77 and 7.71 
3’ 6.95 7.12 and 6.96 
NHPiv 8.42 7.00 and 6.96 
3“, 5“ 6.37 6.57 and 6.30 
CH2a 3.92-3.82 and 3.62-3.52 3.98-3.81 
CH2a’ 4.17-4.04 and 3.98-3.85 3.98-3.81 
CH3pyrrole 2.72 and 2.55 2.62 and 2.55 
CH2b’ 2.22 2.09-1.99 
CH2g’ 1.82-1.72 1.75-1.59 
CH2b 1.97-1.87 and 1.82-1.72 2.09-1.99 
CH2g 1.72-1.62 2.09-1.99 
CH3d 1.145 and 1.135 1.75-1.59 
2”’ (tert-Butylbridge) 1.09 1.34-1.21 
NHPiv (tert-butyl) 0.52 -0.03 to -0.28 
N(CH3)2 1.72 and –1.32 0.9 
NHporphyrin -2.0 -2.20—2.26 
Table 8: 1H-NMR shifts for the bridged/oligomer compounds. 
a) see figure 22 for numeration. Conditions: 2 mM in CDCl3 at 280K. 
 
V.2.4.2.2. Solution structure of the bridged compound 21. 
As the structure in solution is important for the future metal insertion we have pursued our 
studies by NMR spectroscopy taking advantage of NOE effects and the possibility of working 
in two dimensions. The NOE peaks which are relevant in the determination of the 
predominant conformation of 21 are summarized in table 9. 
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NOE 
between 
H3’ H5’ NHPiv NHPiv OCH2a’ 
Me 
pyrrole 
N(CH3)2 NHporphyrin 
H3‘’,5’’ 
H3’  - - - w - - - - 
H5’ -  s m - - - - - 
NHPiv - s  s - - - - - 
NHPiv - m s  - m - - - 
OCH2a’ w - - -  m to s - - - 
Me 
pyrrole 
- - - m m to s  - - m 
N(CH3)2 - - - - - - s m - 
NHporphyrin - - - - - - m  - 
H3 ‘’,5’’ - - - - - m - -  
Table 9: Selected NOE signals observed for 21. 
The first conclusion from these data is a change in the conformation discussed for the aryl 
substituents in V.2.3.5.. The weak NOE which is observed between H3’ and OCH2a’ indicates 
that the Caryl-Oether bond is now in a trans conformation i.e. the structures which can represent 
it are ttt to cct (figure 27). This change is accompanied by a modification of the conformation 
of the Caryl-Namide bond. The strong NOE observed between H5’ and NHPiv excludes a trans 
conformation of the Caryl-Namide bond. The change to a cis conformation is further confirmed 
by the low field displacement of the resonance position of NHPiv from 6.9 ppm to 8.5 ppm. 
So only structures ctt or cct can represents the proper conformation. Finally the medium NOE 
from H5’ to NHPiv eliminates structure cct. The trans character of the Namide-Ccarbonyl is also 
ruled out from the low field displacement of the NHPiv resonance signal from 0.01 ppm to 
0.55 ppm. Therefore only structure ctt can represent the proper conformer as illustrated by 
figure 31. 
From the 15N satellites of the NH signal in the 1H-NMR spectra a coupling constant of 90 Hz 
was obtained. Based on that coupling constant the nitrogen atom was found to have a sp2 
character of almost 100% as for 17a and 17b. According to this result the N-C=O bond has a 
partial double bond character which induces the planarity of the amide group. The double 
bond character also induces a conjugation of the N-C=O with the phenyl group . This again 
implies that the aryl substituent are planar (figure 31). 
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Figure 31: Conformation of the meso aryl substituents in 21 determined from the NOE 
effects. 
This determined conformation is very surprising as the inversion of the geometry of the Caryl-
Namide bond demands energy (around 40 kcal mol
-1) and contrasts with the known crystal 
structures obtained by Collmann for aryl substituents in TPivPP iron complex [85]. 
Further changes are obvious. The meso proton are splitted in a set of two singulets as are the 
b-methyl from the pyrrole. The butyl chains are also splitted in a set of two signals which are 
in part resonating at the same frequencies. This implies that the pyrrole rings from the 
porphyrin are differentiated. This differentiation is due to the bulk induced by the bridge and 
more particularly by the protecting group of the sulphur. This symmetry distortion implies 
that the bridge is nearly parallel under two of the pyrrole rings (figure 32). The molecule 21 is 
sterically constrained as confirmed by the diastereotopy of the OCH2a’ groups. In other words 
little flexibility may be possible in the structure. 
The proximity of the sulphur to the centre of the porphyrin ring is the next important point to 
verify. Namely the sulphur has to point in the direction of the porphyrin ring to enable a 
future coordination to the central iron atom which will be inserted. From the NMR spectra we 
have a clear indication that the sulphur is in the proper position. First the NCH3
 signals are 
splitted into two broad singulets, one of which is found at very high field (d= -1.32 ppm). This 
shielding can only result from the porphyrin ring current as it is established from the NOE 
observed that the phenyl ring is under two pyrrole rings. Second NOE peaks are observed 
between the NCH3 of the sulphur protecting group and the NH signals from the porphyrin. 
The subsequent force field calculation of the structure gives the following picture (figure 32). 
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Figure 32: Structure of 21 based on NMR data after force field optimisation. 
 
V.2.4.3. The free thiol porphyrin 22. 
The metal free complex was next obtained by deprotection of the thiocarbamate group. As 
thiocarbamoyl groups are known to be cleaved by either reductive conditions [93] or strong 
bases [94], both methods were tried to find optimal conditions (table 10). 
Method: Conditions: Result: 
reduction 100 eq. NaH, THF, reflux No reaction 
reduction 1000 eq. NaBH4, THF, reflux, 48 hr. No reaction 
reduction Me3OBF4, then NaBH4, THF, RT No reaction 
reduction 
1000 eq. LiAlH4, THF, reflux 
24 hr. 
Aluminium insertion into 
porphyrin 
reduction 
 500 eq. LiAlH4, 500 eq. AlCl3, THF, 
reflux 
No reaction 
basic deprotection 100 eq. KOMe, MeOH, reflux No reaction 
basic deprotection 100 eq. KOMe, dioxane, reflux 95% yield 
Table 10: Deprotection of the thiocarbamate. 
The deprotection only proceeded under strong basic conditions using 100 eq. of KOMe in 
dioxan at 100°C (scheme 5). The yield obtained was nearly quantitative and the thiol function 
is surprisingly little sensitive to oxidation: leaving the compound in air for more than one day 
did not reveal any oxidation as proved by the clean NMR and mass spectra obtained. 
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Scheme 5: Deprotection of the thiocarbamate. 
As for the other steps the solution structure was determined by NMR. The conformation of 
the aryl substituents of 22 remain identical to the one of 21 as the same NOEs are observed. 
Upon heating the conformation of the aryl moiety did not change. The meso protons, the 
methyl on the pyrrole and the butyl side chains are now giving for each distinct group of 
proton a single resonance signal (table 11). This means that the symmetry of the pyrroles has 
been recovered upon deprotection. Such a situation is induced by a change in the placement of 
the bridge relative to the porphyrin macrocycle. It lies now more perpendicular respective to 
the tetrapyrrolic macrocycle probably to maximize a possible hydrogen bond between the SH 
and nitrogen from the pyrrole. This assumption is confirmed by the exchange peak between 
the NH of the porphyrin and the SH. It is particularly strong whereas the exchange peak with 
water for both the SH and the NHporphyrin
 signal is very weak. The chemical shift of the SH 
which is found at the very high field value of –3 ppm for a thiol group (typical shift for SH: 2 
to 6 ppm) reveals that the thiol functionality is located in the vinicity of the centre of the 
porphyrin ring. Thereby the sulphur atom will be ideally placed for a future coordination with 
the iron atom. 
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Protona) d/ppm 
H10, 20 10.12 
H5’ 8.64 
NHPiv 8.46 
H4’ 7.77 
H3’ 6.94 
H3“, 5“ 6.2 
CH2a 4.05-4.02 and 3.94-3.9 
CH2a” 3.62 
Mepyrrole 2.62 
CH2b 2.12 
CH2g 1.67 
CH3d 1.05 
H2”’ (tert-butylbridge) 0.87 
CH2g’ 0.67 
NHPiv (tert-butyl) 0.55 
CH2b’ 0.47 
NHporphyrin -2.13 
SH -3.01 
Table 11: NMR chemical shifts for 22 
a) see figure 22 for numbering, Conditions: 2 mM in CDCl3 at RT. 
The force field calculation illustrates the structure proposed in solution (figure 33). 
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Figure 33: Force field molecular modelling of the thiol porphyrin 22. 
 
V.2.4.4. The iron insertion. 
Finally the iron was inserted to obtain the target molecule. This step revealed difficulties to 
obtain pure compounds using standard procedures (table 12). 
Method: Conditions: Results: 
Iron (III) salt, solvent FeCl3 hydrate, toluene, reflux No insertion 
Iron (II) salt, base, solvent 
30 eq. FeBr2, 2,6 lutidine 60 eq., 
toluene, reflux 
100% insertion 
< 10% pure 11  
Iron (II) salt, base, solvent 
10 eq. FeBr2, 20 eq. Et3N, toluene, 
reflux 
100% insertion,  
75% pure 11 
Table 12: Iron insertion methods. 
We postulated that the use of a functionalised pyridine counter base- 2,6 lutidine, led to the 
formation of pyridine oxides. The latter are generated by the trace of oxygen which remain 
despites working in a glove-box (O2 level about 0.1 ppm) or with Schlenk tubes. They are 
responsible for porphyrin oxidation probably via the formation of an high valent iron-oxo 
species (scheme 6). 
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Scheme 6: Possible degradation of the porphyrin in the presence of N-oxides 
To circumvent this problem we used triethylamine (scheme 7) as other iron insertion methods 
did not work with an analogue bridged species [95]. 
Actually the use of triethylamine prevents porphyrin oxidation thereby increasing the yield in 
pure product up to 75% (scheme 7). The purification could be achieved simply under an argon 
or nitrogen atmosphere as the iron complex turned out to be stable even after prolonged 
exposure to air. 
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Scheme 7: Iron insertion. 
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V.2.5. Synthesis of the catalase mimic 12. 
The target structure 12 is the following (figure 34). The synthesis relies on the same 
retrosynthesis as for the CPO model 11 (scheme 1). 
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Figure 34: Target catalase model 12. 
 
V.2.5.1. Synthesis of the bridge moiety 16. 
The synthesis of the proper bridge 16 shown in scheme 8 for obtaining the desired structure 
12 is similar to the synthesis used for the sulfo bridge 15. 
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Scheme 8: Synthesis of bridge 16. 
Upon two successive allylether formation and Claisen rearrangement the tetra substituted 
phenol 27 obtained is protected as thiocarbamate. Subsequently the double bounds are 
hydroborated and the alcohol functionalities are subsequently transformed to the 
corresponding mesylate. 
For the sulfo bridge 15 used for the obtainment of the CPO model 11, a Newmann-Kwart 
rearrangement is done before the hydroboration step which yields 26. 
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V.2.5.2. Bridged porphyrins 30 and 31. 
As for 21 the bridge 16 was coupled to pure 20a under dilute conditions and slow addition of 
it to yield the protected phenolate analogue 30 of 21 (scheme 9). 
NH
N
NH
N
O
O
O
NH
HN
O
S
N
19a + 16
Cs2CO3, DMF, 70°C60%
30
O
 
Scheme 9: Synthesis of 30. 
If the UV-Vis spectrum of 30 is not different from the one obtained for 21 the NMR reveals 
slight shifts indicative of a different conformation for the bridge moiety of 30 compared to 21 
(table 13). 
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Protona) d/ ppm for 30 D(d)/ppm from 21 
20 10.10 -0.01 
10 9.71 -0.01 
5’ 8.59 -0.02 
4’ 7.77 0 
3’ 6.98 +0.03 
NHPiv 8.29 -0.13 
3“, 5“ 6.33 -0.04 
CH2a 4.15-3.6 0.2 
CH2a’ 4.15-3.6 0.02 
CH3pyrrole 2.69 and 2.55 -0.03 and 0 
CH2b’ 0.1 -2.12 
CH2g’ 0.03 -1.57 
CH2b 2.2 -0.02 
CH2g 1.75 0 
CH3d 1.14 and 1.12 0 and –0.01 
tert-butyl bridge 1.26 +0.17 
NHPiv (tert-butyl) 0.47 -0.05 
N(CH3)2 2.1 and –2.17 +0.38 and –0.85 
NHporphyrin -2.2 -0.2 
Table 13: NMR chemical shifts for 30 compared to 21. 
The NOE effects which are essentially identical to the one observed for 21 and the 2D-NMR 
spectra lead to the following proposed structure (figure 35). 
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Figure 35: Solution structure of 30. 
In the next step (scheme 10) the thiocarbamate was deprotected under milder conditions as 
only 60 eq. of KOMe were necessary to obtain pure 31 with 95% yield. 
NH
N
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N
O
O
OH
NH
HN
O
O
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Dioxan,D
95%
30
31
 
Scheme 10: Synthesis of 31. 
As for 30 the same NOE signals are comparable to the data obtained for 22. But they are for 
some signals of the bridge moiety stronger. The chemical shifts of the signals which are 
attributed to the bridge moiety are also slightly different (table 14). 
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Protona) d/ppm for 31 D(d)/ppm from 22 
H10, 20 10.14 0.02 
NHPiv 8.36 0.10 
H3“,5“ 6.11 0.09 
CH2a 3.94 0.2 for one set of 21
b) 
CH2a“ 3.65 0.03 
CH3 pyrrole 2.65 0.03 
CH2b 2.06 0.06 
CH2g 1.71 0.06 
H2”’ (tert-butyl) 0.89 0.22 
NHPiv (tert-butyl) 0.53 0.02 
CH2b” 0.5 0.03 
CH2g”’ 0.08 -0.79 
OH -2.15 +0.85 
NHporphyrin -2.29 -0.16 
Table 14: Selected chemical shifts of 31 compared to 22. 
a) see figure 22 for numbering, b) in 22 the corresponding protons are splitted in two 
multiplets (table 11), Conditions: 2 mM 31 , 300 MHz, CDCl3, RT. 
Taken together these observations indicates that the phenolate is closer to the porphyrin core 
than is the thiolate. The perpendicularity of the bridge respective to the porphyrin plane is also 
increased as confirmed by force field calculations (figure 36). 
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31 
Figure 36: Solution structure for free phenol porphyrin 31. 
The conformational analysis based on the NOE effects reveals that the change of geometry 
obtained for the Caryl-Camide bond in comparison with 18a and 20a in the bridged structure 21, 
22 (precursors of CPO model 11) and 30, 31 (precursors of catalase model 12) is a unique 
feature due to bridging. 
Finally the catalase mimic 12 was obtained from metal free precursor in 90% yield using the 
same iron insertion procedure as for 11. Noteworthy the time which was necessary for the 
iron insertion increased from 1 hr. to 12 hr. probably reflecting the difference in the geometry 
between both models and a difference in the redox potential between 22 and 31. 
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VI. Resting State studies. 
 
VI.1. UV-Vis spectroscopy. 
UV-Vis spectroscopy is widely used for the characterisation of porphyrins as it requires 
very small quantities (nanomoles) of product. For iron porphyrin complexes it is a 
powerful method to characterize: 
1. the oxidation state of the iron, 
2. the nature of axial ligation and 
3. the number of ligands. 
The spectra of porphyrins are known since 1883 when Soret [96] identified the most 
intense absorption band of porphyrins. The spectra are reflecting two types of electronic 
transitions which give raise to two distinct types of absorption bands: 
1. a very strong band known as the Soret band and 
2. 10 to 100 times less intense satellite bands in the visible region (500 to 800 
nm). 
The number of distinct satellite bands depends i.a. on the presence or absence of a metal. 
Usually the metal free porphyrins are characterized by four absorption bands in the visible 
region whereas metal containing one only have two bands. The absorption bands are due to 
a p-p* electronic transitions. For metal containing porphyrin complexes the absorption 
bands corresponding to d-d transitions of the metal are not observed as their intensity is 
very low. 
The classification of porphyrin spectra has been established by Gouterman et al. [97]. 
Three type of spectra are encountered with porphyrins. These are: 
1. normal absorption spectra, 
2. hyper absorption spectra and 
3. hypso absorption spectra. 
In normal absorption spectra the Soret band corresponds to a p electron transition from an 
a1u(p) or a2u(p) orbital to an eg(p) orbital. The a1u or a2u orbitals are the HOMO orbitals of 
the porphyrin ring system whereas the eg orbital usually corresponds to the LUMO orbital 
of the porphyrin. 
In hypsoporphyrin spectra the influence of the metal d orbitals induces a blue shift of the 
Soret band respective to the metal free precursor. This is due to the presence of a filled eg 
(dp) orbital of the metal which modifies the energy level of the HOMO and HUMO of the 
porphyrin. 
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With thiolate ligation a third type of spectra is encountered: the hyperporphyrin spectra. 
This is the case for the iron (II) spectrum upon binding of CO (carbon monoxide) and it is 
the signature of the thiolate ligation. Namely only with thiolate as a fifth ligand such a 
spectrum is obtained with hemes upon CO binding. The Soret band is red shifted compared 
to the metal free one and the Soret band is accompanied by new strong absorption bands 
which are not attributed to the HOMO/LUMO transitions. They are due to strong 
interactions of the metal d electrons with the porphyrin orbitals which creates charge 
transfer interactions. Among these spectra the most current case is the presence of a “split 
Soret” band. One Soret band is found blue shifted compared to normal porphyrin spectra 
between 350 and 390 nm whereas the second one is found red shifted between 440 and 480 
nm. The origin of the splitting of the Soret band is complex in the case of heme thiolate 
complexes and can not be explained only by charge transfer interactions between the ring 
and the metal. It is probably due to the transition of a p electron of the thiolate to the 
LUMO of the porphyrin [98]. 
 
VI.1.1. The CPO model 11. 
The UV-Vis spectra obtained with the CPO model 11 reveal some solvent dependence 
regarding the shape of the absorption bands. The Soret band is more broadened in 
methylene chloride than in toluene. The use of MeCN, DMSO or DMF which can 
potentially coordinate to the iron results in contrary to a less broadened band but no shift of 
the absorption maxima are observed. This indicates that DMF, DMSO or MeCN probably 
do not coordinate to 11 as upon coordination a change in the geometry and electron density 
would happen. This would cause a change in the value of the Soret band. 
The results suggests that the CPO model 11 is a five coordinated complex. Namely if 11 
would be a six coordinated complex this would imply that the sixth ligand is a stronger 
ligand than DMSO, DMF or MeCN. But from the synthetic procedure the ligands which 
can occupy the sixth axial position can only be bromide (from the iron dibromide) or water 
(present in the solvents and silica gel used for chromatography). Both ligands are known to 
be weaker ligand than DMSO or DMF which strongly supports the five coordinated state 
for 11. 
The spectrum in toluene (figure 37) is characterized by a broadened Soret band at 406 nm 
with a slight shoulder at 380 nm. After protonation with strong acids such as HCl or HBr 
the Soret band shifts to 390 nm and the shoulder disappears. The modification of the 
spectra upon acid addition indicates that the sulphur is fully deprotonated upon iron 
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insertion. We propose that the shoulder is a contribution of the thiophenolate ring to the 
UV-Vis spectrum. 
In the visible region the spectrum is rather featureless. Only broad bands having maxima at 
512 nm and 580 nm are observed. This pattern is typical of high spin iron (III) complexes. 
The iron oxidation state was also checked by addition of reductants. Upon addition of 
potassium superoxide, tretraethylammonium cyanide or sodium borohydride the Soret 
band is shifted to 418 nm and is less broadened. This 10 nm red shift is typical of a 
reduction process centered on the iron. 
 
VI.1.2. The catalase model 12. 
The UV-Vis spectra of the catalase model 12 are solvent independent with the exception of 
acetonitrile which causes a 2 nm blue shift of the Soret band. The visible region is 
composed of broad bands centered at 485 and 600 nm. As discussed for the CPO model 11 
the absence of solvent effect on the Soret band indicates that 12 is most probably a five 
coordinated iron (III) complex. The shift in MeCN could nevertheless suggest a 
coordination of the solvent to the iron. 
Contrary to 11 the Soret band is clearly separated from a shoulder at 354 nm (figure 37). 
As is the case with 11 the shoulder disappears upon addition of acid and the spectra 
obtained are characterized by a broadened Soret band at 390 nm. The shoulder, based on 
the native protein spectra, is attributed to the phenolate ring [35]. 
 
Figure 37: UV-Vis spectra of complexes 11 and 12 in toluene at RT. 
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VI.2. NMR spectroscopy. 
The use of NMR spectroscopy in paramagnetic species is of great interest since many 
structural informations can be deduced from the spectra of heme proteins. 
 
VI.2.1. Paramagnetic NMR. 
To describe the interaction of a spin system I, S in a magnetic field in liquids one can start 
with the time independent Schrödinger equation: 
H  y = E y .    eq. (1) 
Where H is the spin Hamiltonian operator, E the corresponding observable energy and y 
the eigen function. This is the same formalism as the one used for electrons in a molecule. 
The Hamiltonian for paramagnetic NMR have three terms: 
H   = H Zeeman + H S + H paramagnetic.    eq. (2) 
The scalar spin spin coupling Hamiltonian H S which is important for the EPR 
spectroscopy will be discussed later in VI.2.3. The first term, the spin Zeeman 
Hamiltonian, describes for one spin the energy of the interaction of the magnetic moment 
m, which is proportional to the spin of the nucleus m = É g I and the magnetic field B0. H 
Zeeman becomes: 
H Zeeman= - É g B0 Iz = - É w0 Iz.     eq. (3) 
Where É is the reduced Plank’s constant, w0 the rotation frequency and g the gyromagnetic 
ratio. For a nucleus with a spin number ½ the energy difference for the observable 
transition is then given by: 
DE = É g B0 = É w0.   eq. (4) 
In the nature the nuclei are not isolated, but are part of a molecule. Due to interaction with 
the electronic shells of other atoms of the molecule and with other molecules the effective 
field B’ seen is reduced and the transition energy becomes: 
DE = É g B0 (1 -s) =  É g (B0 – Bdiamagnetic)   eq. (5) 
where the correcting factor s is known as the isotropic shielding constant. 
The third term in eq. 2, the so-called isotropic or paramagnetic Hamiltonian, now 
represents the interaction of the nucleus with the paramagnetic moment, normally an 
unpaired electron, S and has itself two parts: 
H paramagnetic = H dipolar + H contact   eq. (6) 
The first term in eq. 6 is the classical dipole dipole Hamiltonian H dipolar and represents the 
interaction between the dipolar moment of the nucleus observed and the paramagnetic 
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center. The Fermi contact Hamiltonian Hcontact is the result of a finite quantity of electron 
spin density on the place of the nucleus being observed. 
To discuss the paramagnetic effect it is common to use the ratio of the relative change in 
the field and the external field B0: 
(DB/B0)isotropic = (DB/B0)dipolar + (DB/B0)contact    eq. (7) 
For discussion of paramagnetic effects we eliminate the also observed diamagnetic part 
according to eq. (5) by subtraction of that part to get the isotropic (or paramagnetic) shift: 
(DB/B0)isotropic =  (DBobs - DBdiamagnetic) / B0.   eq. (8) 
Both the Fermi contact shift and the pseudocontact shift can be calculated if some 
geometrical data are known or if the components of the magnetization in the x, y and z 
directions are known. Most formula used for determining the value of these shifts relies on 
oversimplifying hypotheses so that they only apply in cases where the symmetry of the 
complex is very high. Thereby their use is quite limited. 
However the numerous studies on heme by NMR have permitted to establish guidelines for 
the attribution of the resonance signals and for determining the predominant origin of the 
paramagnetic shift. As we will deal principally with iron (III) complexes we will next 
develop in VI.2.2. the principles which have been established in this case. 
Additionally the relaxation is important in the understanding of the NMR spectroscopy of 
paramagnetic compounds. By applying radio frequency (RF) pulses to a spin system in a 
magnetic field it is brought into a none equilibrium state. Relaxation is the process by 
which the spins return to their equilibrium state. The spin spin or transverse relaxation time 
T2 directly influences the observed free induction decay (FID) after a RF pulse. A fast 
decay results in a short T2 and after a Fourier transformation (FT) of the time domain 
signal to the frequency domain in broad lines in the spectra. In contrary if T2 is long the 
lines become sharp. The longitudinal relaxation time T1 also influences the NMR spectra, 
mainly the intensity of the observed lines. It is also called spin lattice relaxation time, 
because the spin exchanges energy with the environment. Important for paramagnetic 
NMR is that T2 can always be only equal or lower than T1. 
 
VI.2.2. The 1H-NMR of iron (III) porphyrin complexes. 
The results obtained for iron (III) porphyrin complexes are first depending on the spin state 
of the complex. The two most common spin states encountered for iron (III) are the low 
spin (S=1/2) and the high spin (S=5/2) state. Both spin states are easily distinguished by 
NMR spectroscopy as in the high spin state the relaxation rate (T2=10
-12-10-11 s-1) is 10 
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times higher than for the low spin complexes (T2=10
-11-10-10 s-1). The short T2 for high spin 
iron (III) heme complexes results in broadened signals. As the value of T2 is smaller for 
iron (III) high spin species than for iron (III) low spin species the NMR spectra of high 
spin complexes are characterized by more broadened signals- typically the line width is 
over 300 Hz and up to 1,000 Hz- than for low spin systems where the line width ranges 
from around 100 Hz to 400 Hz. The second difference between both spin states is the range 
of chemical shifts observed. Whereas for high spin species a signal range of over 100 ppm 
is observed, the low spin complexes signals range from –20 to +20 ppm (40 ppm range) 
[99]. 
Most high spin iron (III) complexes which have been studied until now are five 
coordinated complexes as the presence of a sixth ligand usually induces a spin state change 
from high spin to low spin. The estimation of the dipolar and contact shift has been done 
for several TPP iron complexes [100] and for octaalkyl porphyrins [99] as well as for 
natural heme [101]. From these studies the following conclusions appear: 
1. For the meso phenyl substituents the origin of the paramagnetic shift is 
approximately equally distributed between dipolar and contact shifts and is found 
in a range of ±6 ppm. Usually it is found positive for the ortho and para positions 
and negative for the meta position. 
2. For the b pyrrole substituents the isotropic shift is essentially of contact origin and 
is strongly negative. It results in a very large isotropic shift of –30 to –60 ppm for 
the H, CH3 or CH2a at the b pyrrole position. The origin of the negative contact 
shift is the s spin density at the pyrrole positions. A strong s donation of the 
nitrogen lone pair in the Fe-N bond may increase this effect. The further CH2 of the 
alkyl chains at b pyrrole position are practically not affected by the paramagnetic 
shift. 
3. For the meso protons the origin is also essentially the contact shift. This shift is 
found to be very important and is usually positive. This results from a p spin 
density at the meso position which is consistent with the unpaired spin electron 
delocalisation from the dxy, dyz orbitals to the LUMO eg orbital of the porphyrin 
ring system or to p back bonding (charge transfer). 
4. However it has been pointed out that the sign of the contact shift for the meso 
position is dependent on the coordination number of iron. In five coordinated 
complexes the fifth ligand induces an out of plane displacement of the iron which 
results in a less important spin delocalisation to the porphyrin ring. In six 
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coordinated iron complexes the metal is in the “plane” of the porphyrin which 
results in a maximal spin delocalisation [102]. Consequently a positive isotropic 
shift for five coordinated iron (III) complexes and a negative isotropic shift for six 
coordinated iron (III) complexes is observed. 
Accordingly the NMR spectra of high spin iron (III) porphyrin complexes are an essential 
tool for determining the coordination number of the iron. 
 
VI.2.3. NMR spectra of the complexes. 
In order to gain information on the coordination of an eventual sixth ligand to the iron and 
to determine the spin state of the complexes we have recorded their NMR spectra at 
different temperatures. The first point which was decisive was the choice of the solvent. 
Namely most of polar organic and protic solvents can coordinate to the iron. Thus the 
solvents which remain are: toluene or eventually chloroform. Toluene was used first as the 
characterization of catalytic intermediates was done in this solvent. The spectra obtained in 
toluene are characterized by broad lines ranging from –60 to +140 ppm at 295 K. The line 
width measured was up to 1,000 Hz. This is a first indication for an iron (III) high spin 
complex for 11. 
In order to assign the signals which are arising from the bridge moiety the spectra of the 
iron complex of 17b has also been recorded. The later looks like the combined spectra of 
octaalkyl iron (III) porphyrins and of tetraphenyl iron (III) porphyrins. Hence the signals of 
the methyl pyrrole protons, CH2a protons and of the aryl substituents were assigned by 
comparison. 
The important signals for the CPO model 11 (table 15) were assigned according to the data 
obtained with the iron complex of 17b. The signal at 90 ppm was assigned to the H3”,5” 
protons of the thiophenolate moiety as the value is in good agreement with the value 
reported for free thiophenolate iron porphyrin complexes [103]. Moreover this signal is not 
detected in the non bridged complex. 
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Protona) d  /ppm
b)  
d8-toluene
 
d/ppm 
(literature): 
10, 20 -57.1 ~ -50 [100] 
3’ 13.17  [100] 
4’ 10.61 11-13 [100] 
5’ 8.30 [100] 
Me pyrrole 38.00 
35-70c) [99] 
[104] 
CH2a 39.44 and 35.92 30-50 [99] 
3”, 5” 85.33 60 [103] 
2”’ (tert-butyl) or 
CH2a’
d) 
5.37 and -1.57 d) 
Table 15: 1H-NMR of the CPO model 11 at 295 K. 
a): numbering according to figure 22; b) relative to TMS; c) for natural hemes the methyl 
groups give a set of four resonance where two signals are found at 35-45 ppm and two at 
55-70 ppm; d) the literature could not permit to attribute the signal unambiguously. 
The temperature dependence of the spectra in d8-toluene has been obtained in the range of 
–30°C to RT. The Curie plot ( d= f(T) where d is the chemical shift and T the temperature) 
of chosen signals are presented in figure 38. The reference is always the true chemical shift 
uncorrected from the diamagnetic contribution. 
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Figure 38: Curie plot of selected signals for 11 in toluene-d8. 
The results obtained, a quasi linear dependence of the chemical shift d vs. the inverse of 
the temperature T, demonstrate that the porphyrin has a Curie behaviour i.e. no secondary 
Zeeman interactions occur. The splitting of the meso signals by lowering the temperature 
suggests that either several conformations are frozen out or that the complex is not 
symmetric. This finding suggests that the shape of the EPR spectra could be unusual and 
may confirm this result. 
 
VI.3. EPR spectroscopy. 
The use of EPR spectroscopy in the determination of the spin state of iron complexes is a 
preferred method for physical chemists. EPR spectroscopy and NMR are complementary 
to each other. Whereas the NMR gives geometrical information on the molecule the EPR 
deals with the electron repartition in the d orbitals of the iron. Both techniques give the 
spin state but the symmetry around the iron can only be ruled out from the EPR. Nowadays 
the combination of both techniques has led to the development of ENDOR (electron 
nuclear double resonance) spectroscopy. 
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VI.3.1. EPR spectroscopy [105]. 
To interpret the EPR spectra of unpaired electrons we can use the same formalism as for 
NMR spectroscopy. The Zeeman Hamiltonian of eq. 2 becomes for an isolated electron S 
in analogy with eq. 3: 
H Zeeman = - g b  B0  Sz = - É w0 Sz     eq. (9) 
where É is the reduced Plank’s constant, b the Bohr magneton and B0 the magnetic field. 
The g factor is the most widely used information extracted from an EPR spectrum. The 
energy difference is according to eq. 4: 
 DE = g b B0  = É w0.    Eq. (10) 
Usually it is denominated geff as it is the value calculated from the Beff value where the 
resonance occurs. 
To describe additionally the interaction with nucleus spins I the spin spin coupling 
Hamiltonian H S is necessary and g becomes a tensor quantity: 
H S  = g I S eq. (11) 
where is S the electron spin tensor and I the nucleus spin tensor. 
The hyperfine interaction between S and I gives important information on the environment 
of the paramagnetic center. 
In EPR spectroscopy the continuous wave (CW) technique is still widely used and the first 
derivative of the absorption signal registered is plotted vs. the magnetic field. 
For heme protein the Hamiltonian is usually expressed in function of the projection of S 
and I in the x, y, z directions. And has the following expression: 
H   = g b B S + D [Sz2-1/3 S(S + 1)] + E (Sx2-Sy2] eq. (12) 
where E is the rhombic component and D the tetragonal component. 
 
VI.3.2. ENDOR spectroscopy (electron nuclear double resonance) [106]. 
CW-ESR only reflects the spin state and the geometry around the iron but is insufficient to 
reveal the number of ligands coordinated to the iron. NMR on the other hand permits to see 
ligands which possess a nucleus spin suitable for NMR. This situation is fortunately the 
case for many ligands encountered with porphyrins. Therefore since twenty years scientists 
are developing methods which combine the power of both EPR and NMR. The 
combination of both method has led to the ENDOR spectroscopy. 
The value of the coupling constant between the electron spin of the metal and the nuclear 
spin of the nucleus observed by NMR is the most useful piece of information extracted 
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from an ENDOR spectra. It permits to determine the local geometry around the 
paramagnetic center. 
 
VI.3.3. Results for the CPO model 11. 
The EPR spectra of the thiolate complex 11 recorded at 100 K and 5 K do not show any 
temperature dependence of the spin state (figure 39). This results is in contrast with the 
known spin state change of CPO upon lowering the temperature [107]. 
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Figure 39: CW-EPR spectrum at 5K of 11. 
The position of the EPR lines which are found at geff= 8.35, 5.77 3.07 and 2.00 are 
indicative of an high spin configuration. These values are usually obtained for the resting 
state of heme-thiolate proteins at RT or for the heme-substrate complex of them. The 
additional sharp absorption-like line at geff=8.35 and the broad line at geff= 3.07 strongly 
contrast with the previous results obtained by Aissaoui et al. with an aqua complex [108]. 
The aqua complex was namely characterized by sharp first derivative like lines at geff= 
5.67 and at geff=2.00. Nevertheless the spectrum obtained with the CPO model 11 is in 
good agreement with the water free complex of them [109] where no sixth ligand is found. 
The shape of the spectra and the geff values are usually attributed to a rhombic symmetry 
around the iron. This kind of symmetry is also found in native CPO [107], P450cam 
substrate bound [110] and NOS [111]. In as much as the symmetry is concerned the CPO 
model 11 is an excellent mimic of the CPO resting state at higher temperature. The lack of 
spin crossover may be related to the lack of binding a sixth ligand in toluene. Namely the 
change of spin state could be related to the coordination of an additional ligand upon 
freezing the protein structure in CPO. For example the proximal water molecule [10] may 
upon lowering the temperature change its spatial position and coordinate to the iron at the 
g=8.347 
g=5.773 
g=3.079 
*: the signals are artefacts from the machine 
 84
vacant sixth position. This hypothesis is supported by the predominantly low spin character 
of P450cam without substrate where it has been proved by X-Ray diffraction that a water 
molecule coordinates to the iron [112]. 
However the recent progress in simulation of EPR spectra questions the validity of the 
rhombic symmetry explanation for the signals. Namely if one assumes a pure rhombic 
symmetry then E/D=1/3 and the geff values should be 4.3 and 2 approximatively. Therefore 
some authors have proposed that the local symmetry around the iron atom is still axial but 
that the influence of the additional parameters a and F in the description of the spin 
Hamiltonian (see eq. (12)) is not any more negligictable [113]. Accordingly the 
Hamiltonian H S  becomes: 
H S  = g b B S + D [Sz2-1/3 S (S + 1)] + E (Sx2 - Sy2] + a/6 [Sz4+ Sy4+ Sx4- 1/5 S (S + 1) (3S2 
+ 3S-1) + F/160 [35 Sz
4 – 30 S (S + 1) Sz
2 + 25 Sz
2 –6 S (S + 1)+ 3 S2 (S + 1)2] eq. (13). 
The second proposal which is advanced is that the interactions between the geff factors is 
strong and negative (i.e. g^ > g||) [113, 114]. 
A distinction between the two last theses is not possible as the experiments do not permit 
to evaluate the parameters a and F. 
However other possibilities can be enviewed. The first one which would account for the 
broad signal at geff= 3.07 and relies on the degree of flexibility of the CPO model 11. The 
EPR simulations suggest that the signal at geff=3.07 is essentially due to a contribution of 
the sulphur from the bridge. As the sulphur is linked to the porphyrin via a “bridge” a 
certain degree of freedom for the placement of the bridge moiety respective to the 
porphyrin plane is possible. This freedom could generate several crystalline forms of 11. 
This hypothesis is also supported by the temperature dependent NMR measurements which 
have revealed a splitting of the meso resonance signals upon lowering temperature. 
The second possibility would be the role of the solvent used in defining the crystal 
network. Sharp line arise in EPR spectra when the paramagnetic centers are distributed 
randomly respective to the axis of the magnetic field. With toluene there is a tendency to 
form an oriented crystal network. This results in a non random distribution of the complex 
11 in the EPR probe which could be the origin of the broadened signals as well. Moreover 
intermolecular interactions could occur and also yield to a broadening of the line by spin-
spin coupling. 
The last hypothesis is that a large amount of electron spin from the iron is delocalised to 
the sulphur via the s-bond interaction. This would be also accompanied by a large out 
plane displacement of the iron i.e. by a large rhombic distortion. 
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Probably all hypotheses taken together contribute to the shape of the spectra obtained for 
11 and further experiments are required to judge the most adequate proposal discussed 
above. 
 
VI.3.4. Results for the catalase model 12. 
The EPR spectra of the catalase model 12 (figure 40) show marked difference to the 
spectra of the thiolate complex 11 (figure 39). First the signal intensity for 12 at the same 
concentration is greater than for 11. Such a result can be explained by a longer relaxation 
time for 12 than for 11. 
Second the spectra are characterized by two sharp signals at geff=5.83 and geff=2.00. Its 
shape is corresponding to classical first derivative signals in EPR spectroscopy. Whereas 
the spectra of thiolate complex 11 were rather indicative of a rhombic symmetry, the 
phenolate complex 12 presents an axial symmetry with a very weak rhombic distortion 
(indicated by the small shoulder in the geff=5.83 signal). For 12 the simulations [114] fit 
with the experimental spectra. The g|| factor which corresponds to geff= 5.83 represents the 
amount of spin in the z direction (i.e. parallel to the static magnetic field) and the g^ which 
is geff=2.00 the amount of spin in the (x, y) plane. Such a spectrum is typical of a pure high 
spin iron (III) complex [115] and fits with the spectra of Beef Liver Catalase obtained by 
Jung et al. at neutral pH [116]. 
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Figure 40: CW-EPR spectrum at 5K of 12. 
*: the signals are artefacts from the machine 
g=5.831 
g=2.008 
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Attempts to detect an eventual sixth ligand by ENDOR spectroscopy did not reveal any 
nucleus coupling to the iron thereby confirming the NMR conclusions on a five 
coordinated high spin iron (III) complex for 12. There are several proposals to explain the 
different shapes of the EPR spectra of 11 and 12. 
First in the case of the catalase model 12 a p back bonding interaction between the oxygen 
and the iron is not possible as the oxygen atom does not possess d orbitals. As the 
electronegativity of the oxygen is greater than the one of the sulphur, the s bond between 
the oxygen and the iron in 12 is not as strong as in the case of the sulphur in complex 11. 
This means that both the iron and oxygen conserve their spin density in 12 whereas in 11 
the spin density of the iron is displaced to the sulphur. 
Second the geometric characteristics (table 16) of the sulphur iron bond and the oxygen 
iron bond can also account for the results. The iron sulphur bond is longer than the iron 
oxygen bond when the crystallographic data of heme-thiolate proteins are compared to 
catalase (table16). This may also favour the out plane displacement of the iron in 11 
compared to 12. Also the angle of the phenyl-sulphur-iron and of the phenyl-oxygen-iron 
should be smaller for the CPO model 11 than for the catalase model 12. These geometrical 
data implies that the geometrical flexibility for the complex 12 is lower than for complex 
11. Thereby there could be a single crystalline form obtained for 12 upon crystallisation 
which could contribute to sharper ESR signals. 
 
Enzyme Fe-S resp. Fe-O (in Å) Angle (Fe-S-C) resp. Fe-O-C) (in °) 
P450cam 2.31 105.2 
NOS 2.3 105.7 
CPO 2.35 107.5 
BLC 1.98 132.5 
 
Table 16: X-Ray data for heme-thiolate proteins and catalase [117]. 
 
VI.4. Electrochemistry. 
 
VI.4.1. Principle of the method: cyclic voltammetry. 
The complete characterization of the resting state requires the estimation of the redox 
potential. The redox potential is a very important characteristic of the heme proteins as it 
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determines their ability to be reduced by NAD(P)H or a reductase enzyme. The ease of 
reduction is also linked to the ability to bind oxygen. 
The factors controlling the redox potential are complex. Among them the nature of axial 
ligand, the presence of electron withdrawing/donating groups on the porphyrin skeleton, 
the nature of the substituents and the solvent are important factors that determine the value 
of the redox potential. 
To estimate the redox potential the complexes were submitted to cyclic voltammetry. 
Cyclic voltammetry is a versatile method to study electroactive species. The principle is 
extremely simple: the potential of a working electrode is cycled and the resulting current is 
recorded. The electron exchange is achieved at the surface of the electrode. The parameters 
influencing the results are the scanning range of the potential, the scan speed, the salt and 
the solvent. The choice of the scan range is important to ensure a reversible process. The 
scan speed has also to be carefully chosen to avoid non diffusion controlled processes. It 
also depends on the stability or half-life time of the reduced species which is generated 
during the measurement. 
 
VI.4.2. Results. 
The cyclic voltammograms of both complexes 11 and 12 are typical of a reversible process 
which is a metal centered, one electron transfer to the electrode (figure 41). The difference 
between the anodic peak potential and the cathodic peak potential is 80 to 90 mV, a value 
characteristic of iron porphyrin complexes. Interestingly the value of the redox potential 
are very close from one to the other suggesting a minor role of the axial ligand in the 
determination of the redox potential (table 17). 
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Figure 41: Cyclic voltammograms of 11 and 12. 
Conditions: 2.3 mM 11 or 12 in 0.1M LiClO4 DMF solution saturated with LiBr, scan 
speed 100 mV s-1. 
Compound: Ered (mV): Eox (mV): DE (mV): E0 (mV): 
11 -605 -525 80 -565 
12 -640 -550 90 -600 
Table 17: Values of the redox waves measured by cyclic voltammetry. 
This finding is in strong contrast with the influence of the peripherical substituents. For 
comparison the replacement of the N-pivaloyl groups by an amide furan functionality 
shifts the potential positively of 250 mV [118]. This suggests that the protein environment 
is significant for controlling the redox potential and not the nature of the fifth axial ligand 
for a given spin state. More particularly the strong negative values obtained supports that 
the presence of hydrogen bond to the thiolate resp. phenolate is an essential factor in tuning 
the redox potential as demonstrated by Morishima et al. with P450cam mutants [119]. 
Recently Ueyama et al. have also shown that each hydrogen bond to the thiolate sulphur 
results in a positive shift of the redox potential of 250 to 300 mV [120-122]. 
The results with 11 and 12 also support that the thiolate resp. the phenolate strongly 
donates electron density to the iron in the absence of hydrogen bond. 
CPO model 
11 
Catalase 
model 12 
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VI.5. Summary. 
The complete characterization of complex 11 and 12 has revealed that both species are 
high spin five coordinated iron (III) complexes. Therefore, as the data are comparable to 
the literature reports on the native enzymes, both 11 and 12 are good mimic of CPO and 
Beef Liver Catalase respectively. 
The differences observed between 11 and 12 reflects that the axial coordination differ 
between thiolate and phenolate. On the base of NMR data, craft field modelling and 
published X-Ray structures of heme-thiolate proteins and catalase [117] we suggest that 
the angle between the thiolate ligand and the z-axis is smaller than for the phenolate and 
that the iron sulphur distance is greater than the iron oxygen distance. In other words the 
phenolate ring is more perpendicular to the porphyrin plane than is the thiophenolate ring. 
The sulphur has also a stronger s bond to the iron which is reinforced by a p back bonding 
interaction. This results in the displacement of the electron spin of the iron to the sulphur. 
Such a situation does not occur with the oxygen phenolate. 
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VII. Characterization of catalytic intermediates. 
After the characterization of the resting state the next problem was to determine the ability 
of 11 and 12 to form stable complexes with ligands. This investigation requires to find 
ligands with good binding constants and find conditions to minimise side-reactions such as 
porphyrin degradation. 
 
VII.1. Preliminary studies with water. 
As mentioned in VI.3.3. CPO induces a spin state change when the temperature is lowered 
[107]. We have postulated that the binding of a water molecule upon freezing could be the 
reason of this spin crossover phenomenon. In order to verify this assumption we have 
examined the possibility of obtaining a water complex of 11 and 12. Therefore we have 
attempted to detect water binding under several conditions summarized in table 18: 
Solvent: Water (% vol): Time: Result: 
Toluene 3% (toluene saturation) 24 hr No binding 
Toluene 50% (biphasic system) 48 hr No binding 
MTHFa) MTHF saturated with water 48 hr No binding 
Table 18: Attempts to form water complex of 11 and 12. 
a) MTHF= 2-methyltetrahydrofuran. 
The conditions chosen took into account the requirement of the EPR and ENDOR 
techniques which limit the choice of solvent to obtain good results i.e. a good matrix [123]. 
The formation of a water complex was followed by UV-Vis spectroscopy. If water would 
bind to the five coordinated complex a red shift of the Soret band is expected to occur as 
the electron density around the iron is increased. 
Despites several experiments varying the reaction time no change in the UV-Vis spectra of 
both the CPO model 11 and the catalase model 12 were detected. This suggests that water 
does not bind at the sixth axial position of iron. 
To verify this assumption NMR and EPR spectra were also recorded for 11 and 12. The 
NMR spectra remained unmodified with the meso signals being still detected at –50 ppm 
indicating that no coordination of a water molecule to the iron happened at RT either with 
the CPO model 11 or the catalase model 12. 
The freezing of the probes for EPR experiment could give raise to water coordination upon 
geometrical changes when crystallization occurs. The EPR spectra which were obtained 
after the saturation of the solutions with water did reveal minor changes. 
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For CPO model 11 solely the signals at geff= 5.79 and geff= 2.00 which were a minor 
contribution of an high spin iron (III) complex with axial symmetry disappeared. This 
finding indicates that the symmetry of the iron complex became more rhombic. Such a fact 
is per se indicative of a non coordination of water. If water would coordinate a 
displacement of the iron atom back to the porphyrin plane would be expected. Such a 
geometrical modification corresponds to a change from a rhombic to an axial symmetry 
(figure 42). 
Fe3+
L
out of plane displacement 
(rhombic distortion)
Fe3+
L
L'
in plane iron 
(axial symmetry)
represents the porphyrin plane  
Figure 42: Schematic representation of the geometry of five and sixth coordinated 
iron porphyrin complexes. 
The ENDOR spectra of 11 after water addition also did not reveal a coupling between 
water protons and iron. This result indicates that water was not coordinated to the iron, at 
least up to 5 K. 
For the catalase model 12 no change was obtained in the EPR spectra and an ENDOR 
experiment could not reveal the presence of water protons in the vinicity of the iron. Hence 
we also concluded that the water did not bind to 12 as well. 
These results for 11 and 12 suggest two explanations. First water which is known as a 
weak field ligand has a too low binding affinity to the complex. Second sterically 
demanding pivaloyl groups could prevent the binding of a sixth ligand. To get more 
information on the possibility of binding ligands we used a second approach. 
 
VII.2. Binding of strong field ligands. 
In this second approach to evaluate the affinity of our models for a sixth axial ligand we 
have used so-called strong field ligands which are know to bind strongly to the iron. Such 
ligands are e.g. imidazoles, and cyanide. These ligands would induce a change from high 
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spin to low spin system. Hence their binding would be easier to detect by NMR and EPR 
spectroscopy (see VI.2). 
 
VII.2.1. Binding of Imidazole and Imidazole derivatives. 
We first tried to bind imidazole to the CPO model 11 and to the catalase model 12. The use 
of toluene where the solubility of imidazole is poor did not permit to obtain the desired 
complex. Therefore we changed to methylene chloride with the same result and finally to 
DMF where imidazole has a greater solubility. Even then and despites the use of up to 
1,000 equivalents of imidazole no formation of an imidazole complex has been detected 
for 11 or 12 either by UV-Vis or EPR spectroscopy. Therefore we used 2-Methyl-
Imidazole and finally 4-Phenyl-Imidazole which is soluble in toluene and 2-
Methyltetrahydrofuran. For both derivatives the results were the same as for imidazole. 
The unability of the complexes to coordinate imidazole indicates that the binding constant 
are very low. There could be two reasons for this. 
The first one is the steric hindrance induced by the pivaloyl substituents and the butyl side 
chains which also prevent to some extent the access to the iron atom. They are namely 
found in a plane perpendicular to the porphyrin core. Thereby the binding of a sixth ligand 
could only be possible if the ligand is small enough or flexible enough to diffuse between 
the porphyrin plane, the butyl side chains and the “cap” formed by the pivaloyl 
substituents. If this hypothesis is correct the binding of cyanide should be possible. 
The second reason could be the presence of the bromide counter ion or of another species 
in the porphyrin sphere (figure 43). 
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Figure 43: Presence of molecules in the ligand sphere of a porphyrin. 
Although it has been established by both NMR and EPR analysis that the bromide doesn’t 
coordinate, it could still be present in the ligand sphere of the porphyrin thereby reducing 
the accessibility of another ligand. The detection of this counter ion is neither possible by 
the NMR nor by the EPR methods used. 
Further due to the use of triethylamine as a base in the reaction this molecule could also 
interact with the porphyrin in the ligand sphere. As diamagnetic molecule it should be 
detectable by NMR spectroscopy. Unfortunately in the region where the signals of 
triethylamine usually appear they are likely to be masked by the presence of the 
paramagnetic signals arising from the iron porphyrin itself. To verify this hypothesis only 
the use of a ligand able to displace species from the porphyrin ligand sphere would allow a 
change in the characteristics of the complex. 
 
VII.2.2. Binding of cyanide. 
The binding of cyanide was then tested with the CPO model 11 in toluene by adding 
tetraethylammonium cyanide. The first process which has been observed is not the primary 
binding of the cyanide to the iron but a redox process. Cyanide is namely also a known 
reductant of iron porphyrin complexes [124]. As a consequence the UV-Vis spectrum is 
found to be the sum of the corresponding iron (II) porphyrin complex with a maxima of the 
Soret band at 418 nm and of the iron (III) cyanide porphyrin complex characterized by a 
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maxima of the Soret band at 412 nm. The recording of the corresponding NMR spectra 
confirmed: 
1. the reduction from iron (III) to iron (II) which is then in a low spin 
configuration as revealed by the diamagnetic NMR signals obtained. 
2. The binding of cyanide to iron (III) to give a low spin iron (III) complex which 
NMR spectrum ranges from –10 to + 25 ppm. 
The preparation of the low spin complex of 11 with cyanide confirms that the very low 
binding constants found for imidazole could be due to steric hindrance or to the presence 
of a species in the porphyrin ligand sphere. Unfortunately this experiment can not 
determine which of the hypothesis is the most appropriate. 
These results demonstrate that 11 and 12 could be good mimics to stabilize catalytic 
intermediate provided the affinity for the ligand is high enough. These requirements may 
also explain why halides in particular the bromide ion from iron dibromide used for iron 
insertion does not remain coordinated to 11 and 12. 
 
VII.3. Formation of the -OCl complex. 
Given the possibility of binding small ligands we have pursued the characterization of the 
catalytic intermediates proposed for CPO. The first intermediate proposed is the -OCl 
complex which is obviously not the true catalytic species. 
Formation of such a complex in organic solvents can be achieved by two routes (figure 44) 
[20]: 
1. the direct formation via an hypochlorite salt which is soluble in organic solvent 
2. the indirect formation via the preliminary formation of compound I (oxo 
complex) as postulated for the native enzyme. 
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Figure 44: Formation of ClO- complex. 
We chose to use method 1. in a first approach as method 2. requires to first characterise 
compound I which is known to decay rapidly. 
 
VII.3.1. UV-Vis studies. 
The hypochlorite ion is commercially available as natrium hypochlorite aqueous solutions. 
As such aqueous solution are very little soluble in organic solvents they are not suitable for 
quantitative studies but can be used for qualitative comparisons. Therefore using a phase 
transfer catalyst, benzyltriethylammonium chloride, we have prepared methylene chloride 
solution containing hypochlorite [20]. After concentration of the solution the resulting salt 
obtained was a solid. This permits the exact quantification of the amount of hypochlorite 
added. The characterization of the hypochlorite complex of the CPO model 11 and the 
catalase model 12 was undertaken in methylene chloride first as the hypochlorite salt was 
prepared in this solvent. 
For the CPO model 11 the slow disappearance of the Soret band indicated that undesired 
side reactions such as oxidative degradation of the porphyrin core has occurred. The use of 
only 100 equivalent with 11 did not led to this reaction but no changes were observed. 
For the catalase model 12 the addition of up to 1000 equivalents of hypochlorite did not led 
to significant changes except a dilution effect. 
To check the influence of the solvent upon the formation of the ClO- complex we changed 
to toluene. In this solvent hypochlorite is known to be sparingly soluble via the formation 
of a charge transfer complex. 
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For the CPO model 11 the Soret band slowly shifted to 414 nm i.e. a 6-8 nm red shift 
compared the resting state upon addition of 100 equivalents of hypochlorite. This result 
indicates a probable binding of the hypochlorite ion to the iron. As for water the binding of 
hypochlorite results in an increased electron density around the iron, hence an expected red 
shift in the UV-Vis spectra. 
To confirm that the binding species was actually hypochlorite we repeated the experiment 
by using a biphasic system: 10% vol of an aqueous NaOCl solution were stirred with a 
toluene solution of 11 for 30 Min. After phase separation the UV-Vis spectrum obtained 
was identical to the one obtained with the benzyltriethylammonium salt procedure. 
However the results obtained do not permit to eliminate a second hypothesis. It is namely 
reported in the literature [125] that upon addition of hypochlorite to iron porphyrin 
complexes the so-called compound I is formed. Fortunately the UV-Vis, ESR and NMR 
spectra should make it possible to distinguish between the two proposed complexes. 
For the catalase model 12 no changes were detected independent of the quantity of 
hypochlorite added apart from dilution effects. This results seems to indicate that 12 
doesn’t bind hypochlorite and should be confirmed by using other methods. 
 
VII.3.2. EPR studies. 
The binding of ClO- should induce a change in the geometry of the complex and thereby in 
its symmetry. As discussed for water the symmetry should change to a more axial 
symmetry. Consequently the EPR spectra should be modified. 
For the CPO model 11 no changes were observed in methylene chloride indicating that 
obviously no coordination occurred in this solvent. 
When the solvent was changed to toluene the spectra were modified. The signals observed 
before in the region of geff=6-8 and 2.9 disappeared and led to a new single broad signal 
around g=2. As the signals lacks the typical three lines splitting of low spin iron (III) 
porphyrin complexes we propose that the iron is still in a high spin iron (III) state. 
When catalase mimic 12 was used a little change in the geff values were observed both in 
methylene chloride and toluene. This shift could suggest that a coordination had occurred. 
If so it has no influence on the spin state and symmetry of the complex and should be 
confirmed by the formation of HOCl complex which is expected to give a split Soret band 
and permits to use ENDOR spectroscopy which would detect the proton of the HOCl 
ligand. 
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VII.3.3. NMR of 11--OCl. 
To confirm the presence of a sixth ligand which can be judged from the chemical shift of 
the meso protons the NMR spectra of 11--OCl was recorded at RT in toluene d8. The 
signal at -50 ppm disappeared and a new signal around 40 ppm was observed. 
Accompanying this change the signals attributed to the b-methyl and b-CH2 were even 
more positively shifted. These changes clearly indicate that the sixth position is now 
occupied. 
 
VII.4. The HOCl complex. 
As the results obtained with the -OCl addition are not clear for the catalase 12 as the UV-
Vis spectra and EPR spectra do not see clear changes, the characterization of the 
protonated form of the models 11 and 12 was undertaken. Namely the protonation of the 
ClO- complexes of 11 and 12 is expected to give a split Soret band according to the results 
of Wagenknecht and Woggon.[20]. 
 
VII.4.1. UV-Vis characterization. 
First the catalase model 12 in the presence of –OCl was submitted to protonation with 
acetic acid (AcOH) in both methylene chloride and toluene as the EPR and UV-Vis spectra 
of 12-ClO- did not display clear changes. 
The choice of AcOH as source of proton is justified by the nearly neutral pH of 
hypochlorite (pH= 7.2) and by the necessity of using a weak acid to avoid protonation of 
the amide functionalities. Upon addition a clear splitted Soret band appeared as well in 
methylene chloride as in toluene thereby indirectly confirming that 12--OCl had been 
obtained before (figure 45). The possible formation upon AcOH addition of a mixture of 
12-OAc and 12 was checked by addition of acetic acid before hypochlorite. The resulting 
spectra showed that the corresponding Soret band in presence of AcOH was at 408 nm as 
for 12 or 12--OCl. 
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Figure 45: UV-Vis changes upon 12-HOCl formation. 
As the changes are more significant in UV-Vis spectroscopy when the formation of the 
HOCl complex is attempted we turned to the same procedure for having a confirmation of 
our results with the CPO model 11 where there are evidence for the formation of the ClO- 
complex. Contrary to 12 upon addition of acetic acid to 11--OCl no further changes have 
been observed in the UV-Vis spectra in both methylene chloride and toluene. The reason 
for this behaviour is not understood as the EPR spectrum in toluene changed drastically. 
 
VII.4.2. EPR studies. 
Next the EPR spectra of 12-HOCl and 11-HOCl were recorded at 100K. 
For the catalase model 12 the geff values were slightly modified but the shape of the spectra  
is intact. This would tend to indicate that the coordination of HOCl did not happened 
which contradicts the results of the UV-Vis investigation. 
For the CPO model 11-HOCl the EPR spectra changed to a typical axial symmetrical 
spectrum of an iron (III) high spin complex in toluene (figure 46) with geff at 5.79 and 2.00. 
390 nm 416 nm 
408 nm 
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Figure 46: EPR spectrum of 11-HOCl at 5K. 
The formation of the HOCl complex of 11 is only detectable in toluene and not by the 
techniques used in methylene chloride. The reason for this solvent dependency is not yet 
understood. 
 
VII.4.3. Catalytic activity essays. 
In order to check if a catalytic activity, despites the absence of detectable formation of 11-
HOCl in methylene chloride, with the system 11+-OCl+AcOH+CH2Cl2 we have tested 
the system in the presence of monochlorodimedone. This check was important to compare 
the results obtained by Wagenknecht and Woggon. [20]. 
Using their conditions we could calculate a turnover of 38. The fact that attempts to 
produce the HOCl complex of 11 gave no change in UV-Vis, NMR and EPR spectroscopy 
in methylene chloride as compared to the resting state of 11 seemingly contradicts the 
results of the catalytic chlorination of monochlorodimedone. 
It may be that either free HOCl acts as the chlorinated species and is liberated from 11 or 
the complex HOCl-11 is produced in amounts escaping the detection limits of the methods 
used to characterize it. 
 
VII.5. Formation of compound I. 
The next species to characterize is compound I analogue of 11 and 12. First it would 
permit to exclude that upon addition of hypochlorite ion the complex formed from 11 and 
12 are compound I analogues. Second upon addition of chloride it would confirm the 
formation of 11--OCl and 12--OCl. The subsequent addition of acid to these complexes 
would furnish the corresponding HOCl complexes. Third it could eventually allow to 
g=5.794 
g=2.001 
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determine which of the proposed structures for compound I analogues (figure 47) is the 
most appropriate. 
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Figure 47: Structures proposed for compound I analogues with a thiolate ligand. 
 
VII.5.1. Generation of iron oxo species and their characterization. 
The generation of compound I analogues for peroxidase and P450 enzymes has been long 
investigated by chemists. Several methods have been developed with tetraarylporphyrins 
as models as the former proved to be robust against oxidative degradation [126]. 
The methods use different oxygen donors which usually primary forms a peroxy like 
adduct with the iron (figure 48): 
1. hydrogen peroxide [61] 
2. peracids such as meta chloroperoxybenzoic acid (mCPBA) [127] 
3. iodozylbenzene [128] 
4. dioxiranes [129] 
5. ozone [130] 
For 1. and 2. the use of a protic solvent such as methanol is usually necessary to facilitate 
the departure of the corresponding acid (figure 48). The use of dioxirane permits also to 
determine whether the cleavage of the peroxo bond is heterolytic or homolytic [131]. 
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Figure 48: Formation of compound I analogues. 
After generation of the iron oxo species the questions which have to be addressed are: 
1. The oxidation state of iron 
2. If the iron is found in the iron (IV) state: Is the radical centered on the 
porphyrin or on the fifth axial ligand? 
3. For the radical species the type of orbital which contains the radical. 
The characterization of iron oxo species relies on the pioneering work of Dolphin who was 
the first to propose a formulation as an iron (IV) coupled to a radical cation on the 
porphyrin [132]. The best characterized compound I among the enzymes is compound I of 
Horseradisch Peroxidase (HRP). For HRP compound I was characterized by UV-Vis 
[132], resonance Raman [133], Mössbauer [134] and more recently by EXFAS (extended 
X-Ray spectroscopy) [135] spectroscopy. The UV-Vis spectra has a Soret band which 
maxima is the same as for the resting state but which intensity is around the half. In the 
visible region new peaks appear at 650 nm. The Mössbauer spectra are consistent with an 
iron (IV) species in the high spin state as indicated by the Q value. Finally EXFAS reveals 
an iron oxygen bond of 1.64 Å which is consistent with a formulation as an iron oxygen 
double bound. 
All works which have been done with models seems also to indicate that the iron is found 
in the oxidation state (IV) although most of the studies relies only on the UV-Vis 
characterization. 
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VII.5.2. UV-Vis characterization attempts. 
To generate compound I analogues of 11 and 12 we used hydrogen peroxide or mCPBA in 
methylene chloride or toluene (table 19). 
Complex: Solvent: Oxidant: Eq.: Soret initial 
(nm): 
Final Soret 
(nm): 
11 CH2Cl2 H2O2
 Excess a) 408 406 
12 CH2Cl2 H2O2 Excess 
a) 408 408 
11 CH2Cl2 mCPBA 2.5 408 406 
12 CH2Cl2 mCPBA 2.5 408 408 
11 Toluene H2O2 Excess 
a) 408 410 
12 Toluene H2O2 Excess 
a) 408 408 
11 Toluene mCPBA 2.5 408 410 
12 Toluene mCPBA 2.5 to 10 408 408 
Table 19: Formation of compound I. 
a) Conditions: 0.2 ml 30% H2O2 solution was added (10% vol resp. to toluene):the exact 
amount of H2O2 can not be estimated as the partition coefficient of H2O2 is not known. 
In methylene chloride with H2O2 as oxidant the changes observed for the CPO model 11 
were a steady diminution of the intensity of the Soret band which was accompanied by a 
broadening and a slight blue shift to 406 nm. The expected changes in the visible region 
which is usually the appearance of bands in the 650-670 nm region was not detected. The 
changes observed are rather indicative of a degradation of the complex 11 with time 
(steady loss of intensity). 
Upon addition of methanol which could assist compound I formation the decay of the Soret 
band and the destruction of the porphyrin was accelerated but apparently did not help the 
formation of the desired complex. 
For the catalase model 12 under the same conditions the intensity of the Soret band did not 
diminish so rapidly which could be related to a catalase like activity of the complex. 
For the CPO model 11 the use of mCPBA as oxygen donor gave comparable results as 
with H2O2 as oxidant. Moreover mCPBA appears to be a more aggressive oxidant as only 
10 eq. are necessary to destroy the porphyrin within 5 minutes. 
For the catalase model 12 the use of as much as 100 eq. of mCPBA results only in a partial 
destruction of 12 immediately after the addition. Afterwards and within 48 hrs the complex 
12 did not show any further degradation suggesting that a catalase like activity took place. 
When the solvent was toluene the results were different. 
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For the CPO model 11 by both the use of hydrogen peroxide or mCPBA as oxidant the 
Soret band shifts to 410 nm and exhibits a shoulder around 370 nm. This red shift is 
usually typical for compound II formation [136] or for a radical centered on the axial 
ligand and not on the porphyrin or for peroxy like complexes[137]. A peroxy complex 
(figure 15) would result from the non cleavage of the O-O bond. 
For the catalase model 12 the results obtained were also comparable to the data with H2O2 
as oxygen donor again suggesting a catalase like activity of the complex. 
Taken all together these data suggest that: 
1. The process of formation of compound I is solvent dependent. In solvents 
which can liberate a proton the radical could be centered on the porphyrin ring 
as indicated by the absence of change in the position of the absorption maxima. 
In neutral solvents the radical could be centered on the fifth ligand as suggested 
by the red shift observed for the Soret band or more likely the peroxy complex 
would be a stable intermediate. 
2. The presence of an oxygen rather than an sulphur at the fifth coordination 
enhances the stability of the porphyrin. In the case of a phenolate coordination a 
catalase like activity seems to take place whereas this is not the case with a 
thiophenolate ligation. 
 
VII.5.3. EPR characterization. 
As the UV-Vis spectra in toluene show a red shift for the CPO model 11 we repeated the 
experiment in the ESR where the concentration is much higher (from mM to mM). Upon 
addition of 5 equivalents of mCPBA to 11 a mixed spin system appeared composed of: 
1. the mCPBA adduct of the iron porphyrin which is characterized by an high spin 
iron (III) axial spectra with geff= 5.79 and geff=2.001 
2. a contribution of the well known “rhombic iron” at g=4.26 and g=2. 
The addition of further 5 eq. results in the disappearance of the contribution of the mCPBA 
adduct and leaves only the “rhombic iron”. 
When the catalase model 12 was used the spectra changed directly to a line at g=4.26 and 
g=2. This results combined to the absence of a typical decolouration of the solution 
indicates that the spin system related to g=4.26 and g=2 may be a characteristic trace of the 
peroxy complex as stable catalytic intermediate. Namely such spectra have been reported 
by several groups for its formation with synthetic iron porphyrins [138]. 
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Given the hypothesis that the spectra does corresponds to the compound I analogue it 
would mean that the overall spin of the system is 3/2. Such a value can only arise from an 
high spin iron (IV) (S=1) which is ferromagnetically coupled to a radical (S=1/2). As 
practically no EPR characterization of compound I analogues exists and more particularly 
no characterization of models which have a thiolate or phenolate fifth axial ligand the data 
can not be compared to any previous work. Nevertheless combined with the UV-Vis 
spectroscopical data the results suggest that the axial ligand would be involved as a radical 
in compound I analogue. The presence of the signal at geff= 4.26 and geff=2 may be the 
result of a tight coupling between the radical and the iron (IV). This strong coupling could 
be explained by the spanned structures of our models: this is not the case in enzymes where 
the coupling are weak. 
If the complexes obtained would not be compound I analogues but peroxy like complexes 
this would imply that neither the sulphur from the thiophenolate nor the oxygen from the 
phenolate have a strong enough “push” effect to weaken the O-O peroxo bound for a 
cleavage. As a consequence this suggests that the protein environment which is missing in 
our models is essential to assist this cleavage. In turn this means that a “pull” effect is also 
necessary in heme-thiolate proteins to generate compound I or as suggested by new results 
on P450Cam that the catalytic species in heme thiolate protein may be the peroxy complex 
[139]. 
 
VII.6. Peroxo complex. 
In order to check the role of a peroxo complex in the catalytic cycle of NOSs we next have 
attempted its characterization. Peroxo complex can be formed by: 
1. the use of superoxide ion with iron (III) [140] or 
2. the use of a reductant and the addition of oxygen to the iron (II) complex [141]. 
As the first method is more accessible we used it to characterize the peroxo complex. The 
inconvenient is that the solvents which can be used are polar solvents such as DMSO or 
MeCN. They can thereby also coordinate to the iron at the sixth position. For 11 and 12 we 
could notice that the formation proceeds in two steps as mentioned by previous publication 
[141]. First one equivalent of superperoxide reduces the iron (III) to iron (II) and thereby 
generates dioxygen. Probably the iron dioxygen complexes is formed. In a second reaction 
which is very fast the second equivalent of superoxide reduces the complex to form the 
peroxo complex (scheme 11). 
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Scheme 11: Formation of iron peroxo complex. 
The UV-Vis spectra was indicative of reversible processes: upon addition of potassium 
superoxide the Soret band slowly shifted to 418 nm which corresponds to the reduced iron 
(II) complex. At the same time the iron (II) reacted with the second molecule of superoxide 
to give the desired complex which was characterized by a Soret band at 428 nm, a value in 
good agreement with the data found in the literature [142]. With time the Soret band 
returned to 414 nm and finally to 408 nm. This suggests that there is a competition in the 
ligation of superoxide with the solvent. Traces of water could also be responsible for the 
destruction of the peroxo complex upon protonation to furnish in a first step the iron (III) 
water complex (scheme 12). 
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Scheme 12: Possible degradation of the peroxo complex. 
The UV-Vis characterization of the peroxo complex excludes that the complexes which 
have been obtained in the formation of compound I analogues are peroxo complexes. 
Thereby it supports that the EPR set of signals at g=4.26 and g=2 do characterize the so-
called compound I of 11 and 12. 
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VII.7. Summary. 
The CPO model 11 and the catalase model 12 can react only with small ligand molecules 
and show low binding affinity for ligands at the sixth axial position in general. This could 
be explained by the bulk induced by the amide functionalities on the aryl substituents or by 
the presence of a species in the ligand sphere of these complexes. 
The spectroscopic parameters of the CPO model 11 are not completely in agreement with 
earlier data. Nevertheless a catalytic chlorination activity was observed in one case. Thus 
further investigations are required towards a complete understanding of the CPO catalytic 
chlorinations. 
For catalase model 12 seems to have a catalase like activity as the degradation of the 
porphyrin core under oxidative conditions is much less important as for the CPO model 11. 
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VIII. Improvement of the models. 
The data obtained for the CPO model 11 and for the catalase model 12 suggest that steric 
hindrance is a problem for having a good binding to iron for ligands at the sixth position. 
Moreover oxygen binding studies with the oligomeric mixture obtained from 20b [143] 
have indicated that a secondary reaction process occurs upon oxygen binding to iron (II). 
This second reaction is postulated to be the hydroxylation of the N-H bond of the amide by 
the following reaction path (figure 49): 
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Figure 49: Hydroxylation of the amide N-H. 
Taking into account: 
1. the necessity to check the reactivity of the N-H bond in the presence of oxidant 
bound to the iron and 
2. the steric bulk induced by the pivaloyl which could prohibit ligand binding 
we have designed three further models which also respond to the definition of Bruice et al. 
of an ideal enzyme mimic (see V.1.1). 
The CPO model 32 and the catalase model 33 (figure 50) were synthesized to replace the 
amide functionality as face protecting groups. The naphthyl substitution at the meso 
position has been introduced to avoid the formation of m-oxo dimers in the presence of 
oxygen. 
The CPO models 34 and 35 (figure 50) are tailed models starting from 20b. They were 
presumed to be good models as the oligomeric mixture obtained from 20b showed better 
binding affinity for a sixth ligand to the heme iron. Moreover, based on the results obtained 
by Mukaiama et al. [120, 123], the sulphur could be stabilized by the presence of the 
amide group in its vinicity via the formation of an hydrogen bond. The formation of an 
hydrogen bond could also favour the coordination of the sulphur to the iron. The steric 
bulk of the amide group would also protect it from oxidation. 34 and 35 shall also be 
candidates to compare the effect of a thiophenolate vs. an alkyl thiolate axial ligation to the 
heme iron. Hence the CPO model 35 is expected to be a closer model to CPO. The amino 
acid cystein is namely an aliphatic thiol compound. 
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Figure 50: The new models. 
 
VIII.1. Synthesis and characterization of the naphthyl models 32 and 33. 
The synthesis of the models relies on the same procedure used for the CPO model 11 and 
the catalase model 12 (scheme 13). 
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+
 
Scheme 13: Synthesis of 32 and 33. 
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The first step was the porphyrin condensation which proceeds in 70% yield. 
The marked difference compared to the synthesis of 11 or 12 is the ratio for the 
atropisomers which in the present case is about 1:1. This results clearly confirms that steric 
bulk above the porphyrin plane is the reason for the high selectivity obtained during the 
synthesis of the pivaloyl models 11 and 12 in favour of the a,b isomer 17b (85:15). 
As it was the case for 17a and 17b the atropisomerisation of 38a and 38b was also not 
possible under 200°C due to the high energy barrier for the Caryl-Cmeso bond rotation. 
The deprotection of the methyl ether functionality was subsequently successfully achieved 
with the use of BBr3 at RT to give 39. 
The coupling of 39 with the bridge 15 under high dilution proceeds in 60% yield to give 
pure 40. The deprotection of the sulphur to yield the metal free compound 42 was done 
under the same conditions (KOMe in dioxane) as for the synthesis of 22. 
For the catalase model 33 the bridging of 39 with 16 occurs with 65% yield to give 41. The 
deprotection of 41 with KOMe in dioxane proceeds in 95% yield to 43. 
As for the metal free precursor 22 of the CPO model 11 and for the metal free precursor 31 
of the catalase model 12 we used NMR spectroscopy to refine a craft field minimisation of 
both structures 42 and 43 (figure 51). The comparison of the chemical shifts obtained for 
the bridge protons and for the SH resp. OH of the bridge suggests a different porphyrin 
core geometry compared to 22 and 31 (table 20). First the upfield shift of the bridge 
aromatic protons 3” and 5” probably results in a smaller distance of the bridge moiety from 
the porphyrin core. Second the upfield shift of the methyl pyrrole and CH2a  implies that 
the geometry of the porphyrin core is not the same as for the models 22 and 31. We 
propose that the core is more planar which results in an increased p density on the pyrrole 
substituent hence the upfield shift. 
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Protona): d in ppm for 
42 
D(d) (22-42) in 
ppm: 
d in ppm for 
43 
D(d) (43-31): 
10, 20 10.10 -0.02 10.17 +0.03 
CH3 pyrrole 2.19 -0.43 2.21 -0.44 
CH2a 4.05 0 and 0.2 3.92 and 3.84 -0.02 and –
0.10 
CH2g’ 0.5 -0.17 -0.4 -0.32 
H3”,5” 6.13 -0.07 5.95 -0.16 
H2”’ (tert-butyl 
bridge) 
0.88 0.01 0.79 -0.10 
SH or OH -3.01 0.00 -2.19 +0.10 
NHporphyrin -2.03 +0.10 -2.19 +0.10 
Table 20: Selected NMR chemical shifts for 42 and 43 compared to 22 and 31. 
a) Numbering see figure 22. 
 
 
42 
 
43 
Figure 51: Force field modellisation of 42 and 43. 
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Finally the iron insertion using the FeBr2/Et3N method in toluene gave pure CPO model 32 
and pure catalase model 33 in 75% and 90% yield respectively. 
 
VIII.2. Characterization of the resting state of 32 and 33. 
 
VIII.2.1. UV-Vis characterization. 
As for the CPO model 11 and for the catalase 12 the full spectroscopic characterisation of 
CPO model 32 and catalase model 33 was undertaken. 
The UV-Vis spectra were nearly identical to the one obtained for 11 and 12 (figure 52). 
For the CPO model 32 the Soret band was found at 408 nm as for model 11 and it was also 
broadened compared to the metal free precursor 42. In the visible part of the spectrum a 
broad band was observed at 512 nm and at 580 nm. This indicates that the CPO model 32 
is an iron (III) five coordinated species. 
Contrary to the CPO model 11 the reduction of 32 was not total with the use of natrium 
bohrohydride or natrium hydride as reductant. This suggests that the redox potential of 32 
is more negative than the redox potential of 11. 
For the catalase model 33 the Soret band was found at 410 nm which represents a 2 nm 
blue shift compared to model 12. The visible part of the spectrum is as for 12 showing a 
broad absorption band centered at 520 nm and at 580 nm. The characteristic shoulder 
attributed to the iron phenolate ligation in model 12 was found at 356 nm in 33 instead of 
354 nm in 12. All these observations suggests that catalase model 33 is also an iron (III) 
five coordinated species. 
The reduction of 33 with hydrides was also not complete, suggesting a lower redox 
potential for the catalase model 33 compared to catalase model 12. 
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Figure 52: UV-Vis spectra in toluene at RT of 32 and 33. 
 
VIII.2.2. EPR characterization 
The EPR characterization of the CPO model 32 and of the catalase model 33 (figure 53) 
proved to be analogue to the results obtained with the previous models 11 and 12. 
The EPR spectra of the CPO model 32 is characterized by absorption lines found at geff= 
8.391, 5.884, 3.005 and 2.007. This spectra can be interpreted with the same proposals as 
for CPO model 11. The CPO model 32 is probably characterized by a strong s bond 
between the iron and the sulphur and the electron spin density would be delocated from the 
iron to the sulphur. The strong s bond is most probably strengthened by the p back 
bonding interaction between the sulphur and the iron. 
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Figure 53: EPR spectra at 5K in toluene of models 32 and 33. 
For the catalase model 33 the geff values are found at 5.857 and 2.009 respectively. 
Contrary to the previous catalase model 12 the small rhombic distortion indicated in 12 by 
a shoulder in the geff signal at 5.857 totally disappeared. The absence of a shoulder 
indicates that the axial symmetry of the naphthyl model 33 is higher than for the model 12. 
The higher degree of symmetry could be related to a more planar porphyrin core in 
catalase model 33 compared to catalase model 12. 
 
VIII.2.3. NMR characterization. 
Next the NMR spectra were recorded in toluene at RT. 
For the CPO model 32 the spectra ranged from –62 to +82 ppm. The line width of the 
signals were found to be up to 1,000 Hz for the signal at –62 ppm which is attributed to the 
meso protons. These data confirm that the CPO model 32 is as CPO model 11 a high spin 
iron (III) five coordinated species. 
For the catalase model 33 the spectra ranged from –59 ppm to 130 ppm. The line width 
was also found to be up to 1,000 Hz for the meso proton signals found at –59ppm. These 
Catalase 
model 33 
CPO model 
32 
*: the signals are artefacts from the machine 
g=8.391 
g=3.005 
g=5.857 
g=2.009 
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data support that the catalase model 33 is also a high spin iron (III) five coordinated 
complex. 
 
VIII.2.4. Electrochemistry. 
Finally the cyclic voltammetry experiments in DMF with LiClO4 as electrolyte gave redox 
potential values of –660 mV for the CPO model 32 and –680 mV for the catalase model 33 
(table 21). The value which are around 100 mV more negative than for the corresponding 
models 11 and 12 supports the difficult reduction of 32 and 33 in the presence of sodium 
borhydride or natrium hydride as the difference in redox potential between the oxidant and 
reductant is increased. 
Compound: Eox (mV): Eox (mV): DE (mV): E0 (mV): 
32 -610 -710 100 -660 
33 -780 -635 145 -710 
Table 21: Cyclic voltammetry. 
Conditions: 2.3 mM 32 or 33 in 0.1M LiClO4 DMF solution; Scan speed. 500 mV s
-1. 
Further the data comparison suggests that the porphyrin environment and thereby the 
overall geometry of the complex is the decisive factor controlling the redox potential and 
probably not the nature of the axial ligand. 
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VIII.3. Characterization of catalytic intermediates. 
 
VIII.3.1. The ClO-/HOCl complexes. 
 
VIII.3.1.1 UV-Vis characterization. 
Using the same procedures as for the CPO model 11 and the catalase model 12 we first 
have tried to generate the potential ClO– complexes of CPO model 32 and of catalase 
model 33. The UV-Vis characterization (table 22) using either benzyltriethylammonium 
hypochlorite (= salt in table 22) led to comparable results as obtained with 11 and 12. for 
the shifts of the Soret band’s value. 
However the models 32 and 33 were found to be more sensitive to oxidative degradation 
than the parent pivaloyl substituted complexes. 
Compound: Method: Solvent: Soret initial (nm): Soret final (nm): 
32 10% NaOCl CH2Cl2 410 410 
32 salt CH2Cl2 410 410 
33 10% NaOCl CH2Cl2 410 410 
33 salt CH2Cl2 410 410 
32 10% NaOCl Toluene 410 412 
32 salt Toluene 410 414 
33 10% NaOCl Toluene 410 410 
33 salt Toluene 410 412 
32 10% NaOCl 
then AcOH 
CH2Cl2 410 destruction 
33 10% NaOCl 
AcOH 
CH2Cl2 410 destruction 
32 Salt then 
AcOH 
CH2Cl2 410 410 
33 Salt then 
AcOH 
CH2Cl2 410 396 
32 10% NaOCl 
then AcOH 
Toluene 410 destruction 
33 10% NaOCl 
then AcOH 
Toluene 410 390+416 
32 Salt then 
AcOH 
Toluene 410 414 
33 Salt then 
AcOH 
Toluene 410 392+416 
Table 22: UV-vis characterization of the –OCl complexes for 32 and 33. 
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VIII.3.1.2 EPR characterization. 
The EPR characterization of the complexes in toluene did not led to the same results as for 
models 11 and 12. 
For the CPO model 32 we did not get a single broad signal at geff=2 for the spectra as 
found for the parent CPO model 11. Instead the spectra suggests the existence of two spin 
systems. The first spin system corresponds to a typical axial high spin iron (III) complex 
with geff=5.78 and geff=2. The second spin system corresponds to the “rhombic iron” with 
geff=4.26 and geff=2. These results indicate that in the case of the naphthyl substituted 
models 32 the addition of hypochlorite led to the probable formation of the corresponding 
oxo complex rather than to the formation of the desired –OCl complex. The addition of 
acid should confirm this results as acid assists the cleavage of the O-Cl bond of the peroxy 
complex to yield the oxo complex and HCl. 
When acetic acid was added to the system 32+ ClO- in toluene, the spectra obtained was 
the spectra of the pure “rhombic iron” having geff values at 4.26 and 2.00. These results 
suggests that contrary to our proposal for the CPO model 11 the spectra characterized by 
geff values at 4.26 and 2.001 could be characteristic for the oxo complex and not for a 
peroxy complex. 
For the catalase model 33 the EPR experiments gave the spectra of the “rhombic iron” with 
geff values at 4.26 and 2.001 upon addition of ClO
- and upon addition of ClO- and acetic 
acid. These data also indicate that the oxo complex rather than the desired ClO- and HOCl 
complexes is formed upon addition of hypochlorite to the catalase model 32. Further it is 
also not consistent with the interpretation proposed for the catalase complex 12 where we 
have proposed the formation of peroxy complex rather than compound I analogue upon 
addition of peroxides. 
The reason of these different behaviour upon modification of the meso substituents is yet 
not understood and requires further experiments to establish whether the compound I 
analogues do have the same EPR spectra as their corresponding peroxy intermediates. 
In conclusion the naphthyl models are not suitable models for CPO catalytic intermediates. 
From these results it appears that the amide substituents are essential for obtaining –OCl 
complexes of synthetic iron porphyrins. 
 
VIII.3.2. Oxo complex. 
To confirm our findings that the complexes obtained upon addition of hypochlorite are 
actually compound I analogues we used H2O2 and mCPBA to generate the oxo complexes 
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of the CPO model 32. The UV-Vis characterization (table 23) confirmed that the 
complexes obtained previously with hypochlorite are potentially compound I analogues.  
Compound: Method: Solvent: Soret initial 
(nm): 
Soret final 
(nm): 
32 10% vol of a 30% 
aqueous H2O2 solution 
CH2Cl2 406 400 
32 2.5 eq. mCPBA CH2Cl2 406 412 
32 10% vol of a 30% 
aqueous H2O2 solution 
Toluene 406 414 
32 2.5 eq. mCPBA Toluene 406 414 
Table 23: UV-Vis characterization of compound I formation for 32. 
Next the EPR spectra are also identical to the spectra obtained previously upon addition of 
hypochlorite and acid to 32. They are characterized by geff=4.26 and geff=2. 
These results also suggest that the complex obtained with 11 and 12 are not peroxy 
complex but are actually compound I analogues. If this proposal is correct the porphyrin 
environment do not play an essential role on the structure of compound I analogues as the 
EPR signals are identical for the four models synthesized. 
 
VIII.4. Summary. 
The results obtained with the naphthyl models of CPO and catalase show that the pivaloyl 
substituents are more efficient protecting groups respective to an oxidative degradation of 
the porphyrin ring in the presence of oxidants. The better accessibility of the sixth position 
of the iron atom is not advantageous as it led to a higher sensitivity towards oxidative 
degradation. 
A second aspect which would reduce the ligand affinity of models 32 and 33 is the 
hydrophobic character of the complexes. The affinity for polar ligand such as hypochlorite 
is reduced due to hydrophobic repulsion of polar ligands. 
These proposal suggests that residues which have hydrogen bond donors or acceptors and 
are hence polar or polarizable are essential for having good mimics of the CPO and 
catalase enzymes. 
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VIII.5. Synthesis of the tailed models 34 and 35. 
 
VIII.5.1. Synthesis and solution structure of species tailed with a protected 
sulphur. 
Based on the comparison between the naphthyl and pivaloyl substituted models for CPO 
we turned to new models of CPO which would combine: 
1. the necessity to keep pivaloyl substituents and 
2. the necessity of an opened distal side. 
As mentioned in the introduction of this chapter we decided to synthesize tailed models 34 
and 35. 
The synthesis of the CPO model 34 started with the synthesis of the corresponding “tailed” 
bridge moiety 47 by a procedure analogous to the synthesis of bridge 15 (scheme 14). 
OH
+ Cl N
S
Pyridine, 50°C
O N
S
BH3.Me2S, THF, D
then 0°C, 3N NaOH 
and 30% H2O2
S N
O
OH
Et3N, 0°C, CH2Cl2 
then MsCl, o°C to RT.
S N
O
OMs
44
46
47
45
S N
O
45
540°C, 0.01 mbar
25
 
Scheme 14: Synthesis of the tailed bridge 47. 
Then starting from 20b a mono protection of one hydroxy group using iodo methane was 
achieved to give 48 (scheme 15) in 33% yield. This yield was expected from a statistic 
addition of the methyl group to both hydroxy functions, one hydroxy function or none of 
them in 20b. The tailed bridge 47 was coupled to 48 under normal dilution conditions to 
yield the protected sulphur tailed compound 49 (scheme 15). High dilution is not necessary 
in this case as polymerisation is not possible. The introduction of the tailed bridge 47 was 
not accompanied by a red shift of the Soret as for the bridge compounds. 
This result supports that the red shift upon bridging is due to the introduction of the 
bridging moiety. Then this shift is a characteristic feature which is useful to control the 
course of the bridging reaction. 
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Scheme 15: Synthesis of the protected tailed precursor 49. 
To check if the sulphur is in position to subsequently coordinate to the iron the structure in 
solution was determined by NMR spectroscopy using the chemical shifts and the NOE 
effects. 
The first question addressed was the conformation of the amide bond and the related meso 
aryl substituents. For both meso aryl substituents the NOE effects observed between the 
NH amide proton and the neighbouring proton 5’ of the aryl moiety is inexistent. 
According to figure 27 this implies that only structures ttt, tct, tcc and ttc are possible. 
The NOE observed between the tert-butyl substituent and the amide NH proton is strong. 
The amide bond is therefore trans which eliminates structures tcc and tct as shown in 
figure 54. 
For the aryl moiety bearing at position 2’ the OMe group a strong NOE effect is observed 
between the proton of the OMe and proton 3’. Therefore the predominant middle 
conformation of the meso aryl substituent is ttc. 
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For the aryl substituent where the bridge is attached a strong NOE effect is also observed 
between the CH2a’ of the bridge and proton 3’. Therefore the preferred conformation for 
the corresponding aryl moiety is also ttc as shown in figure 54. 
O
H3C
N H
O
= porphyrin ring system
O
NH
O
Aryl
 
Figure 54: Conformation of the meso aryl substituents in 49. 
The conformation obtained with the non bridged strucutre 49 is now comparable to the X-
Ray structure of Collmann [85] for its TPivPP iron complex. These findings also supports 
that only bridging induces a change in the conformation of the ortho amide moiety on the 
meso aryl substituents. 
The second question was to verify that the proximity of the sulphur to the center of the 
porphyrin core. This feature is essential to favour the coordination of the sulphur to the 
iron after iron insertion. 
To answer this problem a first indication is the chemical shift of the N-methyl groups of 
the thiocarbamate protecting group. The N-methyl groups are connected to a nitrogen 
engaged in an amide bound. As the nitrogen has a strong sp2 character the methyl group 
are coplanar and can be distinguished as cis and trans methyl groups provided the 
environment is magnetically not equivalent. Accordingly they give raise to a set of two 
singulets. 
In the precursor 21 of the CPO model 11 they are found at 1.72 ppm and –1.3 ppm whereas 
in the bridge precursor 15 they are found at 3.3 ppm and 3.2 ppm respectively. 
In 49 the signals were found at 2.47 ppm and 1.6 ppm respectively. Compared to the 
precursors 46 and 47 where the corresponding signals are found around 3.0 ppm (resp. 
3.05 and 2.9 ppm) the shifts observed indicate that the sulphur is in the vinicity of a group 
which has a shielding effect. 
However compared to 21 the shielding effect is by far less important which means that the 
sulphur is further away from the porphyrin core. 
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To establish the origin of the shielding which could also be due to an intermolecular effect 
between two porphyrin molecules we have examined the NOE effects observed for the 
protons of the bridge’s arm. 
The CH2g’ protons show a medium NOE to the NH amide proton of the other meso aryl 
substituent. A medium NOE effect is also found from the CH2b’ to the CH2b protons. These 
data suggest that the phenyl group of the tail is lying to some extent under the porphyrin 
core but the sulphur is not in the immediate vinicity of the centre of the porphyrin core. 
Nevertheless the strong affinity of sulphur for iron could be sufficient to permit the 
coordination of the sulphur after iron insertion. 
The force field modellisation which takes into account the NOE effects and chemical shifts 
gives the following structure (figure 55). 
 
Figure 55: Craft field modellisation of 49. 
The second tailed model 35 with an alkyl bridge was also synthesized by using the same 
strategy. The tailed alkyl bridge 54 was synthesized from commercially available d-bromo 
valeric acid 50 (scheme 16). 
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Scheme 16: Synthesis of the alkyl bridge 54. 
As for the thiophenolate analogue 49 the bridge 53 was coupled to porphyrin 48 (scheme 
17) to yield 55. As for 49 the UV-Vis spectrum did not show a red shift of the Soret band 
upon bridging. This supports once again that the red shift is an indication that a bridging 
reaction takes place. 
48+
Cs2CO3, DMF, 60°C86%
S OMs
S
N
54
NH
N
NH
N
O
HN
NH
O
MeO
O
S N
S 55  
Scheme 17: Synthesis of 55. 
The NMR data analysis for the conformation of the meso aryl substituent reveals that the 
same NOE effect are observed i.e. the conformation of the aryl substituents is the same as 
found by Collmann for its TPivPP iron complex. 
The analysis of the conformation of the tail showed that the sulphur is probably not within 
bonding distance of the iron (figure 56). Namely no change for the chemical shifts of the 
N-methyl protons is observed upon bridging. Moreover the analysis of the NOE effects 
show that the protons from the alkyl bridge are not close to any proton of the b-pyrrole 
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substituents or more important to the NHporphyrin protons as is expected from the 
conformational study of 21. These data are consistent with a tail hanging perpendicular to 
the porphyrin plane passing through the meso carbon 5 and 15 as showed by the molecular 
modelling minimization obtained (figure 56). 
 
Figure 56: Craft field modellisation of 55. 
The consequence after the iron insertion appears immediately: after deprotection and iron 
insertion the sulphur of a porphyrin molecule will coordinate to the iron atom of a second 
porphyrin molecule upon iron insertion. An oligomer array would be the resulting 
compound for the iron complex as no steric constraints can force the thiolate ligation to 
build monomers (figure 57). 
Such a situation will probably not be the case for 34 as the phenyl ring induces steric 
hindrance. This hindrance prevents then the formation of oligomers and favours the 
coordination of the sulphur to the heme unit where it is anchored (figure 57). For these 
reasons we did only pursued the synthesis of model 35. 
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Figure 57: Formation of oligomers or monomer with 34 or 35. 
 
VIII.5.2. Deprotection of the sulphur to get model 34. 
The deprotection of the sulphur revealed difficulties as the compound first oxidized 
massively despites using a degassed reaction mixture for the thiophenolate model 49. 
Second the part which was not oxidized was a mixture of two compounds which could not 
be separated as oxidation kept lowering the yields. Therefore the iron was first inserted 
into 49 and the deprotection was attempted (scheme 18). Unfortunately no satisfactory 
conditions were found to yield pure desired 33. 
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Scheme 18: Synthesis of 33 upon iron insertion and deprotection of the sulphur. 
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VIII.6. Summary and perspectives. 
The attempts to obtain better models finally support the approach of bridged structures 
over tailed models. Contrary to the conclusion of Nakamura et al. with hydrogen bonded 
stabilized heme thiolate complex [122] we could not notice such an effect with the 
precursors 49 and 55. Nevertheless the results obtained for metal free tailed porphyrin have 
permit to establish that upon bridging the UV-Vis spectra are red shifted and that the 
conformation of the ortho amide substituents on the meso aryl groups is changed. 
For these reasons the future direction for having better binding constant is probably still to 
use an ortho amide function on the aryl moiety. But instead of having a bulky substituent 
directly linked to the carbonyl group of the amide this one should be anchored at a greater 
distance. For example the replacement of the tert-butyl group by a furan already improved 
the binding abilities of 11 [118]. 
 
  
 
EXPERIMENTAL PART 
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General remarks: 
 
 
Solvents and reagents: 
Solvents for reactions were of HPLC, purissime or purum quality. Solvents for water sensitive 
reactions were dried with the appropriate agent: calcium hydride for methylene chloride, 
sodium for toluene and sodium-benzophenone for ether and tetrahydrofurane. The dried 
solvents were used directly after distillation from the drying material. 
Solvents for oxygen sensitive reactions carried out with Schlenk technique or in the Glove-box 
were dried and distilled before being degassed on high vacuum (3 purge-thaw cycles on high 
vacuum). 
Solvents for chromatography were distilled on a Büchi rotatory evaporator before use. 
Commercially available reagents were supplied by Fluka, Aldrich or Heraeus and used as 
received except otherwise indicated. 
 
Apparatus and material: 
For solvent distillation and removal, a Büchi rotatory evaporator RE 111 was used. Vacuum 
controlled was monitored by Vacuum controller 168 and supplied by a membrane pump MZ 
2C from Vacuubrand. Cooling was achieved via a heat exchanger UWK 300 from Vacuubrand 
filled with isopropanol and temperature was maintained under 5°C. 
For drying compounds, a high vacuum oil pump 2012 from Alcatel was used and vacuum was 
around 10-3 mbar. 
Weighting was achieved with a Mettler AE 163 apparatus with a precision of ± 0.1 mg (>10 
mg weighted product) or ± 0.01 mg (<10 mg weighted). 
Glove-box were supplied by Mercaplex (model 2201) and oxygen and water content were 
monitored by a Teledyne analyser. The value were kept below 3 ppm for oxygen and 10 ppm 
for water. Degassing ante-chamber was done through a membrane pump MZ 2C from 
Vacuuband and solvents were removed via an oil pump Speedivac EV 50 from Edwards. 
 
Purifications: 
Column chromatography were carried out on silica gel 60 (40-63 mm) or on neutral alumina 
supplied by Merck. Packing was done as a slurry of silica or alumina under 0.4 bar pressure 
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(air or argon). Separations were achieved with a pressure of max. 0.2 bar. Probe deposing was 
achieved by dissolving the crude product in a minimum of the eluting mixture and deposing 
through a Pasteur pipette on the top of the column. 
Size (diameter*length) of the column and eluant are given in the experimental section. Solvent 
mixture is indicated as V/V ratio. 
Preparative plates 20 cm*20 cm*2 mm (Silica gel F260) were purchased from Merck. After 
development, the product was recovered by stirring the silica band containing it with the 
appropriate solvent and filtration of silica gel followed by concentration on rotatory 
evaporator. 
Reactions were followed on 5*10 cm thin layer silica gel F260 plates (0.25 mm) from Merck. 
The UV active compounds were detected with a UV-lamp from Camag either at 254 nm or 
366 nm. 
UV inactive compounds or detection of aldehydes or double bonds were revealed by spraying 
the appropriate reagent. Aldehydes were sprayed with 0.4% DNPH in 2M HCl, double bonds 
were revealed by an ethanolic KMnO4 solution and NH2 functions by a 10% Ninhydrine 
ethanolic solution. 
 
Spectroscopic methods: 
UV-Vis spectra were recorded on a HP 8452A diode array spectrophotometer from Helwett-
Packard and worked out with the software UV-Vis Chemstation A.02.04 from Hewlett-
Packard. Precision of measurements is ± 2 nm (diode distance) and only the maxima are 
indicated. The percentages are calculated in reference to the most intense signal. 
Abbreviation: UV-Vis (solvent): l (nm) (relative absorption in %). 
 
NMR spectra for routine analysis were recorded on a Gemini 300 apparatus from VARIAN or 
a BRUCKER DPX 400 with automatic sampler changer. 
The frequency for 1H NMR is 300 MHz and 75 MHz for 13C NMR for the VARIAN apparatus 
and 400.13 resp. 101 MHz for the BRUCKER one. 
Characterizations were done on a BRUCKER DRX 600 NMR-spectrometer with a frequency 
of 600.13 MHz for 1H NMR and 150 MHz for 13C. 
All two dimensional experiments were also recorded on this apparatus. 
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Solvents for NMR measurements were purchased by Dr. Glaser AG, Basel. 
Reference for 1H is the TMS signal and for 13C the solvent signal. 
Spectra are reported as follow for proton spectroscopy: 1H-NMR (frequency in MHz, solvent), 
d: chemical shift in ppm, (multiplicity, coupling constant in Hz, signal attribution, integral 
value). 
Multiplicity is indicated as follow: s = singlet, d = doublet, t = triplet, q: quadruplet, qui = 
quintuplet, sext= sextuplet, m = multiplet, br: broad signal. 
For carbon spectra, the report is : 13C-NMR (frequency, solvent): chemical shift in ppm, 
attribution. 
 
ESR spectra were recorded on a BRUCKER CW-spectrometer in the X-band mode, 10 mW 
power at 100 K. The pulse ESR spectra and low temperature spectra were recorded at the 
Institute of Physical Chemistry of the ETH-Zürich. 
 
Mass spectroscopy: 
For the porphyrins a MALDI-TOF mass-spectrometer LaserTec from Vestec coupled to a 
double canal oscilloscope TDS 520 A from Tectronix were used. The spectra were worked out 
on a Gateway PC-computer using the software Voyager Biospectrometry (version 2.13). 
FAB and EI mass spectrometry were recorded on a doubly focused spectrometer VG-70-250 
from Varian. For EI the ionisation potential was 70 eV. 
 
Cyclic voltammetry: 
Measurements of redox potential were achieved with a polarograph Model 443 from Amel. 
The results were computed with the software Amel (version 5.6E) and EXCEL. 
The working electrode is a glassy-carbon electrode (0.1 mm) which was polished on 
aluminium oxide pasta (0.05 mm) and washed with the solvent used for measurement before 
use. The three electrode configuration was achieved with a Pt-counter electrode and a NaCl-
Calomel (SCE) reference electrode. The electrolyte is a 0.1M LiClO4 DMF solution saturated 
with LiBr to avoid problems of ligand exchange during measurement. 
Before measuring the solution was purged with argon for 15 Min and during the measure was 
maintained under an argon stream passing above the solution. 
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The results are indicated as E0 value in mV uncorrected from the difference of +5 mV due to 
use of NaCl-SCE instead of KCl-SCE system. Precision is ±10 mV. 
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Part A: Porphyrin synthesis. 
 
A.1. Synthesis of the CPO model 11 and the catalase model 12. 
 
The synthesis of compound 13 and 14 were achieved according to literature procedure [20, 
68]. The analysis (spectra and yields) were identical. Therefore their synthesis is not 
reported. 
 
5,15-Bis-(6'-pivaloylamino-2'-methoxyphenyl)-3,7,13,17-tetrabutyl-2,8,12,18-
tetramethyl-porphyrinato- zinc (II) (18a and 18b): 
668.5 mg (2.84 mmol, 1 eq.) 14 in 50 ml acetonitrile were bubbled for 15 Min. with argon. 
814 mg (2.84 mmol, 1 eq) 13 and 54 mg (0.284 mmol, 0.1 eq) pTsOH were added and the 
solution was stirred at RT. for 20 hr under light exclusion. Subsequently 1.047 g (4.28 
mmol, 1.5 eq) o-chloranil were added in 20 ml THF and the reaction mixture was reacted 
for a further 30 Min. The dark-brown solution was evaporated and the residue was filtrated 
by column chromatography (silica gel, 6*20 cm, Hex:EE 3:1+1% Et3N). The fractions 
containing the product were concentrated, redissolved in 125 ml dichloromethane and 25 
ml methanol. To the red solution was added 1.3 g (7.1 mmol, 5 eq) zinc acetate and the 
reaction was refluxed 10 Min. until it turned pink. The solution was neutralized with 200 
ml saturated NaHCO3 solution, filtered over celite. The aqueous phase was extracted three 
times with 100 ml CH2Cl2. The combined organic layers were dried over Na2SO4, filtered 
and evaporated. The residue was further purified by column chromatography (silica gel, 
6*35 cm, Hex:EE 5:1+ 1% Et3N). 
Finally 814.07 mg (53.8%) of the a,b-atropisomer 18b and 174.1 mg (11.3%) of the a,a-
atropisomer 18a were recovered. 
Analysis: 
Yield: 65.1% (53.8% a,b-atropisomer and 11.3% a,a-atropisomer). 
TLC (silica gel, Hex:EE 5:1+1% Et3N): Rf= 0.31 for 18b and Rf= 0.17 for 18a  
HPLC (RP-18 250 mm, gradient MeCN:H2O 90 to 100% MeCN, 50°C): Rt=10.48 Min. 
for 18a and Rt=11.56 Min. for 18b. 
MALDI-TOF: M=1064.8 (M)+. 
UV-Vis (CH2Cl2+1% Et3N): l = 412 nm (100%), 576 nm (8%), 538 nm (7.9%). 
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NMR analysis: 
18a: 
1H-NMR (600 MHz, CDCl3, RT): 
d: 10.15 (s, H10,20, 2H); 8.45 (d, J= 8.36, H5’, 2H); 7.8 (t, J = 8.42, H4’, 2H); 7.12( d, J = 
8.46, H3’, 2H); 6.91(s, NHPiv, 2H); 4.03-3.87 (m, CH2a, 8H); 3.61 (s, OCH3, 6H); 2.58 (s, 
CH3pyrrole, 12H); 2.17 (qui, J= 7.41, CH2b, 8H); 1.74 (sext, J= 7.48, CH2g, 8H); 1.11 (t, J= 
7.24, CH3d, 12H); -0.18 (s, C(O)C(CH3)3, 18H). 
13C-NMR (151 MHz, CDCl3, RT): The signals were attributed with help of HETCOR, 
HMBC and HMQC experiments. 
176.5: C=O; 159.4: C2’; 147.8: C4,6,14,16, 147.1: C1,9,11,19; 144.1: C2,8,12,18; 140.5: C1’; 137.5: 
C; 130.6: C4’; 121.7: C6’; 113.7: C5’; 108.1: C5,15; 106.8: C3’; 97.9: C10,20; 55.9: OCH3; 
39.0: C(CH3)3; 35.5: Cb; 26.3: Caand C(CH3)3; 23.2: Cg; 14.2: Cd; 14.0: CH3pyrrole. 
18b: 
1H-NMR (600 MHz, CDCl3, RT): 
d: 10.21 (s, H10,20, 2H); 8.5 (d, J= 7.69 , H5’, 2H); 7.84 (t, J= 8.3, H4’, 2H); 7.17 (d, J= 7.75, 
H3’, 2H); 6.89, (s, NHPiv, 2H); 4.05-3.95 (m, CH2a, 8 H); 3.69 (s, OCH3, 6H); 2.65 (s, 
CH3pyrrole, 12H); 2.17 (qui, J= 7.6, CH2b, 8H); 1.73 (sext, J= 7.5, CH2g, 8H); 1.1 (t, J= 7.4, 
CH3d, 12H); -0.17 (s, C(O)C(CH3)3, 18H). 
13C-NMR (151 MHz, CDCl3, RT): The signals were attributed with help HETCOR, 
HMBC and HMQC experiments. 176.5: C=O; 159.4: C2’; 147.8: C4,6,14,16 ; 147.1: C1,9,11,19; 
144.1: C2,8,12,18 ; 140.5: C2,8,12,18 ; 137.5: C3,7,17,13 ; 130.6: C4’; 121.7: C1’ ; 113.7: C5’; 108.1. 
C5,15, 106.8: C3’; 97.9: C10,20, 55.9: OCH3; 39.0: C(CH3)3; 35.5: Cb; 26.3. Ca and C(CH3)3; 
23.2: Cg; 14.2: Cd ; 14.0: CH3pyrrole. 
 
a,a-[5,15-Bis-(6'-pivaloylamino-2'-methoxy-phenyl)-3,7,13,17-tetrabutyl-2,8,12,18-
tetramethyl-porphyrin] (17a): 
174.1 mg (16.31 mmol, 1 eq) 18a were dissolved in 20 ml dichloromethane and 25 ml 
concentrated HCl. The green solution was stirred at RT. for 30 Min., the organic phase was 
separated and the aqueous phase extracted twice with dichloromethane. The combined 
organic layers were neutralized with a saturated aquous NaHCO3 solution, separated, dried 
over sodium sulphate, filtered and concentrated. The red residue was purified by column 
chromatography (silica gel, 6*20 cm, Hex 3: EE 1+1% Et3N) to yield 129.2 mg (78%) 17a 
as a violet powder. 
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Analysis: 
Yield: 78%. 
TLC (silica gel, Hex:EE 3:1+1% Et3N): Rf= 0.20 (UV
+, Vis+). 
HPLC (CN 125 mm, Hex:CH2Cl2 8:2, RT): 3.8 Min. 
MALDI-TOF: M=1001.5 (M)+. 
UV-Vis (CH2Cl2+1% Et3N): l = 408 nm (100%), 508 nm (8%), 542 nm (3%), 588 nm 
(1%) 
1H-NMR (300 MHz, CDCl3, RT): 
d: 10.22 (s, H10,20, 2H); 8.47 (d, J = 8.3, H5’, 2H); 7.8 (t, J= 8.46, H4’, 2H); 7.1 (d, J = 8.79, 
H3’, 2H); 7.08 (s, NHPiv, 2H); 4.04 - 3.93 (m, CH2a, 8H); 3.56 (s, OCH3, 6H); 2.61 (s, 
CH3pyrrole, 12H); 2.18 (qui, J = 7.41, CH2b, 8H); 1.77 (sext, J = 7.42, CH2g, 8H); 1.12 (t, J = 
7.42, CH3d, 12H); -0.03 (s, C(O)C(CH3)3, 18H); -2.19 (br, NHporphyrin, 2H). 
13C-NMR (75 MHz, CDCl3, RT.): the signal attribution was determined on the basis of the 
previous results for 17b: 
176.49: C=O: 159.24: C2‘;145.33: C4,6,14,16; 143.71: C1,9,11,19; 141.89: C1‘; 140.03: C2,8,12,18: 
135.79: C3,7,13,17; 130.73: C4‘; 120.29: C1‘; 113.69: C5‘; 107.13: C5,15; 106.99: C3‘; 97.06: 
C10,20; 55.78: OCH3; 39.08: C(CH3)3: 35.50: Cb; 26.39:Ca; 26.29: C(CH3)3; 23.25: Cg; 
14.18: Cd; 13.34: CH3pyrrole. 
 
a,b-[5,15-Bis-(6'-pivaloylamino-2'-methoxyphenyl)-3,7,13,17-tetrabutyl-2,8,12,18-
tetramethyl-porphyrin] (17b): 
1.13 g (1.06 mmol, 1 eq) 18b were dissolved in 100 ml dichloromethane and 30 ml 18% 
HCl. The green solution was stirred for 10 Min. and the aqueous phase was extracted with 
dichloromethane. The organic layers were neutralized with an aqueous NaHCO3 solution, 
separated, dried over sodium sulphate, filtered and evaporated. The residue was purified by 
column chromatography (silica gel, 6*25 cm, Hex:EE 2:1 +1% Et3N) to yield 919.7 mg 
(86.5%) violet powder 17b. 
Analysis: 
Yield: 86.5%. 
TLC (silica gel, Hex:EE=5:1+1% Et3N): Rf=0.21 (UV
+, Vis+). 
HPLC (CN 125 mm, Hex:CH2Cl2 8:2): Rt = 3 Min. 
MALDI-TOF: M=1001.5 (M)+. 
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UV-Vis (CH2Cl2+1% Et3N): l = 408 nm (100%), 508 nm (8%), 542 nm (3%), 588 nm 
(1%) 
1H-NMR (300 MHz, CDCl3, RT): 
d: 10.22 (s, H10,20, 2H); 8.47 (d, J = 8.3, H5', 2H); 7.81 (t, J = 7.9, H4', 2H); 7.13 (d,  J= 8.5, 
H3', 2H); 6.93 (s, NHPiv, 2H); 4.07-3.93 (m, CH2a, 8H); 3.64 (s, OCH3, 6H); 2.60 (s, 
CH3pyrrole, 12H); 2.17 (qui, J = 7.48, CH2b, 8H); 1.72 (sext, J = 7.26, CH2g, 8H); 1.08 (t, J = 
7.42, CH3d, 12H), -0.11 (s, C(O)C(CH3)3, 18H); -2.22 (br, NHporphyrin, 2H). 
13C-NMR (101 MHz, CDCl3, RT.): the signals were attributed from the results obtained 
for 17b. and from a HETCOR spectrum. 176.6: C=O: 159.3: C2‘;145.2: C4,6,14,16; 143.8: 
C1,9,11,19; 142.2: C1‘; 140.03: C2,8,12,18: 135.8: C3,7,13,17; 130.8: C4‘; 120.5 C1‘; 113.7: C5‘; 
107.1:C5,15; 106.8: C3‘; 97.3: C10,20; 55.8: OCH3; 39.1: C(O)C(CH3)3: 35.50: Cb; 26.4: Ca; 
26.3: C(CH3)3; 23.2: Cg; 14.2: Cd; 13.4: CH3pyrrole. 
 
a,a-[5,15-Bis(6'-pivaloylamino-2'-hydroxy-phenyl)-3,7,13,17-tetrabutyl-2,8,12,18-
tetramethyl-porphyrin] (20a): 
129.2 mg (0.13 mmol, 1 eq) 17a were dissolved in 20 ml dichloromethane and 20 ml 
ethanethiol. 654 mg (4.9 mmol, 38 eq) aluminium chloride were added and the green 
solution was stirred overnight at RT. The solution was then diluted with water (100 ml), 
the product was recovered by extraction with dichloromethane. The combined organic 
layers were washed with a saturated sodium hydrogenocarbonate solution, separated, dried 
over sodium sulphate, filtered and evaporated. The residue was purified by column 
chromatography (silica gel, 5*25 cm, CH2Cl2:Hex 7:3 +0.5% MeOH +0.1% Et3N) to yield 
95 mg (75.6%) violet powder 20a. 
Analysis: 
Yield: 75.6. 
TLC(silica gel, CH2Cl2 : Hex 7:3+ 0.5% MeOH + 0.1% Et3N): Rf= 0.4 (UV
+, Vis+). 
HPLC (CN 125 mm, Hex:EE 7:3+0.5% MeOH): 3.1 Min. 
MALDI-TOF: M=973.4 (M)+. 
UV-Vis (CH2Cl2+1% Et3N): l = 408 nm (100%), 510 nm (14%), 576 nm (11.4%), 540 
nm (9.6%). 
1H-NMR (300 MHz, CDCl3, RT): d: 10.29 (s, H10,20, 2H); 8.42 (d, J = 7.9, H5’, 2H); 7.73 
(t, J = 8.24, H4’, 2H); 7.17 (s, NHPiv, 2H); 7.12 (d, J = 8.25, H3’, 2H); 4.22 (s, br, OH, 2H); 
4.05-3.9 (m, CH2a, 8H); 2.68 (s, CH3pyrrole, 12H); 2.18 (qui, J = 7.42, CH2b, 8H); 1.76 (sext, 
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J = 7.63, CH2g, 8H); 1.11 (t, J = 7.3, CH3d, 12H); 0.11 (s, C(O)C(CH3)3, 18H); -2.34 ( br, 
NHporphyrin, 2H). 
13C-NMR (75 MHz, CDCl3, RT): the signals were interpreted by comparison of the data 
obtained for 17a and 18a:176.40: C=O: 155.43: C2‘;145.75: C4,6,14,16; 144.84: C1,9,11,19; 
142.67: C2,8,12,18; 139.21: C1‘,: 136.42: C3,7,13,17; 131.37: C4‘; 117.66: C6‘; 113.28: C5‘; 
111.67:C3‘; 103.66: C10,20; 97.99: C5,15; 39.08: C(CH3)3: 35.48: Cb; 26.47: C(CH3)3; 26.37: 
Ca; 23.27: Cg; 14.14: Cd; 13.21: CH3pyrrole. 
 
a,b-[5,15-Bis-(6'-pivaloylamino-2'-hydroxy-phenyl)-3,7,13,17-tetrabutyl-2,8,12,18-
tetramethyl-porphyrin] (20b): 
400.6 mg (0.4 mmol, 1 eq) 17b were dissolved in 50 ml dichloromethane and 35 ml 
ethanethiol. 2.03 g (15.2 mmol, 33.5 eq) aluminium chloride were added and the green 
solution was stirred overnight at RT. The solution was then diluted with water (200 ml), 
the product was recovered by extraction with dichloromethane. The combined organic 
layers were washed with a saturated sodium hydrogenocarbonate solution, separated, dried 
over sodium sulphate, filtered and evaporated. The residue was purified by column 
chromatography (silica gel, 10*25 cm, Hex:EE 2:1+1% Et3N).) to yield 390 mg (100 %) 
violet powder 20b. 
Analysis: 
Yield: 100% violet powder. 
TLC (silica gel, Hex:EE 2:1+1% Et3N): Rf= 0.48 (UV
+, Vis+). 
HPLC (CN 125 mm, Hex:EE 8:2+0.5% MeOH, RT): 2.6 Min. 
MALDI-TOF: M=973.4 (M)+. 
UV-Vis (CH2Cl2+1% Et3N):  l = 408 nm (100%), 510 nm (14%), 576 nm (11%), 540 nm 
(9.6%) 
1H-NMR (300 MHz, CDCl3, RT): d: 10.32 (s, H10,20, 2H); 8.43 (d, J = 7.9, H5', 2H); 7.77 
(t, J = 8.24, H4', 2H); 7.16 (d, J = 8.24, H3', 2H); 6.92 (br, NHPiv, 2H); 4.6 (s, OH ,2H); 
4,12-4,02 (m, CH2a, 8H); 2.68 (s, CH3pyrrole 12H); 2.19 (qui, J = 7.42, CH2b, 8H); 1.73 
(sext, J = 7.48, CH2g, 8H); 1.09 (t, J = 7.1, CH3d, 12H); -0.01 (s, C(O)C(CH3)3, 18H), -2.22 
(br, NHporphyrin, 2H). 
13C-NMR (101 MHz, CDCl3, RT): the signals were attributed from a HETCOR spectra 
and comparison between 20a and 20b: d: 176.8: C=O: 156.3: C2‘;145.0: C4,6,14,16; 143.9: 
C1,9,11,19; 141.9: C2,8,12,18; 138.9: C1‘,: 136.0: C3,7,13,17; 130.7: C4‘; 118.4: C6‘; 112.5: C5‘; 
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111.9: C3‘; 102.6: C5,15; 97.3: C10,20; 38.7: C(CH3)3: 35.1: Cb; 26.1: C(CH3)3; 26.0: Ca; 
22.9: Cg; 13.7: Cd; 12.8: CH3pyrrole. 
 
Derivatization of 17b to its para-nitrophenylester 17c gave the following NMR analysis:  
1H-NMR (600 MHz, CDCl3, RT): d: 10.11 (s, H10,20, 2 H); 8.84 (d, J = 8.43, H5’, 2H); 
7.93 (t, J = 8.39, H4’, 2H); 7.61 (s, NHPiv, 2H); 7.55 (d, J = 8.21, H3’, 2H); 6.64 (d, J= 8, 
H3’’,5’’, 2H); 6.4 (d, J = 8.01, H2’’,6’’, 2H); 3.98-3.91 (m, CH2a, 8H); 2.68 (s, CH3pyrrole, 
12H); 2.15 (qui, J = 7.69, CH2b, 8H); 1.76 (sext, J = 7.48, CH2g, 8H); 1.12 (t, J = 7.35, 
CH3d, 12H); 0.25 (s, C(O)C(CH3)3, 18H); -2.48 (br, NHporphyrin, 2H). 
A strong NOE effect is observed between the Pivaloyl H‘s and H3’’,5’’ of the phenylester 
moiety, indicative of the (a,b) configuration. 
MALDI-TOF: M=1270.9 (M-1)+ 
UV-Vis (CDCl3): l= 410 nm (100%), 510 nm (8.5%), 580 nm (5.7%), 546 nm (4.2%). 
 
5,15-{(6-pivaloylamino-[4-tert-butyl-2-N,N-dimethylthiocarbamoyl-1,3-phenylen)-bis-
(trimethylenoxy)-di-2,1-phenylen]}-3,7,17,27-tetrabutyl-2,8,12,18-tetramethyl-
porphyrin (21): 
95 mg (80.09 mmol, 1 eq) 20a were dissolved in 100 ml abs. DMF and 1.065 g (3.27 
mmol, 33.5 eq) cesium carbonate were added. The solution was vigorously stirred at 60°C 
for 30 Min. and 59.7 mg (0.12 mmol, 1.2 eq) of 15 in 20 ml abs. DMF were added within 3 
hr. The reaction was then stirred at 60°C for a further 45 Min. 
The red solution was quenched with 250 ml aqueous 10% HCl solution, the aqueous phase 
was extracted with three times with 100 ml TBDME. The combined organic layers were 
neutralized with 300 ml of a saturated NaHCO3 solution, separated, dried over Na2SO4, 
filtered and evaporated. The residue was purified by column chromatography (silica gel, 
5*35 cm, Hex:EE 5:1+1% Et3N) to yield 67.67 mg (53%) red powder 21. 
Analysis: 
Yield: 53%. 
TLC (silica gel, Hex:EE 2:1+ 1% Et3N): Rf= 0.45 (UV
+, Vis+). 
HPLC (CN 125 mm, Hex:EE 85:15+0.5% MeOH, RT): 2.9 Min. 
MALDI-TOF: M=1289.6 (M-1)+. 
UV-Vis (CH2Cl2): l = 414 nm (100%), 510 nm (9.8%), 580 nm (5.7%), 546 nm (4.9%) 
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1H-NMR (600 MHz, CDCl3, 280K): the signal attribution was made with help of COSY, 
NOESY and ROESY spectra at low temperature. d: 10.11 (s, H10, 1H); 9.72 (s, H20, 1H); 
8.61 (d,  J= 7.97, H5’, 2H); 8.42 (s, NHPiv, 2H); 7.77 (t, J = 8.37, H4’, 2H); 6.95 (d, J = 
7.69, H3’, 2H); 6.37 (s, H3’’,5’’, 2H); 4.17-4.04 and 3.98-3.85 (2*m, CH2a’, 2*2H); 3.92-3.82 
and 3.62-3.52 (m, CH2a, 8 H); 2.72 and 2.55 (2*s, CH3pyrrole, 2*6 H); 2.22 (qui, J = 7.42, 
CH2b’, 4H); 1.82-1.72 (m, CH2g’, 4H); 1.97-1.87 and 1.72-1.82 (2*m: CH2b, 2*4H); 1.72 
(br, N(CH3)2, 3H); 1.62-1.72 (2*m, CH2g, 2*4H); 1.15-1.13 (2*t, J = 7.2, CH3d, 12H); 1.09 
(s, H2”’, 9H); 0.52 (s, C(O)C(CH3)3, 18H); -1.32 (br, N(CH3)3, 3H); -2.00 (br, NHporphyrin, 
2H). 
To get a better resolution for NMR the thiocarbamate protecting group (i.e. (CH3)2N-C=O) 
was replaced by a thiothiocarbamate protecting group (i.e. ( (CH3)2N-C=S) 
Analysis: 
TLC (silica gel, Hex:EE 7:1 +1% Et3N): Rf= 0.39 (UV
+, Vis+). 
MS (MALDI-TOF): M=1306 (M)+. 
1H-NMR (600 MHz, CDCl3, RT): 10.11 (s, H20, 1 H); 9.69 (s, H10, 1 H); 8.6 (td, 
1J = 8.06, 
2J = 0.6, H5', 2H), 8.32 (s, NHPiv, 2H); 7.73 (t, J = 8.06 Hz, H4', 2 H); 6.97 (d, J = 7.57, 
H3', 2H); 6.41 (s, H3”,5”, 2H); 4.08 (m, CH2a, 2H); 3.94 (m, CH2a, 2H); 3.84 (m, CH2a, 2H); 
3.81 (m, CH2a, 2H); 3.65 (m, CH2a’; 2H); 3.62 (m, CH2a', 2 H); 2.72 (s, CH3pyrrole attached 
to C3,17, 6H); 2.54 (s, CH3pyrrole attached to C7,13, 6H); 2.32 (s. N(CH3)2, 3H); 2.22 (qui, J = 
7.3, CH2b, 4H); 2.00 (m, CH2b', 2H); 1.94 (m, CH2b', 2H); 1.805 (m, Hg, 4 H); 1.72 (m, 
CH2g', 4H); 1.16 (s, H2”', 9H); 1.155 (m, CH3d, 6H); 1.151 (m, CH3d, 6H); 0.7 (m, CH2b’, 
4H); 0.08 (t, J = 7.3, CH2g’, 2H); 0.07 (m, J=7.3 Hz, CH2g”, 2H); -0.98 (s, N(CH3)2, 3H); -
2.07 (br, NHporphyrin, 2H). 
13C-NMR (150 MHz, CDCl3, RT): 197.4: C=S; 176.93: C=O; 160.0: C2'; 151.46: C4”; 
145.83: C6,14; 145.23: C4,16; 144.5: C1”; 143.87: C1,19; 143.5: C9,11; 141.68: C2,18; 141.35: 
C8,12; 139.19: C1'; 135.88: C3,17; 135.52: C7,13; 130.88: C4'; 126.45: C2”,6”; 122.94: C3”,5”; 
120.63: C6'; 113.11: C5'; 109.85: C3'; 107.46: C5,15; 97.16: C10; 96.33: C20; 70.07: Ca”; 
44.16: NCH3; 39.63: C(O)C(CH3)3; 38.71: NCH3; 35.53: Cb; 35.14: Cb'; 34.2: C1”'; 31.2: 
C2”'; 30.34: Cb”; 28.68: Cg”; 26.37: Ca;; 26.03: Ca'; 23.34: Cg; 23.28: Cg'; 14.22: Cd; 14.03: 
Cd'; 13.69: CH3pyrrole attached to C3,17; 13.22: CH3pyrrole attached to C7,13. 
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5,15-{(6-pivaloylamino-[4-tert-butyl-2-sulfhydryl-1,3-phenylen)-bis-(trimethylenoxy)-
di-2,1-phenylen]}-3,7,17,27-tetrabutyl-2,8,12,18-tetramethyl-porphyrin (22): 
67.67 mg (0.052 mmol, 1 eq) 21 were dissolved in 20 ml degassed dioxane and the 
solution was bubbled for 30 Min. with argon. 1.55 ml (5.2 mmol, 100 eq) KOMe (95% 
powder). The reaction mixture was heated up to 110°C and the green solution was stirred 
for 55 Min. The solution was neutralized after cooling to RT with 100 ml aquous saturated 
NH4Cl solution under argon and the product was recovered by extraction with three times 
50 ml TBDME. The combined organic layers were dried over Na2SO4, filtered and 
evaporated. The residue was purified by column chromatography under argon (silica gel, 
3*25 cm, Hex:EE 4.5:1+1% Et3N) to yield 58 mg (93%) red powder 19. 
Analysis: 
Yield: 93%. 
TLC (silica gel, Hex:EE 5:1+ 1% Et3N).: Rf= 0.22 (UV
+, Vis+). 
HPLC (CN 125 mm, Hex:EE 95:5+0.5% MeOH, RT): 3.8 Min. 
MALDI-TOF: M=1218.9 (M-1)+. 
UV-Vis (CH2Cl2): l = 414 nm (100%), 510 nm (12.6%), 580 nm (9.3%), 544 nm (3.9%) 
1H-NMR (600 MHz, CDCl3, RT): the signal attribution was made with help of COSY, 
NOESY and ROESY spectra. d: 10.12 (s, H10,20, 2H); 8.64 (d, J = 8.24, H5’, 2H); 8.46 (s, 
NHPiv, 2H); 7.77 (t, J = 8.39, H4’, 2H); 6.94 (d, J = 8.24, H3’, 2H); 6.2 (s, H3’’,5’’, 2H); 
4.05-4.02 and 3.94-3.9 (2 m, CH2a, 2*4H); 3.62 (t, J = 7.42, CH2a’, 2*2H); 2.12 (qui, J = 
7.42, CH2b, 8H); 1.67 (sext, J = 7.38, CH2g, 8H); 1.05 (t, J = 7.3, CH3d, 12H); 0.87 (s, H2”’, 
9H); 0.67 (m, CH2g’, 4H); 0.55 (s, C(O)C(CH3)3, 18H); 0.47 (m, CH2b’, 4H); -2.13 (br, 
NHporphyrin, 2H); -3.01 (s, SH, 1H). 
13C-NMR (101 and 151 MHz, CDCl3, RT): the interpretation was done with comparison 
with the corresponding phenolate moiety 31 and a HETCOR spectrum. 
177.0: C=O; 159.34: C2‘; 146.37: C1“; 145.34: C4,6,14,16; 143.76: C1,9,11,19; 141.72: C2,8,12,18; 
139.5: C4“; 138.06: C1‘; 135.61: C3,7,13,17; 130.67: C4‘; 129.30: C4“,6“; 123.14: C3“,5“; 120.60: 
C6‘; 113.13: C5‘; 108.16: C3‘,10,20; 97.09: C5,15; 68.34: Ca‘; 39.70: C(O)C(CH3)3; 35.36: Cb; 
33.6: C1“‘; 31.23: Cb‘; 30.94: C2“‘; 29.06: Cg‘; 26.99: C(O)C(CH3)3; 26.32: Ca; 23.13: Cg; 
14.17: Cd; 13.39: CH3pyrrole. 
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5,15-{(6-pivaloylamino-[4-tert-butyl-2-thiolato-1,3-phenylen)-bis-(trimethylenoxy)-di-
2,1-phenylen]}-3,7,17,27-tetrabutyl-2,8,12,18-tetramethyl-porphyrinato iron (III) 
(11): 
To 12.2 mg (10 mmol, 1 eq) 22 were added in a Schlenktube 21.57 mg (0.1 mmol, 10 eq) 
iron (II) dibromide and 27.9 ml (0.2 mmol, 20 eq) triethylamine and 3 ml of toluene. The 
mixture was degassed three times in the high vacuum and refluxed for one hour. 
Subsequently the reaction was filtered over celite and concentrated. The residue was 
further purified through column chromatography (silica gel, 2*20 cm, Hex:EE 8:1) under 
argon to yield 9.55 mg (75%) 11 as a brown solid. 
Analysis: 
Yield: 75 %. 
TLC (silica gel, Hex:EE 7:1): Rf= 0.39 (UV
+, Vis+). 
MS (MALDI-TOF): M=1272 (M)+. 
UV-Vis (toluene): l = 408 nm (100%), 512 nm (br, 10%) 
NMR (600 MHz, toluene-d8, RT): -57.1 (br, H10,20, 2H); 8.3 (H5’, 2H); 10.6 (H4’, 2H); 
12.7 (NHPiv, 2H); 13.17 (H3’, 2H); 35.9 and 39.4 (CH2a, 8H); 38 (CH3pyrrole, 12H); 85.3 
(H3",5", 2H); all other signals between –10 and +10 ppm could not be assigned. 
ESR (10K, toluene): g//= 8.347 and g^=3.079 (br) for five coordination state; g//= 5.773 
and g^=2.00 for six coordination state. 
Cyclic voltammetry (DMF, 0.1M LiClO4, RT): E
0= -565 mV vs SCE. 
 
Iron(II) complexes: 
Iron(II) sulphate: 
A UV sample solution of 11 in 2 ml THF was stirred in the glove-box with a large excess 
of sodium borhydride for 30 Min. 
Analysis: 
UV-Vis (THF): l= 420 nm (100%), 484 nm (26%), 538 nm (14.9%), 570 nm (12.4%). 
MALDI-TOF: M=1273 (M)+. 
The sample was not stable enough to allow a further characterization. 
 
5,15-{(6-pivaloylamino-[4-tert-butyl-2-N,N-dimethyloxythiocarbamoyl-1,3-phenylen)-
bis-(trimethylenoxy)-di-2,1-phenylen]}-3,7,17,27-tetrabutyl-2,8,12,18-tetramethyl-
porphyrin (30): 
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To a solution of 52.2 mg (53.6 mmol, 1 eq) 20a in 55 ml abs. DMF under argon was added 
594.0 mg (2.09 mmol, 34 eq) cesium carbonate and the supension was stirred at 80°C (oil 
bath temperature) for 30 Min. Then 32.8 mg (73.84 mmol, 1.2 eq) 16 in 5 ml abs. DMF 
were added within 3 hours. After cooling the solution was diluted with 50 ml 10% HCl and 
extracted with four times with 30 ml TBME. The combined organic layers were then 
washed twice with 150 ml saturated aqueous solution of NaHCO3, dried over sodium 
sulphate, filtered and evaporated. The residue was further purified by column 
chromatography (silica gel, 4*25 cm, Hex:EE 4:1+ 1% Et3N) to afford 14.2 mg (55%) red 
solid 30. 
Analysis: 
Yield: 55%. 
TLC(silica gel, Hex :EE 4:1+1% Et3N): Rf= 0.33 (UV
+, Vis+). 
MS (MALDI-TOF): M=1291 (M)+. 
UV-Vis (CDCl3): l = 414 nm (100%), 510 (10.4%); 542 (5.9%). 
1H-NMR (300 MHz, CDCl3, RT): 
d:10.1 (s, H20, 1H); 9.71 (s, H10, 1H); 8.59 (d, J= 8.26, H5', 2 H); 8.29 (s, NHPiv, 2H); 7.77 
(t, J = 8.3, H4', 2H); 6.98 (d, J = 7.7, H3', 2H); 6.33 (s, H3”,5”, 2H); 4.15-3.6 (m, Ha,a',a”, 
12H); 2.69 (s, CH3pyrrole attached to C3,17, 6H); 2.55 (s, CH3pyrrole attached to C7,13, 6H); 2.2 
(m, Hb,b', 8H); 2.1 (s, N(CH3)2, 6H); 1.75 (m, Hg,g', 8H); 1.26 (s, H2”', 9H); 1.14 (J = 7.2, Hd, 
6H); 1.12 (t, J = 7.2, Hd', 6H); 0.47 (s, NHC(O)C(CH3)3, 18H); 0.1 (td, 
1J = 15; 2J = 3, Hb”, 
4H); 0.03 (td, 1J = 15; 2J= 3, Hg”, 4H); -2.2 (br, NHporphyrin, 2H). 
13C-NMR (151.0 MHz, CDCl3, RT):  
 
5,15-{(6-pivaloylamino-[4-tert-butyl-2-hydroxy-1,3-phenylen)-bis-(trimethylenoxy)-
di-2,1-phenylen]}-3,7,17,19-tetrabutyl-2,8,12,18-tetramethyl-porphyrin (31): 
To a solution of 14 mg (10.84 mmol, 1 eq) 30 in 3 ml abs. dioxane was added under argon 
48 mg (650.8 mmol, 60 eq) KOMe (95% powder) and the solution was stirred at 90°C 
(oilbath temperature) for 3 hours. 
After cooling the solution was diluted with 30 ml of a 10% HCl solution and extracted four 
times with TBME. The organic layers were then washed twice with an aqueous saturated 
NaHCO3 solution, dried over sodium sulphate, filtered and concentrated. The residue was 
further purified by column chromatography (silica gel, Hex:EE 4:1+ 1% Et3N) to yield 9.7 
mg (74%) red solid 31. 
Analysis: 
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Yield: 74%. 
TLC (silica gel, Hex:EE 1:1+1% Et3N): Rf= 0.5 (UV
+, Vis+). 
MS (MALDI-TOF): M=1203 (M)+. 
UV-Vis (CDCl3): l = 414 nm (100%), 512 (8.2%); 546 (4.2%); 572 (3.4%). 
1H-NMR (500 MHz, CDCl3, RT): the signals were attributed by COSY and NOESY 
experiments.  d: 10.14 (s, H10,20, 2H);  8.62 (dd, 1J = 7.8, 2J = 0.76, H5', 2H); 8.36 (s, 
NHPiv, 2H); 7.77 (t, J = 8.3, H4', 2H); 6.95 (dd; 
1J = 7.5, 2J = 0.82, H3', 2H); 6.11 (s, H3”,5”, 
2H); 3.94 (t, J = 7.7, Ha,a', 8H); 3.65 (t, J= 4.9, Ha”, 4H); 2.65 (s, CH3pyrrole, 12H); 2.06 
(qui, J = 7.7, Hb,b', 8H); 1.71 (sext, J = 7.7, Hg,g', 8H); 1.06 (t, J = 7.7, Hd,d', 12H); 0.89 (s, 
H2'“, 9H); 0.53 (s, C(O)C(CH3)3, 18H); 0.5 (m, Hb”, 4H); 0.08 (m, Hg”, 4H); -2.15 (s, OH, 
1H); -2.29 (s, NHporphyrin, 2H). 
13C-NMR (125 MHz, CDCl3, RT): the signals were attributed by HMQC, HMBC 
experiments. 
176.99: C=O; 159.46: C1'; 146.16: C1”; 145.71: C4,6,14,16; 143.99: C1,9,11,19; 141.94: C2,8,12,18; 
139.59: C4”; 139.16: C2'; 135.81: C3,7,13,17; 130.82: C4'; 125.51: C2”,6”; 122.84: C3”,5”; 
120.74: C6'; 113.07: C5'; 108.88: C3'; 107.38: C5,15; 97.45: C10,20; 68.94: Ca”; 39.68: 
C(O)C(CH3)3; 35.42: Cb,b'; 33.83: C1'“; 31.24: C2'“; 29.06: Cb”; 26.98: C(O)C(CH3)3; 26.36: 
Ca,a'; 24.93: Cg”; 23.31: Cg,g'; 14.2: Cd,d'; 13.4: CH3pyrrole. 
 
5,15-{(6-pivaloylamino-[4-tert-butyl-2-hydroxy-1,3-phenylen)-bis-(trimethylenoxy)-
di-2,1-phenylen]}-3,7,17,27-tetrabutyl-2,8,12,18-tetramethyl-porphyrinato iron (III) 
(12): 
To 9.7 mg (8.05 mmol, 1 eq) 31 were added in a Schlenk tube 17.4 mg (0.08 mmol, 10 eq) 
FeBr2 and 22.5 ml (0.16 mmol, 20 eq) triethylamine in 3 ml toluene and degassed three 
times at high vacuum. The mixture was stirred overnight at reflux and after cooling filtered 
through celite. Then it was purified by column chromatography (silica gel, 1*25 cm, 
Hex:EE 8:1) to yield 10.1 mg (100%) green solid 12. 
Analysis: 
Yield: 100%. 
TLC(silica gel, Hex:EE 1:1): Rf= 0.5 (UV
+, Vis+). 
MS (MALDI-TOF): M=1255 (M)+. 
UV-Vis (toluene): l = 408 nm (100%, e=11.24*104 M-1.cm-1). 
ESR (10K, toluene): g//= 5.857, g^=2.009. 
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Cyclic voltammetry (DMF, 0.1M LiClO4, RT): E
0= -600 mV vs SCE. 
 
A.2. Synthesis of the CPO model 32 and catalase model 33: 
 
5,15-Bis-(2'-methoxynaphthyl)-3,7,13,17-tetrabutyl-2,8,12,18-tetramethyl-
porphyrinato-zinc (II) (37a and 37b): 
A 90 ml acetonitrile solution of 931 mg (5 mmol, 1 eq) 2-methoxynaphthylaldehyde 36 
was bubbled 15 Min. with argon and then 1.43 g (5 mmol, 1eq) 13 were added. The 
solution was stirred at RT. for 24 hr and 1.84 g (7.5 mmol, 1.5 eq) o-chloranil in 20 ml of 
THF were added. After 30 Min. 4.58 g (25 mmol, 5 eq) zinc acetate were added with 20 ml 
of methanol and the solution was refluxed for 1 hr. The solution was neutralized with 250 
ml of saturated sodium hydrogenocarbonate solution and filtered through celite. The 
product was retained on celite and the celite was washed with dichloromethane until it was 
colourless. The solvent was evaporated and the crude product was purified by column 
chromatography (silica gel, 15*30 cm, Hex:CH2Cl2 1:1, 3l then 1:2, 3l). Two fractions 
containing the pure atropisomers were collected, evaporated to yield resp. 960.4 mg 
(39.8%) 37a and 946.5 mg (39.3%) 37b. 
Analysis: 
Yield: 79.1%. 
TLC (silica gel, Hex:CH2Cl2 1: 1): Rf= 0.34 for 37b and 0.14 for 37a (UV
+, Vis+). 
MALDI-TOF: M=964.6 (M)+. 
UV-Vis (CH2Cl2): l = 414 nm (100 %), 510 nm (12.6 %), 580 nm (9.3 %), 544 nm (3.9 
%) 
1H-NMR (CDCl3, 300 MHz, RT): 
37b (a,b-atropisomer): d: 10.16 (s, H10,20, 2H); 8.32 (d, J = 9.12, H4', 2H); 8.04 (d, J = 
8.24, H5', 2H); 7.71 (d, J = 9.07, H8', 2H); 7.33 (t, J = 7.43, H6', 2H); 6.91 (t, J = 7.66, H7', 
2H); 6.61 (d, J = 8.58, H3', 2H); 4.0-3.85 (m, CH2a, 8H); 3.73 (s, OCH3, 6H); 2.17 (s, 
CH3pyrrole, 12H); 2.12 (qui,  J= 7.6, CH2b, 8H); 1.71 (sext,  J= 7.4, CH2g, 8H); 1.07 (t, J = 
7.3, CH3d, 12H). 
37a (a,a-atropisomer): d: 10.16 (s, H10,20, 2H); 8.31 (d, J = 9.13, H4', 2H); 8.03 (d, J = 
8.24, H5', 2H); 7.73 (d, J = 9.28, H8', 2H); 7.31 (t, J = 6.87, H6', 2H); 6.84 (t, J = 7.97, H7', 
2H); 6.43 (d, J = 8.73, H3', 2H); 4.0-3.8 (m, CH2a, 8H); 3.79 (s, OCH3, 6H); 2.18 (s, 
CH3pyrrole, 12H); 2.11 (qui, J = 7.6, CH2b, 8H); 1.72 (sext, J = 7.36, CH2g, 8H); 1.06 (t, J = 
7.3, CH3d, 12H). 
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As the characterization is unambiguous with the analyses performed, 13C carbon spectra 
have not been recorded. 
 
a,a-5,15-Bis-(2'-methoxynaphthyl)-3,7,13,17-tetrabutyl-2,8,12,18-tetramethyl-
porphyrin (38a): 
289.4 mg (0.3 mmol, 1eq) 37a. were dissolved in 100 ml dichloromethane and stirred for 
30 Min. at RT. with 50 ml of concentrated HCl solution. The solution was then diluted 
with 250 ml water and extracted 3 times with dichloromethane. The combined organic 
layers were neutralized with a saturated sodium hydrogenocarbonate solution, separated, 
dried over sodium sulphate, filtered and concentrated to yield quantitative 38a as a violet 
solid. 
Analysis: 
Yield: quantitative. 
TLC (silica gel, Hex:CH2Cl2 1:1): Rf= 0.14 (UV
+, Vis+). 
MALDI-TOF: M= 902 (M)+. 
UV-Vis (CH2Cl2): l = 414 nm (100%), 508 nm (8.3%), 542 nm (2.9%), 572 nm (2.9%) 
1H-NMR (300 MHz, CDCl3, RT): 
d: 10.20 (s, H10,20, 2H); 8.33 (d, J = 9.06, H4', 2H); 8.04 (d, J = 8.24, H5', 2H); 7.72 (d, J = 
9.0, H8', 2H); 7.34 (t, J = 7.08, H6', 2H); 6.92 (t, J = 8.24, H7', 2H); 6.67 (d, J = 8.58, H3', 
2H); 3.93 (t, J = 7.69, CH2a, 8H); 3.74 (s, OCH3, 6H); 2.21 (s, CH3pyrrole, 12H); 2.13 (qui, J 
= 7.41, CH2b, 8H); 1.69 (sext, J = 7.35, CH2g, 8H); 1.05 (t, J = 7.41, CH3d, 12H); -2.05 (br, 
NHporphyrin, 2H). 
The characterization was unambiguous therefore no 13C NMR spectra has been recorded. 
 
a,b-5,15-Bis-(2'-methoxynaphthyl)-3,7,13,17-tetrabutyl-2,8,12,18-tetramethyl-
porphyrin (38b): 
289.4 mg (0.3 mmol, 1 eq) 37b were dissolved in 100 ml dichloromethane and stirred for 
30 Min. at RT. with 50 ml of concentrated HCl solution. The solution was then diluted 
with 250 ml water and extracted 3 times with dichloromethane. The combined organic 
layers were neutralized with a saturated sodium hydrogenocarbonate solution, separated, 
dried over sodium sulphate, filtered and concentrated to yield quantitative 38b as a violet 
solid. 
Analysis: 
Yield: 100%. 
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TLC(silica gel, Hex:CH2Cl2 1:1): Rf= 0.34 (UV
+, Vis+). 
MALDI-TOF: M=902 (M)+. 
UV-Vis (CH2Cl2): l = 412 nm (100%), 508 nm (18.2%), 576 nm (15.2%), 542 nm 
(13.7%) 
1H-NMR (300 MHz, CDCl3, RT): d: 10.24 (s, H-10,20, 2 H); 8.29 (d, J = 9.06, H4', 2H); 
8.05 (d, J= 8.24, H5', 2H); 7.66 (d, J= 9.22, H8', 2H); 7.37 (t, J = 7.96, H6', 2H); 6.98 (t, J = 
6.98, H7', 2H); 6.8 (d, J = 8.51, H3', 2H); 3.96 (t, J = 6.59, CH2a, 8H); 3.68 (s, OCH3, 6H); 
2.23 (s, CH3pyrrole, 12H); 2.16 (qui, J = 7.2, CH2b, 8H); 1.72 (sext, J = 7.2, CH2g, 8H); 1.08 
(t, J = 7.2, CH3d, 12H); -2.01 (br, NHporphyrin, 2H). 
The characterization is unambiguous therefore no 13C NMR spectra has been recorded. 
 
a,a-5,15-Bis-(2'-hydroxy-naphthyl)-3,7,13,17-tetrabutyl-2,8,12,18-tetramethyl-
porphyrin (39): 
271 mg (0.3 mmol, 1 eq) 38a were dissolved in 50 ml dry dichloromethane and cooled to 
0°C. 867 ml (9 mmol, 30 eq) BBr3 were added, the solution was warmed up to RT. and 
stirred overnight. The solution was quenched with water, extracted with dichloromethane. 
The combined organic layers were washed twice with saturated sodium 
hydrogenocarbonate solution, separated, dried over sodium sulphate, filtered and 
concentrated. The residue was purified by column chromatography (silica gel, 6*25 cm, 
Hex:EE 4:1+ 0.1% Et3N) to yield 244.3 mg (93%) violet solid 39. 
Analysis: 
Yield: 93%. 
TLC (silica gel, Hex:EE 4: 1): Rf= 0.1 (UV
+, Vis+). 
MALDI-TOF: M=880 (M+5)+. 
UV-Vis (CH2Cl2): l = 414 nm (100%), 510 nm (12.6%), 580 nm (9.3%), 544 nm (3.9%) 
1H-NMR (300 MHz, CDCl3, RT): the signal attribution was made with help of COSY, 
NOESY and ROESY spectra. d: 10.3 (s, H10,20, 2H); 8.28 (d, J = 8.79, H4', 2H); 8.06 (d, J= 
8.24, H5', 2H); 7.64 (d, J = 8.92, H8', 2H); 7.38 (t, J = 6.99, H6', 2H); 7.02 (t, J = 6.93, H7', 
2H); 6.76 (d, J = 8.3, H3', 2H); 5.1 (br, OH, 2H); 4.02-3.9 (m, CH2a, 8H); 2.31 (s, 
CH3pyrrole, 12H); 2.14 (qui, J = 7.21, CH2b, 8H); 1.7 (sext, J = 7.48, CH2g, 8H); 1.06 (t, J = 
7.24, CH3d, 12H); -2.1 (br, NHporphyrin, 2H). 
The characterization is unambiguous therefore no 13C NMR spectra has been recorded. 
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5,15-{(6-naphthyl-[4-tert-butyl-2-S-N,N-dimethylthiocarbamoyl-1,3-phenylen)-bis-
(trimethylenoxy)-di-2,1-phenylen]}-3,7,17,27-tetrabutyl-2,8,12,18-tetramethyl-
porphyrin (40): 
244.3 mg (0.28 mmol, 1 eq) of 39 were dissolved in 230 ml abs. DMF and 3.09 g (9.5 
mmol, 34 eq) of cesium carbonate were added. The mixture was stirred at 80°C for 30 
Min. and 213.4 mg (0.42 mmol, 1.5 eq) of 13 in 20 ml abs. DMF were added over 3 hr. 
The red mixture was then cooled to RT., diluted with 300 ml 10% HCl and extracted 3 
times with TBME. The combined organic layers were washed twice with a saturated 
sodium hydrogenocarbonate solution, separated, dried over sodium sulphate, filtered and 
concentrated. The residue was purified by column chromatography (Hex: EE, 3.5:1+ 0.1% 
Et3N) to yield 234.8 mg (70.5%) red powder 40. 
Analysis: 
Yield: 70.5%. 
TLC(silica gel, Hex:EE 7:2): Rf= 0.14 (UV
+, Vis+). 
MALDI-TOF: M=1194 (M)+. 
UV-Vis (CDCl3): l = 418 nm (100%), 510 nm (7%), 544 nm (1.2%), 590 nm (0.3%). 
1H-NMR (600 MHz, CDCl3, 280K): the signal attribution was made with help of COSY, 
NOESY and ROESY and TOCSY spectra. d: 10.1(s, H20, 1H); 9.7 (s, H10, 1H); 8.31 (d, J = 
8.9, H4', 2H); 8.12 (d, J = 8.6, H5', 2H); 8.0 (d, J = 8.6, H8', 2H); 7.54 (t, J = 7.2, H6', 2H); 
7.53 (d, J = 8.9, H3', 2H); 7.39 (t, J = 7.2, H7', 2H); 6.31 (s, H3”,5”, 2H); 4.05 and 3.62 (m 
and t, J = 8.5, CH2a’, 2*2H); 3.94 and 3.84 and 3.48 (t and 2*m, J = 8.1, CH2a, 4H and 
2*2H); 2.23 and 2.15 (2*s, CH3pyrrole, 2*6H); 2.18 (qui, J= 7.9, CH2b,, 4H), 1.9 and 1.85 
(2*m, CH2b,, 2*4H); 1.8 (br, N(CH3)2, 3H); 1.8 and 1.7 (sext, J = 7.3 , CH2g, 2*4H); 1.13 
(t, J = 7.5Hz, CH3d,, 12H); 1.09 (s, H2”’, 9H); 0.6 and 0.55 (m, CH2b’, 2*2H); 0.01 (t, J = 
8.5 , CH2g’, 4H); -0.98 (br, N(CH3)2, 3H); -1.9 (br, NHporphyrin, 2H). 
To get a better resolution for NMR the thiocarbamate protecting group (i.e. (CH3)2N-C=O) 
was replaced by a thiothiocarbamate protecting group (i.e. ( (CH3)2N-C=S) 
 
Analysis: 
TLC (silica gel, Hex:EE 7:2+1% Et3N): Rf=0.15 (UV
+, Vis+). 
MS (MALDI-TOF): M=1214 (M+5)+. 
UV-Vis (CDCl3): l = 418 nm (100%), 510 (6.3%); 544 (3.4%). 
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1H-NMR (600 MHz, CDCl3, RT): 10.12 (s, H20,  H); 9.65 (s, H10, 1H); 8.3 (d, J = 9, H4', 
2H); 8.13 (d, J = 8.5, H5', 2H); 8.0 (d, J = 8.0, H8', 2H); 7.54 (d, J = 9.0, H3', 2H); 7.53 (t, J 
= 8.0, H6', 2H); (td, 
1J = 7.7, 2J = 0.9, H7', 2H); 6.37 (s, H3”, 5”, 2H); 4.05-3.98 (m, CH2a’, 
2H); 3.94 (t, J = 8.0, CH2a, 4H); 3.84-3.79 (m, CH2a, 2H); 3.78-3.74 (m, CH2a, 2H); 3.58-
3.5 (m, Ha’, 2H); 2.4 (s, NCH3, 3H); 2.23 (s, CH3pyrrole attached to C3,17, 6H); 2.21-2.16 (m, 
Hb, 4H); 2.15 (s, CH3pyrrole attached to C7,13, 6H); 2.02-1.89 (2*m, Hb, 4H); 1.85-1.75 (m, 
Hg, 4H); 1.71 (sext, J =7.3, Hg, 4H); 1.17 (s, H2”', 9H); 1.14 (t, J = 7.3, Hd, 6H); 1.13 (t, J = 
7.3, Hd, 6H); 0.85-0.78 (m, Hb’, 2H); 0.75-0.64 (m, Hb’, 2H); 0.49 (td, 
1J = 13.5, 2J = 4.0, 
Hg’, 2H); 0.09 (td, 
1J = 13.5, 2J = 4.3, Hg’, 2H); -0.6 (s, NCH3, 3H); -1.9 (br, NHporphyrin, 
2H). 
13C-NMR (150 MHz, CDCl3, RT): 197.5: C=S; 157.64: C2'; 151.06: C4”; 145.82: C4,6,14,16; 
144.37: C1”; 142.93: C9,11; 142.89: C1,19; 141.12: C2,18; 140.82: C8,12; 137.39: C4'a; 135.84: 
C3,17; 135.3: C7,13; 130.47: C4' 129.05 C1a'; 127.67: C5'; 127.1: C7'; 126.62: C8'; 126.31: 
C2”,6”; 126.24: C1'; 123.81: C6'; 122.51: C3”,5”; 116.41: C3', 111.36: C5,15; 96.1: C10; 95.61: 
C20; 71.02: Ca” '; 44.44: NCH3; 38.4: NCH3; 35.74: Cb;, 35.09: Cb'; 34.24: C1” '; 31.22: C2” '; 
30.11: Cg” '; 28.92: Cb” '; 26.54: Ca; 26.14: Ca'; 23.42: Cg; 23.36: Cg'; 14.25: Cd,d'; 13.8: 
CH3pyrrol attached to C3,18,; 13.47: CH3pyrrol attached to C7,13. 
 
5,15-{(6-naphthyl-[4-tert-butyl-2-sulfhydryl-1,3-phenylen)-bis-(trimethylenoxy)-di-
2,1-phenylen]}-3,7,17,27-tetrabutyl-2,8,12,18-tetramethyl-porphyrin (41): 
71.1 mg (59.8 mmol, 1 eq) 40 were dissolved in 25 ml of previously degassed dioxane and 
the solution was bubbled with argon for 30 Min. 1.76 ml (0.598 mmol, 100 eq) of a 25% 
KOMe solution in methanol were added and the solution was heated to 100°C under an 
argon stream. After 5 ml of the green solution were evaporated, the stream was stopped 
and the solution was stirred at 100°C for a further 20 Min. After cooling the reaction was 
quenched under argon with 150 ml of a saturated ammonium chloride solution and 
extracted twice with 50 ml of dichloromethane. The organic layers were dried over sodium 
sulphate, filtered and concentrated. The residue was purified by column chromatography 
(silica gel, 5*25 cm, Hex:EE 8:1+0.1% Et3N) to yield 65 mg (97%) red solid 41. 
Analysis: 
Yield: quantitative. 
TLC (silica gel, Hex:EE 8:1): Rf= 0.6 (UV
+, Vis+). 
MALDI-TOF: M=1168 (M)+. 
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UV-Vis (CDCl3): l = 416 nm (100%), 510 nm (7.7%), 576 nm (1.2%), 544 nm (2.1%) 
1H-NMR (600 MHz, CDCl3, RT): the signal attribution was made with help of COSY, 
NOESY and ROESY and TOCSY spectra. 
d: 10.1 (s, H10,20, 2H); 8.31 (d, J = 9, H4', 2H); 8.14 (d, J = 8, H5', 2H); 8.05 (d, J = 8, H8', 
2H); 7.54 (d, J = 9, H3', 2H); 7.52 (t, J = 8, H6', 2H); 7.38 (t, J = 7.2, H7', 2H); 6.13 (s, 
H3”,5”, 2H); 4.05 (m, CH2a, 4H), 3.88 (t, J = 7.4, CH2a, 4H); 3.75 (t, J = 7.9, CH2a', 4H); 
2.19 (s: CH3pyrrole, 12H); 2.08 (qui, J = 7.5, CH2b,, 8H); 1.66 (sext, J = 7.6, CH2g, 8H); 1.02 
(t, J = 7.2, CH3d,, 12 H); 0.88 (s, H2”’, 9H); 0.5 (m, CH2b', g', 8H); -2.03 (br, NHporphyrin, 2H); 
-3.01 (s, SH, 1H). 
13C-NMR (150 MHz, CDCl3, RT): 157.8: C2'; 147.3: C1”; 146.7: C4,6,14,16;; 143.7: C1,9,11,19; 
141.8: C2,8,12,,18; 140.5: C2”,6”; 138.3: C4'a; 136.3: C3,7,13,17; 131.0: C4' 130.1 C1a'; 128.3: C5'; 
127.7: C7'; 127.2: C8'; 125.6: C2”,6”; 124.81: C6'; 121.7: C3”,5”; 118.3: C3', 112.2: C5,15; 97.3: 
C10; 72.0: Ca” '; 36.2: Cb;, 34.9: C1”'; 31.9: C2”'; 28.5: Cb’; 27.2: Ca; 24.4: Cg; 24.0: Cg'; 
14.90: Cd; 14.3: CH3pyrrole. 
 
5,15-{(6-naphthyl-[4-tert-butyl-2-N,N-thiolato-1,3-phenylen)-bis-(trimethylenoxy)-di-
2,1-phenylen]}-3,7,17,27-tetrabutyl-2,8,12,18-tetramethyl-porphyrinato iron (III) 
(32): 
To 11.2 mg (10 mmol, 1 eq) 5 were added in a Schlenk tube 21.57 mg (0.1 mmol, 10 eq) 
FeBr2 and 27.9 ml (0.2 mmol, 20 eq) triethylamine and 3 ml of toluene. The mixture was 
degassed three times in the high vacuum and refluxed for one hour. Subsequently the 
reaction was filtered over celite and concentrated. The residue was further purified through 
column chromatography silica gel, 2*15 cm, Hex:EE 8:1,) under argon to yield 32 as a 
brown solid. 
Analysis: 
Yield: 89%. 
TLC (silica gel, Hex:EE 4:1): Rf= 0.65 (UV
+, Vis+). 
MS (MALDI-TOF): M=1174 (M)+. 
UV-Vis (toluene): l = 406 nm (100%), 486 ( %); 578 ( %); 582 ( %). 
ESR( 10K, toluene): g//= 5.809 and and g^=3.098 (br) for five coordination state and g//= 
8.347 and g^=2.006 for six coordination state. 
Cyclic voltammetry: E0=-660 mV vs SCE in DMF at RT. 
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5,15-{(6-naphthyl-[4-tert-butyl-2-N,N-dimethyloxythiocarbamoyl-1,3-phenylen)-bis-
(trimethylenoxy)-di-2,1-phenylen]}-3,7,17,27-tetrabutyl-2,8,12,18-tetramethyl-
porphyrin (42): 
To a solution of 44 mg (50 mmol, 1 eq) 39 in 45 ml abs. DMF was added under argon 
556.9 mg (1.71 mmol, 34 eq) cesium carbonate and the suspension was stirred at 80 °C (oil 
bath temperature) for 30 Min. Then 30.8 mg (60 mmol, 1.2 eq) 16 in 5 ml abs. DMF were 
added within 3 hours. After cooling the reaction mixture was diluted with 50 ml 4N HCl 
and extracted four times with 25 ml TBME. The combined organic layers were then 
washed twice with an aqueous saturated NaHCO3 solution, dried over Na2SO4, filtered and 
evaporated. The crude product was purified by column chromatography (silica gel, 3*20 
cm, Hex:EE 4:1+0.1% Et3N) to yield 30.9 mg (51.5%) red solid 42. 
Analysis: 
Yield: 51.5%. 
TLC (silica gel, Hex:EE 7:1).: Rf=0.44 (UV
+, Vis+). 
MS (MALDI-TOF): M=1194 (M)+. 
UV-Vis (CDCl3): l = 416 nm (100%), 510 (9.7%); 578 (4.7%); 542 (4.3%). 
1H-NMR (300 MHz, CDCl3, RT): the signals were attributed by COSY, TOCSY, NOESY 
experiments. d: 10.12 (s, H20, 1H); 9.7 (s, H10, 1H); 8.3 (d, J =9.1, H4', 2H); 8.13 (d, J = 
8.0, H5', 2H); 7.93 (d, J = 8.0, H8', 2H); 7.56 (d, J = 8.0, H3', 2H); 7.54 (t, J = 8.0, H6', 2H); 
7.35 (td, 1J = 8.0, 2J = 0.76, H7', 2H); 6.24 (s, H3”,5”, 2H); 4.1-3.8 (m, Ha,a', 12H); 2.22 (s, 
CH3pyrrole attached to C3,17, 6H); 2.2 (s, N(CH3)2, 3H); 2.17 (s, CH3pyrrole attached to C7,13, 
6H); 2.08 (qui, J = 7.4, Hb, 8H); 1.75 (sext, J = 7.4, Hg, 8H); 1.28 (s, H2'“, 9H); 1.11 (t, J = 
7.4, Hd, 8H); 1-0.78 (m, Hb’, 2H); 0.72-0.5 (m, Hb’, 2H); 0.3 (m, Hg’, 2H); 0.02 (m, Hg’, 
2H); -1.73 (s, N(CH3)2, 3H); -2.2 (s, NHporphyrin, 2H). 
13C-NMR (75 MHz, CDCl3, RT): the signals were attributed by HMBC and HMQC 
experiments. 184.8: C=S; 158.2: C2'; 146.79: C4”; 146.55: C4,16; 146.28: C6,14,1”; 143.32: 
C1,9,11,19; 141.62: C2,18; 141.43: C8,12; 137.77: C4'a; 136.09: C3,17; 135.63: C7,13; 131.04: C4'; 
129.72: C1'a; 128.19: C5'; 128.13: C7'; 127.54: C8'; 127.39: C2”,6”; 127.14: C1'; 124.43: C6'; 
121.79: C3”,5”; 117.91: C3'; 111.63: C5,15; 97.08: C10; 96.21: C20; 71.82: Ca”; 42.24: NCH3; 
36.17: NCH3; 35.64: Cb; 34.6: Cb'; 34.35: C1”'; 32.09: C2”'; 30.12: Cg”; 28.56: Cb”; 26.96: 
Ca; 26.72: Ca'; 23.81: Cg; 23.77: Cg'; 14.67: Cd; 14.42: Cd'; 14.15: CH3 attached to C3,17; 
13.94: CH3 attached to C7.,13. 
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5,15-{(6-naphthyl-[4-tert-butyl-2-hydroxy-1,3-phenylen)-bis-(trimethylenoxy)-di-2,1-
phenylen]}-3,7,17,27-tetrabutyl-2,8,12,18-tetramethyl-porphyrin (43): 
To a solution of 15 mg (12.6 mmol, 1 eq) 42 in 5 ml abs. dioxane was added 36.5 mg   
(0.38 mmol, 30 eq) potassium methoxide and the suspension was stirred at 90°C (oil bath 
temperature) for 3 hours. After cooling the mixture was diluted with saturated ammonium 
chloride solution and extracted three times with TBME. Then the combined organic layers 
were dried over sodium sulphate, filtered and evaporated. The residue was purified by 
column chromatography (silica gel, 2*15 cm, Hex:EE 8:1+0.1% Et3N) to yield 5.7 mg 
(41%) red solid 43. 
Analysis: 
Yield: 41%. 
TLC(silica gel, Hex:EE 7:1): Rf=0.44 (UV
+, Vis+). 
MS (MALDI-TOF): M=1105 (M)+. 
UV-Vis (CDCl3): l = 416 nm (100%), 512 (7.3%); 570 (2.8%); 546 (2.7%). 
1H-NMR (500 MHz, CDCl3, RT): the signals were attributed by COSY and NOESY 
experiments. d:10.17 (s, H10,20, 2H); 8.32 (d, J = 9.07, H4'; 2H); 8.14 (d, J = 7.5, H5', 2H); 
7.79 (d, J = 7.5, H8', 2H); 7.63 (d, J = 8.85, H3', 2H); 7.53 (t, J = 7.5, H6', 2H); 7.32 (td, 
1J = 
7.5, 2J = 0.9, H7', 2H); 5.95 (s, H3”,5”, 2H); 3.92 (m, Ha, 4H); 3.89 (t, J = 7.2, Ha’,4H); 3.84 
(m, Ha, 4H); 2.21 (s, CH3pyrrole, 12H); 2.1 (qui, J = 7.4; Hb, 8H); 1.68 (sext; J = 7.5, Hg', 
8H); 1.04 (t, J = 7.3, Hd, 12H); 0.79 (s, H2"’, 9H); 0.65 (m, Hb’, 4H); -0.4 (m, Hg’, 4H); -
2.19 (br, OH, NH porphyrin, 3H). 
13C-NMR (125 MHz, CDCl3, RT): the signals were attributed by HMQC and HMBC 
experiments. 157.8. C2'; 147.3: C1'; 146.7: C4,6,14,16; 143.7: C1,9,11,19; 141.8: C2,8,12,18; 140.5: 
C2”,6”; 138.3: C4'a; 136.3: C3,7,13,17; 131: C4', 130.1: C1'a; 128.4: C1'; 128.3: C5'; 127.8: C7'; 
127.2: C8'; 125.6: C2”,6”; 124.8: C6'; 121.7: C3”.5”; 118.3: C3', 112.2: C5,15; 97.3: C10,20; 72.0: 
Ca”; 36.2: Cb,b'; 34.9: C1”';31.9: C2” '; 28.5: Cb"'; 27.2: Ca,a'; 24.4: Cg” '; 24.0: Cg,g'; 14.9: Cd,g'; 
14.3: CH3pyrrole. 
 
5,15-{(6-naphthyl-[4-tert-butyl-2-hydroxy-1,3-phenylen)-bis-(trimethylenoxy)-di-2,1-
phenylen]}-3,7,17,27-tetrabutyl-2,8,12,18-tetramethyl-porphyrinato iron (III) (33): 
To 5.7 mg (5.15 mmol, 1 eq) 40 were added in a Schlenk tube 11.2 mg (0.05 mmol, 10 eq) 
iron (II) dibromide and 14.4 ml (0.10 mmol, 20 eq) triethylamine in 2 ml toluene. The 
mixture was degassed three times at high vacuum and stirred overnight at reflux and after 
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cooling filtered through celite. Then it was purified by column chromatography (silica gel, 
Hex:EE 8:1, 1*25 cm) to yield 10.1 mg (100%) green solid. 
Analysis: 
Yield: 100%. 
TLC (silica gel, Hex: EE 4:1): Rf= 0.5 (UV
+, Vis+). 
MS (MALDI-TOF): M=1158 (M)+. 
UV-Vis (toluene): l = 410 nm (100%, e= 14*104 M-1cm-1) 
ESR (10K, toluene): g//=5.831 and g^=2.008. 
Cyclic voltammetry: E0= -710 mV vs SCE in DMF at RT. 
 
A.3. Synthesis of the tailed models 34 and 35: 
 
a,b-[5-(6'-pivaloylamino-2'-methoxyphenyl)-15-(6’-pivaloylamino-2’-hydroxy-
phenyl)-3,7,13,17-tetrabutyl-2,8,12,18-tetramethyl-porphyrin] (48): 
50 mg (51.36 mmol, 1 eq) 17b were dissolved in 10 ml abs. DMF under a dry and inert 
atmosphere. 251 mg (0.77 mmol, 15 eq) cesium carbonate were added and the suspension 
was stirred at 70°C (oil bath temperature) for 30 min. After cooling at RT 2.88 ml (46.23 
mmol, 0.9 eq) methyliodide were added and the reaction mixture was stirred for 2.5 hr at 
RT. The reaction was quenched with 20 ml 10% aqueous HCl solution and the aqueous 
phase extracted three times with 20 ml CH2Cl2. The combined organic layers were dried 
over Na2SO4, filtered and concentrated. The crude product was purified by column 
chromatography (silica gel, 3*25 cm, Hex: EE 6:1 +1% Et3N) to yield 18.1 mg (35.6%) 48 
as a violet powder. 
Analysis: 
Yield: 35.6%. 
TLC (silica gel, Hex: EE 4:1+1% Et3N): Rf=0.24 (UV
+, Vis+). 
MS (MALDI-TOF): M=987 (M)+. 
UV-Vis (CDCl3): l = 408 nm (100%), 512 (7.3%); 570 (2.8%); 546 (2.7%). 
1H-NMR (600 MHz, CDCl3, RT): the spectrum was interpreted with support of NOESY, 
COSY and TOCSY spectra. d: 10.29 (s, H10,20, 2H); 8.49 (d, J = 8.54, H5’(Ar with OMe), 
1H); 8.42 (d, J = 8.47 Hz, H5’ (Ar with OH), 1H); 7.84 (t, J = 8.57, H4’ (Ar with OMe), 
1H); 7.75 (t, J = 8.47, H4’ (Ar with OH t, 1H); 7.18 (d, J = 8.44Hz, H3’ (Ar with OH) 1H); 
7.16 (d, J = 8.57, H4’ (Ar with OMe), 1H); 6.96 (s, NHPiv (Ar with OMe), 1H); 6.94 (s, 
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NHPiv (Ar with OH), 1H); 4.09-3.95 (m, CH2a, 8H); 3.64 (s, OCH3, 3H); 2.70 (s, 
CH3pyrrole (on C3,7), 6H); 2.62 (s, CH3pyrrole (on C13,17), 6H); 2.26-2.16 (m, CH2b, 8H); 1.78-
1.71 (m, CH2g, 8H); 1.12-1.09 (m, CH3d, 12H):; -0.02 (s, NHC(O)C(CH3)3 (Ar with OH), 
9H); -0.05 (s, NHC(O)C(CH3)3 (Ar with OMe), 9H); -2.04 (s, NHporphyrin, 2H). 
13C-NMR (150 MHz, CDCl3, RT): 176.92: C=O (Ar with OMe); 176.82: C=O (Ar with 
OH), 159.47: C2’ (Ar with OMe); 155.85: C2’ (Ar with OH); 145.83: C1,9; 145.63: C4,6; 
144.79: C2,8; 144.45:C14,68; 142.73: C1,9; 142.6: C11,19; 140.29: C1’ (Ar with OH); 139.81: 
C1’ (Ar with OH); 136.64: C3,7 (Ar with OMe); 136.19: C13,17 (Ar with OH); 131.59: C4’ 
(Ar with OH); 131.33: C4’ (Ar with OMe); 120.0: C6’ (Ar with OMe); 118.3: C6’ (Ar with 
OH); 114.1: C5’ (Ar with OMe); 113.3: C5’ (Ar with OH); 108.51: C3’ (Ar with OH); 
102.95: C10,20; 98.02: C5,15; 56.17: OMe; 39.45 and 39.46: C(CH3)3; 35.81: Cb; 26.71 and 
26.66: Ca and C(CH3)3; 23.55 and 23.53: Cg; 14.53 and 14.58: Cd; 13.76: CH3pyrrole. 
 
a,b-[5-(6'-pivaloylamino-2'-methoxy-phenyl)-15-(6’-pivaloylamino-2’-oxy-(2”-
propan-1”-S-N,N-dimethythiocarbamoyl-4”tert.butyl-phenylen)-phenyl)-3,7,13,17-
tetrabutyl-2,8,12,18-tetramethyl-porphyrin] (49): 
To 228 mg (0.231 mmol, 1eq) 41 in 200 ml abs.DMF were added under a dry and inert 
atmosphere 1.28g (3.92 mmol, 17 eq) cesium carbonate. The reaction mixture was stirred 
at 70°C (oil bath temperature) for 30 Min. 129.4 mg (0.346 mmol, 1.5 eq) 28 dissolved in 
15 ml abs. DMF were added within 10 Min. The reaction mixture was stirred for further 45 
Min at 70°C. After cooling at RT the reaction was quenched in 500 ml 10% aqueous HCl 
solution. The product was extracted three times with 100 ml diethylether and once with 50 
ml CH2Cl2 from the aqueous phase. The combined organic layers were dried over Na2SO4, 
filtered and concentrated. The crude product was purified by column chromatography 
(silica gel, 8*20 cm, Hex:EE 3:1+1% Et3N) to yield 252 mg (86.4%) 49 as a violet powder. 
Analysis: 
Yield: 86.4%. 
TLC (silica gel, Hex:EE 5:1 + 1% Et3N).: Rf=0.1 (UV
+, Vis+). 
MS (MALDI-TOF): M=1263 (M)+. 
UV-Vis (CH2Cl2): l = 410 nm (100%), 508 (9%); 540 (4.2%); 576 (4.4%) ; 660 (2.7%). 
1H-NMR (600 MHz, CDCl3, RT): the spectrum was interpreted with support of NOESY, 
COSY and TOCSY spectra. d: 10.20 (s, 2H): H10,20; 8.5 (d, J = 8.49, H5’ (Ar with OMe), 
1H); 8.43 (d, J = 8.44, H5’ (Ar with bridge), 1H); 7.82 (t, J = 8.58, H4’ (Ar with OMe ), 
1H); 7.77 (t, J = 8.57, H4’ (Ar with bridge), 1H); 7.13 (d, J = 7.84, H3’ (Ar with OMe), 
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1H); 7.12 (d, J = 7.98, H3’ (Ar with bridge), 1H); 7.11 (s, NHPiv (Ar with OMe), 1H); 6.96 
(s, H5”,6”, 2H); 6.81 (s, NHPiv (Ar with bridge), 1H); 6.67 (s, H3”, 1H); 4.02 (t, J = 7.64, 
CH2a’, 2H); 4.06-3.99 (m, CH2a (butyl chain on C2,8), 4H); 3.92-3.91 (m, CH2a (butyl 
chain on C12,18), 4H); 3.61 (s, OCH3, 3H); 2.63 (s, CH3pyrrole
 (on C13,17), 6H); 2.61 (s, 
CH3pyrrole
 (on C3,7), 6H); 2.47 (s, N(CH3)2, 3H); 2.27 (t, J = 7.6, CH2g’, 2H); 2.16 (qui, J = 
7.5, CH2b (butyl chain on C2,8), 4H); 2.12 (qui, J =7.5, CH2b (butyl chain on C12,18), 4H); 
1.73 (sext, J =7.6, CH2g (butyl chain on C2,8), 4H); 1.70 (sext, J =7.6, CH2g (butyl chain on 
C12,18), 4H); 1.6 (s, N(CH3)2, 3H); 1.49 (qui, J =7.79, CH2b’, 2H); 1.07 (t, J =7.79, CH3d 
(butyl chain on C2,8), 6H); 1.04 (t, J = 7.4, CH3d (butyl chain on C12,18), 6H); 0.88 (s, H2”’, 
9H); -0.02 (s, C(O)C(CH3)3 (Ar with OMe), 9H); -0.15 (s, C(O)C(CH3)3 (Ar with bridge), 
9H); -2.2 (s, NHporphyrin, 2H). 
13C-NMR (150 MHz, CDCl3, RT): 176.94: C=O (Ar with OMe; 176.89: C=O (Ar with 
bridge); 159.64: C2’ (Ar with OMe); 158.79: C2’ (Ar with bridge); 152.88: C4”’; 145.67: 
C4,6; 145.39: C14,16; 145.02: C1’”; 144.048: C1,9,11,19; 142.25 and 142.22: C2,7,11,17; 140.56: 
C1’ (Ar with bridge); 140.38: C1’ (Ar with OMe); 137.53: C6’”; 136.1: C3’ (Ar with bridge) 
and 135.98: C3’ (Ar with OMe); 131.14: C4’ (Ar with bridge); 131.01: C4’ (Ar with OMe); 
126.98: C3’”; 124.32: C5’”; 123.94:C5”’; 120.44: C6’ (Ar with bridge); 113.68: C6’ (Ar with 
OMe); 113.87: C5’ (Ar with bridge); 113.68: C5’ (Ar with OMe); 107.8: C3’ (Ar with 
bridge); 107.2: C3’ (Ar with OMe); 97.53: C5,15; 68.17: Ca’; 56.14: OCH3; 39.46 and 39.35: 
C(CH3)3; 35.84 and 35.8: Cb; 34.55: C(CH3)3 from bridge; 31.53 and 31.43: N(CH3)2 and 
Cg’; 31.16: C(CH3)3 from bridge; 30.09: Cg’; 26.71: Ca and C(CH3)3 from amide; 26.58: 
C(CH3)3 from amide; 23.59 and 23.51: Cg; 14.52 and 14.49: Cd; 13.8 and 13.73: CH3pyrrole. 
 
a,b-[5-(6'-pivaloylamino-2'-methoxy-phenyl)-15-(6’-pivaloylamino-2’-oxy-(2”-
propan-1”-S-N,N-dimethythiocarbamoyl-4”tert.butyl-phenylen)-phenyl)-3,7,13,17-
tetrabutyl-2,8,12,18-tetramethyl-porphyrin] (55): 
67 mg (0.68 mmol, 1 eq) 48 were dissolved in 30 ml abs. DMF under a dry, inert 
atmosphere. 751.7 mg (2.31 mmol, 34 eq) cesium carbonate were added and the reaction 
mixture was stirred to 70°C (oil bath temperature) for 30 Min. 23.24 mg (0.81 mmol, 1.2 
eq) 51 dissolved in 5 ml abs. DMF were added and the reaction was stirred for one hour at 
70°C. The reaction was quenched after cooling at RT with 100 ml 10% aqueous HCl 
solution. The product was extracted by three times 50 ml TBDME. The combined organic 
layers were dried over Na2SO4, filtered and concentrated. The crude product was purified 
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by column chromatography (silica gel, 5*25 cm, Hex:EE 5:1 + 1% Et3N) to yield 51.8 mg 
(65%) 55 as a violet powder. 
Analysis: 
Yield: 65%. 
TLC (silica gel, Hex:EE 5:1+1% Et3N).: Rf=0.25 (UV
+, Vis+). 
MS (MALDI-TOF): M=1175 (M-2)+. 
UV-Vis (CH2Cl2): l = 408 nm (100%), 508 (8.8%); 542 (4.2%); 576 (3.9%) ; 628 (2%). 
1H-NMR (600 MHz, CDCl3, RT): the spectrum was interpreted with support of NOESY, 
COSY and TOCSY spectra. d: 10.29 (s, 2H): H10,20; 8.5 (d, J = 8.53, H5’ (Ar with OMe), 
1H); 8.44 (d, J = 8.53, H5’ (Ar with bridge), 1H); 7.81 (t, J = 8.58, H4’ ( Ar with OMe), 
1H); 7.78 (t, J = 8.56, H4’ (Ar with bridge), 1H); 7.13 (d, J = 8.58, H3’ (Ar with OMe), 
1H); 7.12 (d, J = 8.44, H3’ (Ar with bridge), 1H); 7.09 (s, NHPiv (Ar with OMe), 1H); 6.85 
(s, NHPiv (Ar with bridge), 1H); 4.07-4.01 (m, CH2a (on C2,8), 2H); 3.98 (t, J = 7.14 Hz, 
CH2a’, 2H); 4.0-3.92 (m, CH2a (on C2,8,12,18), 6H); 3.60 (s, OCH3, 3H); 3.39 (s, N(CH3)2, 
3H); 3.01 (s, N(CH3)2, 3H); 2.61 (s, CH3pyrrole (on C3,7), 6H); 2.60 (s, CH3pyrrole (on C13,17), 
6H); 2.45 (t, J = 7.5, CH2e, 2H); 2.24-2.14 (m, CH2b, 8H); 1.77-1.70 (m, CH2g, 8H); 1.19 
(qui, J = 7.03, CH2b, 2H); 1.10 (t, J = 7.37, CH3d (on C12,18), 6H); 1.09 (t, J = 7.4, CH3d (on 
C2,8), 6H); 1.01 (qui, J = 7.63, CH2d’, 2H); 0.66 (qui, J = 7.69, CH2g”, 2H); -0.02 (s, 
C(O)C(CH3)3 (Ar with bridge), 9H); -0.01 (s, C(O)C(CH3)3 (Ar with OMe), 9H); -2.22 (s, 
NHporphyrin, 2H). 
13C-NMR (150 MHz, CDCl3, RT): 197.2: C=S; 176.70: C=O (Ar with OMe); 176.54: 
C=O (Ar with bridge); 159.27: C2’ (Ar with OMe); 158.5: C2’ (Ar with bridge); 145.30: C5’ 
(Ar with OMe); 145.06: C5’ (Ar with bridge); 144.08 and 144.01: C4,6,14,16; 142.25 and 
142.24: C1,9,11,19; 140.46 and 140.41: C3,7,13,17; 136.14 and 136.03: C1’; 131.12 and 131.05: 
C4’; 120.58 and 120.34: C6’; 113.88 and 113.73: C5’, 108.15: C3’ (Ar with OMe); 107.79 
and 107.27: C5,15; 107.14: C3’ (Ar with bridge); 97.56: C10,20; 68.45: Ca’; 56.13: OCH3; 
45.38: N(CH3)2; 39.5 and 39.39: C(CH3)3; 37.03: Ce’; 35.90 and 35.84: Cb; 28.49: Cb’; 
28.12: Cd’; 26.71: C(CH3)3; 26.71 and 26.60: Ca; 25.0: Cg’; 23.59 and 23.57: Cg; 14.55: Cd; 
13.76 and 13.74: CH3pyrrole. 
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Part B: Synthesis of the different bridge moieties. 
 
B.1. Bridge 15. 
The synthesis of bridge 15 was done from 23 by A. Pfiffner according to a literature 
procedure [62]. Therefore the synthesis of 15 is not reported. 
 
B.2. Bridge 16. 
The synthesis of 29 has been done by Dr. O. Forrer and was a generous gift from her. 
Therefore the synthesis is not reported here. 
 
O-(2,6-dimesyloxypropyl-4-tert-butyl-1-phenyl)-N,N-dimethylthiocarbamoyl (16): 
To a solution of 111.6 mg (0.31 mmol, 1 eq) 29 in 10 ml dry CH2Cl2 under argon was 
added at 0°C 105.6 ml (0.757 mmol, 2.4 eq) triethylamine and after 30 Min. 58.9 ml (0.757 
mmol, 2.4 eq) methanesulfonyl chloride. The solution was warmed to RT. and stirred for 
two hours. Then it was diluted with 10 ml CH2Cl2 and washed with 10 ml 4N HCl. The 
aquous phase was extracted further twice with CH2Cl2 and the combined organic layers 
were washed with brine, dried over sodium sulfate, filtered and evaporated. The residue 
was chromatographed ( SiO2, 3*20 cm, Hex:EE 1:1) to yield 62.7 mg (39%) colorless oil. 
Analysis: 
Yield: 39%. 
TLC: Rf=0.68 (Hex: EE 1: 2, 254
+). 
MS: M=510 (M)+ 
1H-NMR (300 MHz, CDCl3, RT): 
d: 7.16 (s, H3, 5, 2 H); 4.58 (t, J=2.54 Hz, H1”,2 H); 3.83 and 3.5 (2*m, H3”, 2*2 H); 3.75 
and 3.4 (2*m, Hg, 2*4 H); 3.05 (br, N(CH3)2, 6 H); 2.83 (m, Ha, 4 H); 1.93-1.8 (m, Hb,6”, 8 
H); 1.7-1.45 (m, H4”,5”, 8 H); 1.28 (s, H2’, 9 H). 
 
B.3. Bridge 47. 
4-tert-butyl-1-allyoxy-phenyl (24): 
The synthesis was done according to [70]. All spectroscopic characterizations are identical 
to the data reported. 
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2-allyl-4-tert-butyl-1-phenol (25): 
The synthesis was done according to [70]. All spectroscopic characterization are identical 
to the data reported 
 
2-allyl-4-tert-butyl-1-N,N,-dimethylthiocarbamoyloxy-phenyl (44): 
2 g (10.51 mmol, 1 eq.) 25 in 5 ml abs. DMF were added to the suspension and the 
solution was stirred further for 10 Min at RT until no hydrogen more evolved. To the 
brown solution was added 1.06 g (15.76 mmol, 2.1 eq.) N, N-dimethylthiocarbamoyl 
chloride at RT. The reaction mixture was then stirred at 70°C (oil bath temperature) for 3.5 
hr. After cooling to RT the solution was diluted with 100 ml aquous 10% NaOH solution 
and extracted three times with 30 ml diethylether. The combined organic layers were then 
washed three times with 50 ml of water, dried over Na2SO4, filtered over active charcoal 
and concentrated. The crude product was distilled under high vacuum in a Kugelrohr 
apparatus to yield 1.66 g (57%) 44 as a colorless oil. 
Analysis: 
Yield: 57% 
TLC (silica gel, Hex:EE 5:1): Rf=0.4 (254
+) 
MS (EI; 70eV): 277 M+ (8.6%); 205 [M-72]+ (22.6%); 88 [M-169] (100%); 72 [M-205] 
(80%); 57 [M-220]+ (20%). 
1H-NMR (CDCl3, 400 MHz): 7.3-7.2 (m, H3,5, 2H); 7.0 (d, J= 8.33 Hz, H6, 1H); 6.1-5.9 
(m, Hb, 1H); 5.2-5.1 (m, Hg, 2H); 3.45 (s, N(CH3)2, 3H); 3.35 (s, N(CH3)2, 3H); 3.44 (d, J= 
7.8 Hz, Ha, 2H); 1.3 (s C(CH3)3, 9H). 
13C-NMR (CDCl3, 101 MHz): 188: C=S; 150.24: C1; 149.3: C4; 136.85: C5; 131.96: C2; 
127.59: C6; 124.59: C3; 122.98: Cb; 116.30: Cg.; 43.66: N(CH3)2; 38.9: N(CH3)2; 35.4: Ca; 
34.92: C(CH3)3; 31.85: C(CH3)3. 
 
S-(2-allyl-4-tert-butyl-1-phenyl)-N,N-dimethylcarbmoyl (45): 
1.39 g (5.01 mmol, 1eq.) 44 were preheated at 120°C and pyrrolyzed in a quartz tube 
heated at 540°C under 3.10-2 mbar vacuum over 30 Min. The product collected on the 
cooling finger was then diluted with diethylether and transferred in a ballon. After 
evaporation of the solvent the crude product was purified by column chromatography 
(silica gel, 3*25cm, Hex:EE 5:1) to yield 988.3 mg (71%) 45 as an orange oil. 
Analysis: 
Yield: 71% 
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TLC (silica gel, Hex:EE 5:1): Rf=0.27 (254
+) 
MS (EI; 70eV): 277 M+ (7.3%); 237 [M-40]+ (15%); 205 [M-72]+ (17%); 72 [M-205]+ 
(100%); 57 [M-220]+ (27%). 
1H-NMR (CDCl3, 400 MHz): 7.4 (d, J= 8.05 Hz, H6, 1H); 7.3-7.2 (m, H3,5, 2H); 6.1-5.9 
(m, Hb, 1H); 5.1-5.0 (m, Hg, 2H); 3.5 (d, J= 7.5Hz, Ha, 2H); 3.15 (s (br), N(CH3)2, 3H); 
3.05 (s (br), N(CH3)2, 3H); 1.3 (s, C(CH3)3, 9H) 
13C-NMR (CDCl3, 101 MHz): the C=O signal has not been detected; 153.5: C1; 144.2: C4; 
137.6: C5,2; 127.4: C3; 124.48: Cb; 116.27: Cg; 39.23: N(CH3)2; 3734: Ca; 35.16: C(CH3)2; 
31.62: C(CH3)2. 
 
S-(2-oxypropyl-4-tert-butyl-1-phenyl)-N,N-dimethylcarbamoyl (46): 
832.3 mg (3 mmol, 1 eq.) 45 were dissolved in 5 ml dry THF under dry and inert 
atmosphere. To the solution were added at 0°C 540 ml ( 3.24 mmol, 1.8 eq.) BH3-Me2S 
complex. The solution was stirred for 3 hr at RT. Then 2.5 ml (7.5 mmol, 2.5 eq) aquous 
3M NaOH solution and 2.4 ml (7.5 mmol, 2.5 eq.) 30% aquous H2O2 solution were 
dropped slowly to keep the temperature below 10°C. The solution was then stirred for 1 hr 
at RT. The reaction mixture was diluted with 20 ml brine and extracted three times with 20 
ml diethylether. The combined organic layers were washed once more with 25 ml brine, 
dried over Na2SO4, filtered and concentrated. The crude product was dried at high vacuum 
to yield 797.1 mg (90%) 46 as a colorless oil. 
Analysis: 
Yield: 90% 
TLC (silica gel, Hex:EE 5:1): Rf=0.27 (254
+, Cer+) 
1H-NMR (DMSO, 400 MHz): 7.34-7.28 (m, H6, 3, 2H); 7.25-7.22 (m, H3, 1H); 4.42 (t, J= 
5.3 Hz, CH2g,,2H); 3.4 (qui, J=5.3 Hz, CH2b, 2H); 3.05 (s, (br), N(CH3)2, 3H); 2.95 (s (br), 
N(CH3)2, 3H); 2.7 (t, J= 5.3 Hz, CH2a, 2H); 1.25 (s, C(CH3)3, 9H). 
13C-NMR (DMSO, 101 MHz): 166.21: C=O; 153.2: C1; 146.85: C4; 138.08: C5; 127.37: 
C2; 125.17: C3; 124.25: C6; 61.2: Cg; 37.48: N(CH3)2; 35.24: N(CH3)2; 34.81: Ca; 31.85: 
C(CH3)2; 31.54: Cb. 
 
S-(2-mesyloxypropyl-4-tert-butyl-1-phenyl)-N,N-dimethylthiocarbamoyl (47): 
500 mg (1.69 mmol, 1 eq.) 46 were dissolved in 5 ml dried CH2Cl2 under a dry and inert 
atmosphere and cooled to 0°C. To the solution were added 283 ml (2.03 mmol, 1.2 eq.) 
triethylamine and the reaction mixture was stirred for 30 Min. 157.8 ml (2.03 mmol, 1.2 
 158
eq.) mesitylchloride were then added and the solution was stirred for 1 hr at RT. The 
solution was diluted with 10 ml CH2Cl2 and shaked with 10 ml aquous 10% HCl solution. 
The aquous layer was extracted twice with 5 ml CH2Cl2. The combined organic layers 
were then washed with twice 10 ml brine, dried over Na2SO4, filtered and concentrated. 
The crude product was purified by column chromatography (silica gel, 3*25 cm, 500 ml 
CH2Cl2 pure then CH2Cl2:MeOH 99:1) to yield 487 mg (77%) product which crystallized 
after one week at 5°C. 
Analysis: 
Yield: 77% 
TLC (silica gel, Hex:EE 5:1): Rf=0.27 (254
+) 
1H-NMR (DMSO, 400 MHz): 7.4-7.2 (m, H3,5,6, 3H); 4.18 (t, J=6.0 Hz, Hg, 2H); 3.15 (s, 
SO2(CH3), 3H); 3.17 (s (br), N(CH3)2, 3H); 2.9 (s (br), N(CH3)2, 3H); 2.75 (t, J= 6.0Hz, 
Ha, 2H); 1.9 (qui, J= 6Hz, Hb, 2H); 1.27 (s, C(CH3)3, 9H). 
13C-NMR (DMSO, 101 MHz): 165.21: C=O; 152.58: C1; 144.60: C4; 137.38: C5; 126.70: 
C2; 124.39: C3; 123.80: C6; 69.76: Cg; 36.56: N(CH3)2; 36.5: C(CH3)3; 34.63: N(CH3)2; 
34.63: Ca; 30.90: C(CH3)2; 29.96: Cb. (the C mesylate signal is propably masked by the 
DMSO solvent peaks) 
 
B.4. Bridge 54. 
d-thio valeric acid (51): 
9.3 g (50 mmol, 1 eq.) d-bromo valeric acid 50 were dissolved in 50 ml abs. ethanol. 3.8 g 
(50 mmol, 1 eq.) thiourea were added and the reaction mixture was refluxed for 3 hr. 35 ml 
(140 mmol, 2.8 eq.) 4N aquous NaOH solution were added and the solution was refluxed 
for further 2 hours. After cooling at RT the ethanol was removed under vacuum. The 
aquous solution was extracted once with 10 ml diethylether. The aquous phase was then 
acidified to pH=4.5 with 6 N HCl and extracted three times with 20 ml diethylether. The 
combined ether phases were dried over Na2SO4, filtered and concentrated. 5.95 g (89%) 34 
as a colorless oil were obtained. The crude product was used without further purification. 
Analysis: 
Yield: 89% 
TLC (silica gel, Hex:EE 5:1): Rf=0.27 (bromocresol green
+) 
1H-NMR (CDCl3, 400 MHz): 12.00 (s (br), COOH, 1H); 2.44 (t, J = 7.1, H5, 2H); 2.21 (s, 
SH, 1H); 2.19 (t, J = 7.5, H2, 2H); 1.6-1.5 (m, H3,4, 4H). 
13C-NMR (CDCl3, 101 MHz): 174.68: COOH; 33.46: C5; 24.07: C2; 23.8: C3; 23.63: C4. 
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d-S-N,N-dimethylthiocarbamoyl-valeric acid (52): 
500 mg (3.37 mmol, 1 eq) 51 were dissolved in 5 ml abs. pyridine under a dry inert 
atmosphere. 692 mg (1.5 mmol, 1.5 eq.) N,N-dimethythiocarbamoyl chloride were added 
to the solution. The reaction was stirred at 50°C for 2.0 hr. After cooling at RT the solution 
was poured in 10 ml water. The aquous phase extrated three times with 20 ml CH2Cl2. The 
combined organic layers were washed with brine, dried over Na2SO4, filtered and 
concentrated. The crude product was purified by distillation at high vaccuum (5.10-2 mbar, 
210°C) to yield 474 mg (57%) 35 as a colorless oil. 
Analysis: 
Yield: 57% 
TLC (silica gel, Hex:EE 5:1): Rf=0.27 (254
+) 
UV-Vis (CHCl3): l (nm): 277 (100%) 
MS (EI): 221 (M+) (28%), 121 (M-100)+ (70%), 88 (M-133)+ (100%) 
1H-NMR (CDCl3, 400 MHz): 11.97 (s (br), COOH, 1H); 3.43 (s, N(CH3)2, 3H); 3.32 (s, 
N(CH3)2, 3H); 3.19 (t, J = 7.1, H5, 2H); 2.22 (t, J = 7.3, H2, 2H); 1.6-1.5 (m, H3,4, 4H). 
13C-NMR (CDCl3, 101 MHz): 197: C(S); 175.07: C(O)OH; 37.16: C5; 34.06: N(CH3)2; 
28.79: C2; 24.64: C3,4. 
 
d-S-N,N-dimethylthiocarbamoyl-pentan-1-ol (53): 
To 11.5 mg (0.504 mmol, 1 eq.) 52 were added 604.5 ml (0.604 mmol, 1.2 eq.) 1M 
BH3.THF complex. After the end of gas evolution a yellow solution formed which was 
stirred for further 1 hr at RT. The solution was diluted with 5 ml diethylether and the 
resulting suspension was taken in 10 ml aquous 10% HCl solution. After separation of the 
organic layer the aquous phase was extracted three times with 5 ml diethylether. The 
combined organic layer were washed with 15 ml brine, then with water. After drying over 
Na2SO4 and filtration the solvent was evaporated. The crude product was purified by 
column chromatography (silica gel, 2*25 cm, CH2Cl2:MeOH 95:5) to yield 82.3 mg (79%) 
of a colorless oil. 
Analysis: 
Yield: 79% 
TLC (silica gel, Hex:EE 5:1): Rf=0.27 (254
+) 
MS (EI): 207 (M+) (8%); 174 (M-33)+ (6%), 121 (M-86)+ (68%); 88 (M-119)+ (100%) 
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1H-NMR (CDCl3, 400 MHz): 5.29 (s (br), OH, 1H); 3.66 (t, J = 6.45, H1, 2H); 3.54 and 
3.36 (s, N(CH3)2, 6H); 3.28 (t, J = 7.45, H5, 2H); 1.73 (qui, J = 7.45, H2, 2H); 1.61 (m, H4, 
2H); 1.49 (m, H3, 2H). 
13C-NMR (CDCl3, 101 MHz): 197.97: C(S); 63.13: C1; 37.16: C5; 35.64 and 31.82: 
N(CH3)2; 37.9: C5; 28.92: C4; 25.52: C3. 
 
d-S-N,N-dimethylthiocarbamoyl-1-mesityloxy-pentane (54): 
80 mg (0.385 mmol, 1 eq.) 53 were dissolved in dry CH2Cl2 under a dry and inert 
atmosphere. After cooling at 0°C 64.5 ml (0.463 mmol, 1.2 eq.) triethylamine were added 
and the solution was stirred for 15 Min. 36 ml (0.463 mmol, 1.2 eq) mesitylchloride were 
added and the solution was stirred 3 hr at RT. The reaction mixture was diluted with 5 ml 
CH2Cl2 and extracted with 5 ml of a 10% aquous HCl solution. The aquous phase was then 
extracted three times with 5 ml CH2Cl2 each. The combined organic layers were dried over 
Na2SO4, filtered and concentrated. The crude product was dried at high vacuum to yield 
109.3 mg (99%) yellow oil 37 which crystallized after a week at 5°C. 
Analysis: 
Yield: 99% 
TLC (silica gel, Hex:EE 5:1): Rf=0.27 (254
+) 
1H-NMR (CDCl3, 400 MHz): 4.24 (t, J = 6.44, H1, 2H); 3.55 and 3.37 (s, N(CH3)2, 3H); 
3.29 (t, J = 7.32, H5, 2H); 3.00 (s, OSO2CH3, 3H);1.85-1.75 (m, H2,3,4, 6H). 
13C-NMR (CDCl3, 101 MHz): 197.97: C(S); 70.18: OSO2CH3; 37.81: C1 and N(CH3)2; 
37.46: C5 and N(CH3)2; 29.06: C2; 28.65: C4; 25.14: C3. 
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Part C: Spectroscopic characterisation of iron complexes. 
 
Most of the results are to be found in the part Results and Discussion and are therefore not 
repeated here. Only experimental conditions are described or precised. 
 
C.1. UV-Vis spectroscopy 
All UV-Vis experiments have been recorded using a Helwett-Packard diode array 
spectrometer (see general remarks). The experiments have been saved on the UV-Vis 
computer, and additionally copied on a CD-ROM to allow future consultancy. For each file 
the solvent has been added in the commentary of the first spectra and for each spectra 
recorded in a file the added species and the time after initial measurement have been 
precised. 
Two kinds of experiments have been performed. The first experiment has been the 
determination of the absorption coefficient e for models 11 and 12. The second 
experiments are either quantitative or qualitative experiments to form complexes with the 
iron complexes. 
 
a) Determination of the absorption coefficient 
As porphyrin have a very large absorption coefficient ranging from 104-106 M-1 for their 
most intense absorption band a stock solution of the porphyrin to be studied has been 
prepared, having a concentration of 10-3 M. 
For the CPO model 11 the solution was prepared under argon to avoid oxidation of the 
compound. As a precaution the solution was kept under light exclusion for the same 
reason. After each probe prelevement for UV-Vis measurement the solution was flushed 
with argon. 
For the catalase model 12 the solution has been prepared without any special precaution 
regarding the obtention of an inert atmosphere. 
For each prepared concentration three probes have been measured to judge the 
reproducibility of the determination. When one result was obviously out of the measured 
range of the other two experiments (20% deviation) a fourth measurement has been 
performed. From the set of measures a linear regression has been performed. 
To refine the curve a graphic containing the data has been drawn. From this graphic the 
range of linearity i.e. the domain where the Beer-Lambert law applies- has been 
determined. From the set of measurements which were retained a novel linear regression 
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was done. If the obtained value of the linear regression coefficient was over 0.998 the 
obtained value of the slope was determined to be the absorption coefficient. If this was not 
the case, each set of three measurements plotted was examined and a “manual” trace was 
done to examine whether one value fits to the trace and was retained or if the average of 
the measured absorption had to be taken as value for determining the slope. From these 
new data the coefficient was recalculated. 
In both cases the variation of the absorption coefficient calculated has been less than 10% 
and whatever the calculation the regression coefficient was found to be above 0.997. 
The precision of the determination of the coefficient is estimated to be ±20%. 
 
b) Qualitative experiments 
To observe the changes which occurred by addition of a ligand, the ligand has first been 
added to the solution in a large excess to determine whether an effect was observed or not. 
When an effect has been observed a quantitative experiment has been performed to 
determine the minimum of equivalents required to get the effect. 
When the addition of a large excess resulted in the destruction of the porphyrin the added 
quantity was reduced at each trial by the half until either a change has been observed in the 
spectra or no change appeared in the spectra. In this case the time after addition has been 
recorded. 
c) Quantitative experiments 
A 2 ml solution having an absorbance of 1-1.5 has been prepared for quantitative 
experiments. The absorbance of the solution at “resting state” was measured to determine 
the quantity of porphyrin present in the solution. Then an exact equivalent quantity of a 
ligand was added and the change upon time of the spectra were recorded. 
 
C.2. EPR spectroscopy 
The EPR sample have been prepared so that an initial porphyrin concentration of 5 10-3 M 
has been obtained. This concentration represents the best compromise between a detectable 
EPR trace and the requirement of conserving an “isolated” magnetic state for each 
molecule. 
For the experiments a first record of a spectra was taken in Basel at 110 K including a 
resting state spectra and the spectra resulting upon addition of a ligand. From the same 
batch of porphyrin the experiment was repeated at 5 to 15K at the ETH of Zürich for the 
complex species. 
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The results are found in the part Results and Discussion. 
 
C.3. NMR spectroscopy 
The NMR experiments were conducted under the same concentration conditions as for 
EPR. The spectra for high spin species were recorded in three parts to cover the full range 
of chemical shifts concerned. 
The results are found in the Part Results and discussion. 
 
C.4. UV-Vis studies on the resting state 
For the resting state the influence of the solvent on the Soret has been determined using 
porphyrin solution having an absorbance of 1-1.6 AU. 
The results are shown in the next table: 
Compound: Solvent Soret Band (nm) 
CPO Model 11 methylene chloride 406 
 toluene 406 
 acetonitrile 406 
 DMSO 406 
Catalase model 12 methylene chloride 408 
 toluene 408 
 acetonitrile 406 
 DMSO 408 
 
Then the influence of the addition of acid to the porphyrin solution was examined in 
toluene. The results are summarized in the next table. When two absorption maxima are 
found due to broadening of the band the most intense maxima is underlined. 
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acid compound Soret band (nm) after addition Soret band initial (nm) 
11 402 406 
12 394 408 
32 402 408 
 
 
HBr 
33 400 408 
HCl 11 388 + 412 406 
 12 388+ 412 408 
 32 390+ 416 408 
 33 388 + 412 408 
 
 
C.5. HOCl and ClO- complexes 
The characterization of these complexes is found in part Results and Discussion. 
 
1. Oxo complexes 
The characterization of these complexes is found in the part Results and Discussion. 
 
2. Peroxy complexes 
The characterization of this complex of CPO model 11 is found in the part Results and 
Discussion. 
 
  
 
ANNEXES 
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Abbreviations. 
Å: Ångstrom  
AcOH: acetic acid 
Ala: Alanine 
AlCl3. aluminium chloride 
Arg: Arginine 
Asn: Aspargine 
Asp: aspartic acid 
AU: absorption unit 
BBr3: bortribromide 
BCl3: bortrichloride 
BH3.Me2S: borhydride dimethylsulfide complex 
BH4: tetrahydrobiopterin 
13C: carbon 13 isotope 
CaM: calmodulin 
CDCl3: deutero chloroform 
°C: grade Celcius 
CH2Cl2: dichloromethane 
Cl-: chloride ion 
COSY: correlation spectroscopy 
CPO: Chloroperoxidase from Caldariomyces fumago 
CV: cyclic voltammetry 
CW: continuous wave 
Cys: cystein 
D: dimensional 
d: doublet (in NMR spectroscopy) 
dn: n deuterium atoms (in NMR solvent) 
d: chemical shift (in NMR spectroscopy) 
D: reflux 
dB: decibel 
DMF: dimethyl formamide 
DMSO: dimethyl sulfoxide 
e: absorption coefficent 
e-: electron 
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EE: ethyl acetate 
EI: electron impact 
ENDOR: electron nuclear double resonance spectroscopy 
ESEEM: electron spin echo enveloppe modulation spectroscopy 
EPR: electron paramagnetic resonance 
Eq.:equation 
eq or eq.: equivalent 
ESR: electron spin resonance 
Et3N: triethyl amine 
Et2O: diethylether 
eV: electron volt 
EXFAS: extended X-ray absorption fine structure 
FAB: fast atom bombardement 
FAD: flavin adenine dinucleotide (oxidized form) 
FADH2: flavin adenine dinucleotide (reduced form) 
FeBr2: iron dibormide 
FeCl3: iron (III) chloride 
FID: Free induction decay 
FMN: flavin mononucleotide 
FT: Fourier transformation 
g: ESR g value 
GHz: Gigahertz 
Gly: glycine 
Glu: glutamic acid 
h: Plank’s constant 
É: reduced Plank’s constant 
H+: proton 
1H: proton 
HBr: hydrobromic acid 
HCl: hydrochloric acid 
HETCOR: heteronuclear correlation spectroscopy 
Hex. hexane 
His: histidine 
HMBC: heteronuclear multiple bond correlation spectroscopy 
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HMQC: heteronuclear multiple-quantum coherence correlation spectroscopy 
H2O2: hydrogen peroxide 
HOCl: hypochlorite acid 
HOMO: highest occupied molecular orbital 
HPLC: high performance liquid chromatography 
hr: hour 
HRP: horseradish peroxidase 
Hz: Hertz 
Ile: isoleucine 
J: coupling constant (in NMR spectra) 
K: grade Kelvin 
KOMe: potassium methylate 
LiAlH4: lithium aluminium hydride 
LiBR: lithium bormide 
LiClO4. lithium perchlorate 
l: wavelength 
LUMO: lowest unoccupied molecular orbital 
M: mole 
m: multiplet (in NMR spectra) 
m: meta 
m: middle 
M-1: per mole 
MALDI-TOF: matrix assisted desorption time of flight spectroscopy 
mCPBA: meta-chlorperbenzoic acid 
Me: methyl 
MeCN: acetonitrile 
mg: milligramm 
Min: minutes 
ml: milliliter 
mM: millimole 
Me3OBF4. trimethyloxy tetrafluoroboride 
MeOH: methanol 
MO: molecular orbital 
MS: mass spectroscopy 
Ms: mesyl 
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MSCl: mesylchloride 
MTHF: 2-methyltetrahydrofuran 
mV: millivolt 
mW: milliwatt 
MW: molecular weight 
N: normality 
15N: nitrogen isotope 15 
NMR: nuclear magnetic resonance spectroscopy 
NAD+: nicotineamide adenine dinucleotide (oxidized form) 
NADP+: nicotinamide adenine dinucleotide phosphate (oxidized form) 
NADH: nicotineamide adenine dinucleotide (reduced form) 
NADPH: nicotinamide adenine dinucleotide phosphate (reduced form) 
NaH: natrium hydride 
NaOH: natrium hydroxide 
NHA: N-hydroxyarginine 
nm: nanometer 
NO or .NO: nitirc oxide 
NOE: nuclear overhauser enhancement 
NOS: Nitric oxide synthase 
NOESY: nuclear overhausen spectroscopy 
O2: oxygen 
O2
.-: superoxide ion 
o: ortho 
-OCl: hypochlorite 
p: para 
P450: cytochrome P450 
Phe: phenylalanine 
Piv: pivaloyl 
ppm: part per million 
Pro: proline 
Q: quadrupole splitting parameter (in Mössbauer spectroscopy) 
qua: quadruplet (in NMR spectroscopy) 
qui: quintuplet (in NMR spectroscopy) 
Rf: retention factor (chromatography) 
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RF: radio frequency 
ROESY: reversed Overhouser enhancement spectroscopy 
RT: room temperature (295K) 
Rt: retention time (in HPLC) 
s: singulet (in NMR spectroscopy) 
s: strong 
s: second 
s-1: per second 
Ser. serine 
sext. sextuplet (in NMR spectroscopy) 
SCE: standard calomel electrode 
SOD: super oxide dismutase 
t: triplet (in NMR spectroscopy) 
TBME: tertbutylmethylether 
tert: tertiary 
Thr. threonine 
TLC: thin layer chromatography 
TMS: tetramethylsilane 
TpivPP: tetra-[ortho-(pivaloylamino)phenyl porphyrin 
TPP: tetraphenylporphyrin 
TO: turnover 
TOCSY: total correlated spectroscopy 
Tyr: tyrosine 
UV-Vis: ultra-violet visible 
Val: valine 
V/V: volume to volume 
vol: volume 
w. weak 
Xaa: amino acid undefined 
Xhy: amino acid with hydrophobic character 
 170
References. 
 
[1]: a) J.C. Kendrew, P.J Pauling,. Proc.Roy.Soc (London), 1956, 237A, 255-276, b) H. 
Scouloudi, Nature, 1959, 183, 374-376, c) H. Scouloudi, Proc.Roy.Soc. (London), 
1960, A258, 181-201. 
[2]: W. Küster, Hoppe-Seyler’s, Z.Physiol.Chem, 1912, 82, 433-463. 
[3]: H. Fischer, K. Zeile, Ann.Chem., 1929, 468, 58-98. 
[4]: M. Sono, M.P. Roach, E.D. Coulter, J.H. Dawson, Chem.Rev., 1996, 96, 2841-2887. 
[5]: D.R. Morris, L.P. Hager, J.biol.Chem., 1966, 241, 1763-1768. 
[6]: M. Feelish, J.S. Stamler in Methods in Nitric Oxide research, Wiley &Sons, 1996. 
[7]: J.A. Peterson, S.E. Graham, Structure, 1998, 6, 1079-1086. 
[8]: M. Sundaramoorthy, J.M. Mauro, A.M. Sullivan, J. Terner, Acta Cryst., 1995, D51, 
842-844. 
[9]: P.L. Feldman, O.W. Griffith, D.J. Stuehr, C&EN News, 1993, Dec 20, 26-38. 
[10]: M. Sundaramoorthy, J. Terner, T. L. Poulos, Structure, 1995, 3, 1367-1377. 
[11]: T.L. Poulos, B.C. Finzel, I.C. Gunsalus, G.C. Wagner, J. Kraut, J.Biol.Chem, 1985, 
260, 16122-16130. 
[12]: C.A. Hasemann, K.G. Ravichandran, J.A. Peterson, J. Deisenhofer, J.Mol.Biol., 
1994, 236, 1169-1185. 
[13]: K.G. Ravichandran, S.S. Boddu Palli, C.A. Hasemann, J.A. Peterson, J. Deisenhofer, 
Science, 1993, 61, 731-736. 
[14]: J.R. Cupp-Vickery, T.L. Poulos, Struct.Biol., 1995, 2, 144-153. 
[15]: S.Y. Park, H.Shimizu, S-I. Adachi, A. Nakagawa, I. Tanaka, K. Nakahara, H. Shoun, 
E. Obayashi, H. Nakamura, T. Lizuka, Y. Shiro, Natural Stuctural Biology, 1997, 4, 
827-832. 
[16]: B.R. Crane, A.S. Arvai, D.K. Gosh, C. Wu, E.D. Getzoff, D.J. Stuehr, J.A. Tainer, 
Science, 1998, 279, 2121-2126. 
[17]: P.R. Ortiz de Montellano, in Cytochrome P450. Structure, Mechanism and 
Biochemistry., 2nd ed., Plenum, New York, 1995, pp 537-574. 
[18]: I. Schlichting, J. Berendzen, K. Chu, A.M. Stock, S.A., Maves, D.E. Benson, R.M. 
Sweet, D. Ring, G.A. Petsko, S.G. Sligar, Science, 2000, 287, 1615-1622. 
[19]: R. Raag, T.L. Poulos, Biochemistry, 1989, 28, 917-922. 
[20]: H.A. Wagenknecht, Dissertation, Universität Basel, 1998. 
 171
[21]: S. Nagano, M. Tanaka, Y. Watanabe, I. Morishima, Biophys.Biochem.Res.Commun., 
1995, 207, 417-423. 
[22]: M.R.N. Murthy, T.J. Reid, A. Sicignano, N. Tanaka, G. Rossman, J.Mol.Biol., 1981, 
152, 465-499. 
[23]: P-F. Chen, A-H. Tsai, V. berka, K.K. Wu, J.Biol.Chem., 1997, 272, 6114-6118. 
[24]: a) M. Humberg, I. Björkhem, J.Biol.Chem., 1971, 246, 7411-7416 b) S. Shapiro, J.U. 
Piper, E. Caspi, J.Am.Chem.Soc, 1986, 104, 2301-2305. 
[25]: J.T. Groves, J.Chem.Edu., 1985, 62, 928-931. 
[26]: S. Shaik, M. Filatov, D. Schröder, H. Schwarz, Chem.Eur.J., 1998, 4, 193-199. 
[27]: N. Harris, S. Cohen, M. Filatov, F. Ogliaro, S. Shaik, Angew.Chem., 2000, 112, 
2070-2074. 
[28]: M. Newcomb, R. Shen, S.-Y. Choi, P.H. Toy, P.F. Hollenberg, A.D.N. Vaz, M.J. 
Coon, J.Am.Chem. Soc., 2000, 122, 2677-2686. 
[29]: M.A. Marletta, J.Biol.Chem., 1993, 268, 12231-12234. 
[30]: A.R. Hurshman, C. Krebs, D.E. Edmondson, B.H. Huynh, M.A. Marletta, Biochem., 
1999, 38, 15689-15696. 
[31]: C.C.-Y. Wang, H.M. Douglas, J.T. Groves, J.Am.Chem.Soc, 1999, 121, 12094-
12103. 
[32]: R.D. Libby, A.L. Shedd, A.K. Phipps, T.M. Beachy, S.M. Gertsberger, J.Mol.Biol., 
1992, 267, 1769-1775.  
[33]: M.T. Green, J.Am.Chem.Soc., 1999, 121, 7939-7940. 
[34]:T.L.Poulos, J. Kraut, J.Am.Chem.Soc., 1980, 255, 8199-8205. 
[35]: A. Deisseroth, A.L. Dounce, Phys.Review, 1970, 50, 319-375. 
[36]: M.R.N. Murthy, T.J. Reid, A. Sicignano, N. Tanaka, G. Rossmann, J.Mol.Biol., 
1981, 152, 465-499. 
[37]: B.K.Vainshtein, W.R. Melik-Adamyan, V.V. Barynin, A.A. Vagin, A.I.Grebenko, 
V.V. Borisov, K.S. Bartels, I. Fita, M.G. Rossmann, J.Mol.Biol., 1986, 188, 49-cc. 
[38]: E.F. Yusifov, A.I. Grebenko, V.V. Barynin, A.A. Vagin, W.R. Melik-Adamyan, 
Sov.Phys.Crystallogr., 1989, 34, 1451-1456. 
[39]: R.J.M. Corral, H.M. Rodman, J. Margolis, B.R. Landau, J.Biol.Chem., 1974, 249, 
3181-3182. 
[40]: D.Keilin, E.F. Hartree, Proc.Roy.Soc., 1937, Ser. B, 173. 
[41]: J.B. Sommer, A.L. Dounce, Science, 1937, 85, 366-367. 
[42]: A.G. Malmon, Biochim.Biophys.Acta, 1957, 26, 233-240. 
 172
[43]: M. Weissbluth in Structure and Bonding, Springer Verlag, Berlin, Vol 2, pp 8-10. 
[44]: A. L. Blach, Coord.Chem.Rev., 2000, 202-202, 349-377. 
[45]: I. Fita, M.G. Rossann, J.Mol.Biol., 1985, 185, 21-37. 
[46]: J. Everse, K.E. Everse, M.B: Grisham, in Peroxidase in Chemistry and Biology, CRC 
Press, Boca Raton, 1991, Vol 1. 
[47]: G.R. Schonbaum, B. Chance in The enzymes, PD Boyer ed., 1976, Vol 13, pp 408-
463. 
[48]: B. Chance, J.Biol.Chem., 1949, 180, 947-959. 
[49]: B.Chance, J.Biol:chem., 1952, 194, 471-481. 
[50]: L.L. Ingraham in Biochemical mechanisms, Wiley, New York, 1962, p 71. 
[51]: D. Dolphin, A. Forman, D.C. Borg, J.Fayer, R.H. Felton, Proc.Natl.Sci.U.S., 1971, 
614-618. 
[52]: G.A. Hamilton, Adv.Enzymol., 1969, 32, 55-96. 
[53]: R.C. Jarnagin, J.H. Wang, J.Am.Chem.Soc., 1958, 80, 6477-6481.  
[54]: A.W. Wagenknecht, W.D. Woggon, Chem.Biol., 1997, 4, 367-372. 
[55]: for a review on heme models see: F.A. Walker, Iron porphyrin chemmistry in 
Encyclopedia of inorganic chemistry, B.R. King Ed., 1987 and references therein. 
[56]: W.D. Woggon, Topic in Current Chemistry, 1996, 184, 40-96. 
[57]: B. Stäubli, Dissertation, Zürich, 1989. 
[58]: B.Boitrel, A. Lecas, Z. Renko, E.Rose, New.J.Chem, 1989, 13, 73-.99 
[59]: Y. Naruta, F. Tani, N. Ishibara, K. Maruyama, J.Am.Chem.Soc., 1991, 113, 6865-
6872. 
[60]: B. Garcia, C-H. Lee, A. Blaskó. T.C. Bruice, J.Am.Chem.Soc., 1991, 113, 8118-
8126. 
[61]: A. Robert, B. Loock, M. Momenteau, B. Meunier, Inorg.Chem., 1991, 30, 706-711. 
[62]: T. Leifels, W-D. Woggon, in preparation. 
[63]: E. Baciocchi, T. Boshi, L. Cassioli, C. Galli, L. Jaquinod, A. Lapi, R. Paolesse, K.M. 
Smith, P. Tagliatesta, Eur.J.Org.Chem, 1999, 3281-3286. 
[64]: C. Claude, H.A. Wagenknecht, W-D. Woggon, Helv.Chem.Acta, 1998, 81, 1506-
1520. 
[65]: A. Blaskó, B. Garcia, T.C. Bruice, J.Org.Chem., 1993, 58, 5738-5747. 
[66]: R. Belal, M. Momenteau, B. Meunier, J.Chem.Soc., Chem.Commun., 1989, 409-411. 
[67]: H. Aissaoui, Dissertation, Basel, 1999. 
 173
[68]: H. Aissaoui, S. Ghirlanda, C. Gmür, W-D. Woggon, Journal of molecular catalysis A 
Chemical, 1996, 113, 393-402. 
[69]: A.W. Wagenknecht, W-D. Woggon, Angew. Chem., 1997, 109, 404-407. 
[70]: B. Saübli, H. Fretz, U. Piantini, W-D. Woggon, Helv.Chim.Acta, 1987, 70, 1173-
1193. 
[71]: L.K. Gottwald, E.F. Ullman, Tetrahedron Lett., 1969, 36, 3071-3074. 
[72]: H.Ogoshi, H. Sugimoto, T. Nishiguchi, T. Watanabe, Y. Matsuda, Z-I. Yoshida, 
Chemistry Letters, 1978, 29-32. 
[73]: R.Young, C.K. Chang, J.Am.Chem. Soc., 1985, 107, 898-909. 
[74]: J.P. Collman, R.R. Gagne, C.A. Reed, T.R. Halbert, G. Lang, W.T. Robinson, 
J.Am.Chem.Soc., 1975, 97, 1427-1439. 
[75]: M.J. Gunter, L.N. Mander, J.Org.Chem., 1981, 46, 4792-4795. 
[76]: R. Boitrel, E. Camilleri, Y. Fleche, A. Lecas, E. Rose, Terahedron Lett., 1989, 30, 
29323-2926. 
[77]: Y. Aoyama, K. Saita, H. Toi, H. Ogoshi, Tetrahedron Lett., 1987, 28, 4853-4856. 
[78]: M.A. Lisicki, P.K. Mishra, A.A. Bohthner-By, J.S. Lindsey, J.Phys.Chem., 1988, 92, 
3400-3403. 
[79]: J.A. Shelnutt, X-Z. Song, J-G. Ma, S-L. Jia, W. Jentzen, C.J. Medforth, Chem.Soc. 
Rev., 1998, 27, 31-41. 
[80]: C.G. Kalodimos, I.O. Gerothanassis, J.Am.Chem.Soc., 1998, 120, 6407-6408. 
[81]: a) see ref 15, b) R.A. Freitag, J.A. Mercer-Smith, D.G. Whitten, J.Am.Chem.Soc., 
1981, 103, 1226-1230. 
[82]: O. Forrer, Dissertation, Basel, 1999. 
[83]: L. Mu, postdoctoral work, Basel, 2000. 
[84]: G. Scherer, Dissertation, Freiburg im Breisgau, 1990. 
[85]: J.P. Collman, R.C. Gagne, C.A. Reed, T.R. Halbert, G. Lang, W.T. Robinson, J.Am. 
Chem.Soc., 1975, 97, 1427-1439. 
[86]: J.A. Shelnutt, C.J. Medforth, M.D. Berber, K.M. Barkigia, K.M. Smith, 
J.Am.Chem.Soc., 1991, 113, 4077-4087. 
[87]: the optimization was done using the molecular modelling software Chemdraw 3D 
and the force field program MM2. 
[88]: S.H. Pine in Organic Chemistry, Mc Graw Hill international editions, 5th Ed.,1987, 
365 
[89]: A.M.F. Ueberwasser, Dissertation, Zürich, 1995. 
 174
[90]: T. Inaba, I. Umezawa, M. Yuasa, T. Inoue, S. Mihashi, H. Itokawa, K. Ogura, 
J.Org.Chem, 1987, 52, 2957-2958. 
[91]: A.B.J. Parusel, T. Wondimagegn, A. Gosh, J.Am.Chem.Soc., 2000, 122, 6371-6374. 
[92]: a) S.G. DiMagno, A.K. Wertsching, C.R. Koss, J.Am.Chem.Soc., 1995, 117, 8279; b) 
ibid.,1994, 116, 8344; c) S.G. DiMagno, R.A. Williams, M.J. Therein, J.Org.Chem., 
1994, 59, 6943. 
[93]: S.H. Pine in Orgenic Chemistry, Mc Graw Hill International Editions, 5th Edition, 
281 and 295. 
[94]: J.T. Green in Protective goup in organic chemistry, Academic Press New York. 
[94]: H. Aissaoui, personal communication. 
[96]: J.L. Soret, Compt.Rend., 1883, 97, 1267. 
[97]: L.K. Hanson, W.A. Eaton, S.G. Sligar, I.C. Gunsalus, M. Gouterman, C.R. Connell, 
J.Am.Chem.Soc., 1976, 98, 2672-2674. 
[98]: J.P. Collman, T.N. Sorrell, B.M. Hoffman, J.Am.Chem.Soc., 1975, 97, 913-914. 
[99]: I. Bertini, C. Luchina, in NMR of Paramagnetic Molecules in Biological Systems, 
Physical Bioinorganic Chemistry series,A.B.P. Lever and H.B. Gray eds, 1986. 
[100]: R.U. Cheng, L. Latos-Grazynski, A.L. Balch, Inorg.Chem., 1982, 21, 2412-2418. 
[101]: D.L. Budd, G.N. La Mar, K.C. Langry, K.M. Smith, R. Nayyir-Mazhir, 
J.Am.Chem.Soc., 1979, 101, 6091-6096. 
[102]: G.N. La Mar, D.L. Budd, K.M. Smith, K.C. Langry, J.Am.Chem.Soc., 1980, 102, 
1822-1827. 
[103]: R.D. Arasasingham, A.L. Balch, C.R. Cornman, J.S. de Ropp, K. Egushi, G.N. La 
Mar, Inorg.Chem., 1990, 29, 1847-1850. 
[104]: L. Bianci, I. Bertini, S. Marconi, R. Pierattelli, S.G. Sligar, J.Am.Chem.Soc., 1994, 
116, 4866-4873. 
[105]: For review see: H.M. Schwarz, J.R. Bolton, D.G. Borg in Biological Applications of 
Electron Spin Resonance, Wiley&sons Eds., 1972, Chapter one. 
[106]: For review see: J. Hütterman, R. Kappl, in Metal Ions in Biological Systems, H. 
Sigel Ed., 1987, Vol 22, 1-80. 
[107]: P.F. Hollenberg, L.P. Hager, W.E. Blumberg, J. Peisach, , J.Biol.Chem., 1980, 255, 
4801-4807. 
[108]: H. Aissaoui, R. Bachmann, A. Schweiger, W-D. Woggon, 3rd European ESR 
Meeting, Leipzig, 1997, 24-29 August. 
[109]: H. Aissaoui, R. Bachmann, unpublished results. 
 175
[110]: J.D. Liscomb, Biochemistry, 1980, 19, 3590-3599. 
[111]: A-L. Tsai, V Berka, P-F. Chen, G. Palmer, J.Biol.Chem., 1996, 271, 32563-32571. 
[112]: T.L. Poulos, B.C. Finzel, A.J. Howard, Biochemistry, 1986, 25, 5314-5322. 
[113]: J.R. Pilbrow in Transition Ion in Electron paramagnetic Paramagnetic Resonanc, 
Clarendon Press, Oxford, ISBN 0-19-855214-9, 129. 
[114]: S. Stoll, A. Schweiger, in preparation. 
[115]: G. Feher, in Electron Paramagnetic Resonance with Application to Selected 
Problems in Biology”, Gordon& Breach Science publishers, 1970, chapter II, 48-77. 
[116]: H. Rein, O. Ristau, F. Hackenbergger, F. Jung, Biochim.Biophys.Acta, 1968, 167, 
538-546. 
[117]: Measurement taken from the structures found in the Cambridge crystallographic 
database. 
[118]: L. Mu, W-D. Woggon, in preparation. 
[119]: S. Yoshioka, S. Takahashi, K. Ishimori, I. Morishima, J.Inorg.Biochem., 2000, 81, 
141-151. 
[120]: T. Ueno, N. Nishikawa, S. Moroyama, S. Adachi, K. Lee, T. Okumura, N. Ueyama, 
A. Nakamura, Inorg.Chem., 1999, 38, 1199-1210. 
[121]: N. Ueyama, N. Nishikawa, Y. Yamada, T. Okumura, T. Nakamura, 
J.Am.Chem.Soc., 1996, 118, 12826-12827. 
[122]: N. Ueyama, N. Nishikawa, Y. Yamada, T. Okumura, S. Oka, H. Sakurai, A. 
Nakamura, Inorg.Chem., 1998, 37, 2415-2421. 
[123]: R. Bachmann, personal communication 
[124]: C. Brewer, Inorg.Chim.Acta., 1988, 150, 189-192 and ref 1 to 5 therein. 
[125]: L. Weber, G. Haufe, Z.Chem., 1989, 3, 88-100. 
[126]: A.W. van der Made, J.W.H. Smeetes, R.J.M. Nolte, W. Drenth, 
J.Chem.Soc.Chem.Commun., 1983, 1205-1206 
[127]: T. Wolter, W. Meyer-Klaucke, M. Mürther, D. Mandon, H. Winkler, A.X. 
Trautwein, R. Weiss, J.Inorg.Biochem., 2000, 78, 117-122 
[128]: a) J.T. Groves, T.E. Nemo, J.Am.Chem.Soc., 1983, 105, 5786-5791; b) ibid, 1979, 
101, 6243-6248. 
[129]: S. Wolowiec, L. Latos-Grazynski, Inorg.Chem, 1998, 37, 2984-2988 
[130]: H. Fuji, T. Yoshimura, H. Kamada, Inorg. Chem., 1997, 36, 6142-6143. 
[131]: Blumberg, J. Peisach, B.A. Wittenberg, J.B.J. Wittenberg, Biol. Chem., 1968, 243, 
1854-1862. 
 176
[132]: D. Dolphin, A. Forman, D.G. Borg, J. Fajer, R.H. Felton, Proc.Nat Aca.Sci, 1971, 
69, 614-618 
[133]: T.H. Moss, A. Ehrenberg, A.J. Bearden, Biochemistry, 1969, 8, 4159-4162. 
[134]: W.J. Chuang, H.E. Van Wart, J. Biol.Chem., 1992, 267, 13295-13301. 
[135]: J.E. Penner-Hahn, K.S. Eble, T:J: MacMurry, M. Renner, A.L. Blach, J.T: Groves, 
J.H. Dawson, K.O. Hodgson, J.Am.Chem.Soc., 1986, 108, 7819-7825. 
[136]: A.L. Bach, L. Letos-Grazynski, M.W. Rennner, J.Am.Chem.Soc., 1985, 107, 2983-
2985. 
[137]: J.T. Groves, Y. Watanabe, J.Am.Chem.Soc., 1986, 108, 7834-7836. 
[138]: J.N. Burstyn, J.A. Roe, A.R. Miksztal, B.A. Shaevitz, G. Lang, J.S. Valentine, 
J.Am.Chem.Soc., 1988, 110, 1382-1388. 
[139]: S. Sligar, 5th Conference of Bioinorganic chemistry, Toulouse, July 17th-20th, 2000 
[140]: E. McCandisch, A.R. Miksztal, M. Nappa, A.Q. Sprenger, J.S. Valentine, J.D. 
Stong, T.G. Spiro, J.Am.Chem.Soc, 1980, 102, 4268-4271 
[141]: C.H. Welborn, D. Dolphin, B.R. James, J.Am.Chem.Soc., 1981, 103, 2869-2871 
[142]: M. Selke, J.S. Valentine, J.Am.Chem.Soc., 1998, 120, 2652-2653. 
[143]: A. Zuberbühler, S. Kaderli, C. Claude, unpublished experiments. 
 177
Acknowledgments 
 
I would like to thank the persons without who this work would not have this final form. 
Particularly the collaboration with Stefan Stoll from Prof. Arthur Schweiger’s group at the 
ETH Zürich was decisive in the confirmation and refinement of the results obtained in 
Basel. 
In Basel the work done by Dr. Gerd Scherer, NMR departement of the chemistry 
departement, provided key results during the synthesis and characterization of the 
intermediates and final products. His competence, useful discussions and correction of the 
manuscript were essential for this work. 
I would like to thank Prof. Th. Kaden for having been the co referent of this work. 
I thank for their service and disponibility the technical staff of the university Basel: the 
analytical departement with Dr. Nadig for the measurement of mass spectra, the 
“Werkstatt”: Mr. Cabrera, Kohler and Maier, for their numerous interventions on the 
material, the “Materialausgabe”: Mr. Vogel, Böhler and Mrs. Huber for providing and 
ordering the products and the secretaries Mrs Mambelli-Johnson and Rieser for solving 
administrative problems. 
I am deptful for the synthesis of key intemediates to Andreas Pfiffner and to the students 
who worked for me: Marc Bornand, Michael Müller, Remo Stohler, Fabian Stapf and 
Andrea Studer. 
Thanks also to the members of Prof. Woggon’s group for the good relationship during my 
work. Particularly appreciated and of good remember are Dr. Hamed Aissaoui for his 
helpful discussions, “moral” and technical support, Dr. Richard French for his computer 
and practical knowledges. 
 
Finally I am deptful to the Swiss National Fundation for Science for a grant from Sept 
1996 to Sept 1998 and to the Kanton Basel Stadt for an assistentship position from October 
1998 until October 2000. 
 178
Lebenslauf 
 
 
Name: CLAUDE 
Vorname: Cécile 
Geburtsdatum:  11.12.1973 
Nationalität: Frankreich 
Zivilstand: Ledig 
 
Ausbildung: 
11/04/2001: Dissertationsprüfung mit dem Prädikat „cum laude“ 
09/1996-10/2000: Dissertationsarbeit unter der Leitung von Prof. Dr. Wolf-Dietrich 
Woggon, Institut für organische Chemie der Universität Basel (Schweiz) 
„Enzyme models of Chloroperoxidase and catalase“ 
09/1995-07/1996: Diplom in Feinchemikalien, Universität Rouen (Frankreich) 
„Synthese und Charakterisierung von Phosphorhaltigen Verbindungen 
und deren Anwendung in der Wittig-Horner Reaktion“ 
09/1993-07/1996: Spezialisierung in “Feinchemikalien und Ingenieurswesen”, I.N.S.A. 
(Institut National des Sciences Appliquées), Rouen (Frankreich) 
Ingenieursdiplom in „Feinchemikalien und Ingenieurswesen“ 
09/1991-08/1993: Ingenieurstudien, I.N.S.A., Lyon (Frankreich) 
Besuch einer europäischen Ingenieursausbildung 
07/1996:  Matura Typ C (Mathemathik und Physik-Chemie) mit dem Predikat 
„sehr gut“ 
 
Berufserfahrung: 
Seit 11/2000: ZLB Bioplasma AG, Bern (Schweiz) 
Validierungspezialistin 
10/1998-10/2000: Universität Basel, Institut für organische Chemie, Basel (Schweiz) 
Assistentin der Hauptfachpraktika in organischer Chemie 
03/1995-07/1995: Rhône-Poulenc Agrochimie, Centre de Recherche de La Dargoire, Lyon 
(Frankreich). 
„Synthese von Imidazolinonen als potentielle Fongiziden“ 
 179
Publikationen 
 
 
Poster: 
1. Claude, C., Mu, L., Woggon, W-D, 2000: Poster for the 5th EUROBIC Conference in 
Toulouse (F), (16-20th July 2000). 
2. Schweiger, A., Stoll, S., Claude, C., Woggon, W-D., 2000: Poster for the 42nd Rocky 
Mountain Conference on analytical Chemistry in Broomfield (Colorado), (July,30th-
August 3rd, 2000), abstract submitted. 
3. Claude, C., Woggon, W-D., Towards Models for Catalase and P-450 Enzymes. 
Phenolate versus Thiolate Ligation to Iron Porphyrins., 1999, Poster for the Regio-
Symposium in Lucelles (F). 
 
Publications: 
1. Woggon, W-D., Wagenknecht, H-A., Claude, C., J.Bioinorg.Chem., 2000, 78, in 
press. 
2. Woggon, W-D., Aissaoui, A., Bachmann, R., Claude, C., Schweiger, A., 
Wagenknecht, H-A., 1998, Second Electronic Conference on Synthetic Organic 
Chemistry. 
3. Wagenknecht, H-A., Claude, C., Woggon, W-D., Helv.Chim.Acta, 1998, 81(8), 
1506-1520. 
 180
Eidesstattliche Erklärung. 
 
 
 
Ich erkläre, dass ich die Dissertation „Enzyme Models of Chloroperoxidase and Catalase“ 
nur mit der darin angegebenen Hilfe verfasst und bei keiner anderen Fakultät eingereicht 
habe. 
 
 
 
Basel, 19. März 2001 
 
 
 
Cécile CLAUDE. 
